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Summary
The protozoan parasite Trypanosoma brucei undergoes major differentiation 
events during its complex life cycle which involves the tsetse fly and mammal as obligate 
hosts. At the same time it alternates between proliferative and non-proliferative forms. In 
higher eukaryotes differentiation and the cell cycle are controlled by complex signalling 
networks many of which involve protein kinases as components and, by analogy, this 
would be expected to be the situation in T. brucei. However, very little is known about 
cellular signalling in this parasite and the work presented in this thesis is a study of two 
T. brucei protein kinases as an approach to the identification of pathways regulating 
differentiation and the cell cycle.
Two approaches were followed: firstly, the characterisation and purification of a 
60 kDa autophosphorylating protein kinase from T. brucei that was found to be 
expressed in a stage-specific manner (Hide et al., 1994). This protein kinase activity was 
found to localise in the 100 000 g supernatant of total extracts of bloodstream forms and 
this supernatant was used as the starting material for purification. Using anion-exchange 
chromatography as the first purification step, the autophosphorylating protein kinase was 
detected in two peaks of activity eluting at slightly different salt concentrations. A 
number of different chromatography matrices were then tested for their suitability in the 
further purification of the protein kinase and a further level of purification was achieved 
using a Sepharose to which the protein kinase inhibitor H-9 had been immobilised. In 
addition new assays for measuring activity were developed, one of which, based on 
autophosphorylation in solution was found to be robust and informative.
The second approach taken was to isolate and sequence a full length cDNA 
corresponding to an amplified cDNA fragment (Hua and Wang, 1994) for which the 
predicted peptide sequence showed homology to catalytic domain sequences of a rat 
protein kinase C family member and the Drosophila protein kinase polo. Isolation and 
sequencing of genes encoding T. brucei protein kinase C family members would provide 
valuable evidence for cell signalling in this parasite and provide tools to complement 
earlier studies on protein kinase C like activities in T. brucei (Keith et al., 1990). A clone 
was isolated in a screen of a ^ g tll cDNA library using a probe homologous to the 
original amplified cDNA fragment. Partial sequencing of the insert has shown that it is a 
chimaera of cDNAs for a ribosomal protein S4 homologue and for a protein kinase (this
part of the chimaera includes a section identical to the probe). Hybridisation of Southern 
blots of T. brucei genomic DNA to probes from the ribosomal protein and protein kinase 
coding regions, under high stringency conditions, shows that both sequences are of T. 
brucei origin but that the two sequences are not co-linear in the genome. Comparisons of 
the two predicted peptide sequences with protein sequences in the databases show that 
the open reading frames for both proteins are incomplete. The open reading frame for the 
protein kinase homologue is probably almost complete but there is no 3 ' stop codon. The 
5' coding sequence could be complete but there could be an upstream start codon not 
contained within the clone isolated. The putative protein kinase has all the defining 
features of a member of the polo-like kinase family and is clearly not a protein kinase C. 
Polo-like kinases are implicated in regulation of mitotic spindle formation and therefore 
mitosis, and the T. brucei enzyme would be worthy of further study given that mitosis 
and spindle formation are very different in T. brucei compared to higher eukaryotes.
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Chapter One
Introduction
1
1.1 Trypanosoma brucei
Trypanosoma brucei is a single-celled protozoan belonging to the Order Kinetoplastida, 
the defining feature of this Order being the kinetoplast, a specialised structure containing 
the mitochondrial DNA. T. brucei belongs to the Salivaria which are digenetic parasites 
transmitted by feeding tsetse flies. The other Section of Trypanosoma, the Stercoraria, 
which includes Trypanosoma cruzi (the agent of South American trypanosomiasis), are 
only very distantly related to T. brucei. The early evolutionary history of T. brucei and 
other trypanosomatids is currently controversial and it is not clear whether the ancestors 
of T. brucei first became parasitic in an invertebrate or vertebrate host (reviewed by 
Vickerman, 1994; Maslov and Simpson, 1995).
The classification of the Salivarian trypanosomes is summarised in Fig. 1.1. The 
T. brucei subspecies T. b. brucei, T. b. gambiense and T. b. rhodesiense belong to the 
subgenus Trypanozoon and are morphologically indistinguishable. They have 
traditionally been identified on the basis of their host range, the severity of the disease 
they cause in man, their infectivity to laboratory rodents and their geographical 
distribution. T. b. brucei which is found throughout the tsetse belt of Africa causes the 
disease nagana in cattle and also infects wild animals, but does not infect man. T. b. 
gambiense infects man causing chronic disease, infects laboratory rodents poorly and is 
found in West and Central Africa. T. b. rhodesiense infects man causing acute disease, 
but also infects wild and domestic animals as well as laboratory rodents and is found in 
East Africa (Hoare, 1972). However, many examples are known where these criteria 
have proved unsatisfactory and more recently techniques such as isoenzyme and DNA 
analysis have been used to try to define these subspecies (e.g. Hide et al., 1990; reviewed 
by Gibson, 1986). Among the other subgenera of Salivaria, T. congolense is particularly 
important as a pathogen of cattle. Human African trypanosomiasis occurs in 36 African 
countries in which a total of over 50 million people are at risk and about 25,000 new 
cases are reported annually, although this is probably an underestimate (Kuzoe, 1993). 
As well as causing disease in both humans and livestock, the threat from trypanosome- 
infected tsetse flies severely restricts the use of land that would otherwise be suitable for 
agriculture.
Trypanosoma brucei is among the best characterised protozoan parasites. As 
well as its importance as a pathogen, T. brucei is of interest as an organism that diverged
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very early from the main eukaryotic lineage (Sogin et al., 1989) and as a single cell that 
undergoes major differentiation events in alternating between mammalian and insect 
hosts. The life cycle of T. brucei species is outlined briefly in Section 1.1.1. In 
subsequent sections some of the unusual structures and processes of the trypanosome 
cell are described in more detail.
1.1.1 Life cycle
Fig. 1.2 (from Vickerman, 1985) shows the developmental cycle of Trypanosoma brucei 
species. Following injection of non-dividing metacyclic forms into the dermal tissue of 
the mammalian host by the feeding tsetse fly, the trypanosomes enter the draining 
lymphatics and bloodstream The trypanosomes differentiate into the slender bloodstream 
forms which divide with a doubling time of about 6 hours. The slender bloodstream 
forms are dependent on uptake of glucose from the host which they convert to pyruvate 
by glycolysis. The mitochondrion in these forms is small and lacks a functional 
tricarboxylic acid cycle. The bloodstream forms are vulnerable to the host immune 
system and antibody recognition results in parasite killing. However, the surface of the 
cell in the bloodstream stages is completely covered by a coat of variant surface 
glycoprotein (VSG) that in dividing bloodstream forms can be replaced by an 
antigenically different variant. In the simplest possible situation, during the time that 
parasitaemia is increasing, the majority of the population may express a single type of 
VSG (the “homotype”) to which the host mounts an immune response. As the antibody 
response becomes effective against the homotype the parasite population falls 
dramatically but one of the unrecognised “heterotypes”, previously expressed by only a 
few cells, outgrows the others to give rise to a new homotype. Therefore a chronic 
infection can develop with regular waves of parasitaemia. However, in most cases the 
situation is probably considerably more complex (reviewed by Barry and Turner, 1991).
The continuance of infection in the mammal depends on the cycle described 
above, but towards the end of each peak of parasitaemia a significant proportion of the 
population will consist of intermediate and short stumpy cells that are non-dividing as 
well as the dividing population of slender forms. These have a less elongate flagellum 
than the slender forms, and the mitochondrion is larger and has enzymes that will be 
needed in the insect procyclic stage where proline is the parasite’s major energy source.
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The differentiation process that produces these forms is not well understood but appears 
to be irreversible (Matthews and Gull, 1994a; Hamm et al., 1990). Cell division is 
probably required for VSG switching (Matthews and Gull, 1994a) so stumpy cells that 
remain within the mammalian host will eventually be cleared by the immune system due 
to their inability to change their surface coat. It is generally accepted that the stumpy 
forms represent a pre-adaptation for transmission to the tsetse fly, but the production of 
non-dividing stumpy forms may have a further advantage to the parasite as a way of 
limiting the population within the host, thereby reducing the danger of early host death. 
Stumpy forms can be produced in experimental infections in immunosuppressed animals 
(Balber, 1972), suggesting that VSG-specific antibodies cannot be the trigger for their 
production, although the production of stumpy forms may well involve an exogenous 
factor (Seed and Sechelski, 1989).
Blood ingested by the feeding tsetse passes through to the midgut where stumpy 
bloodstream forms transform into the procyclic form. The bloodmeal in the insect midgut 
is separated from the midgut epithelium by the chitinous peritrophic membrane (reviewed 
by Miller and Lehane, 1993) and differentiation of the trypanosomes occurs in the space 
between the membrane and the midgut wall. Whether the trypanosomes pass into the 
space at the posterior (open) end of the membrane or pass directly through the anterior 
membrane is currently controversial (Maudlin and Welbum, 1994). Death is likely to be 
the normal fate for slender bloodstream forms taken up in the bloodmeal although, in 
vitro, slender forms can differentiate through to established procyclics (Bass and Wang, 
1991; Matthews and Gull, 1994b). The differentiation events that occur include the loss 
of the VSG coat (Overath ef a/., 1983; Ziegelbauer et al., 1990; Ziegelbauer et al., 1993) 
and the appearance of a new invariant surface glycoprotein known as procyclin or PARP 
(Roditi et al., 1989; Roditi and Pearson, 1990). Body length also increases and the 
mitochondrion, partly activated in the stumpy form, undergoes further changes in 
structure and enzyme complement. The kinetoplast also changes its position from the 
extreme posterior of the cell to lie close to the nucleus. Concomitant with these 
differentiation events is re-entry into a dividing cell cycle (Matthews and Gull, 1994a+b) 
with the kinetoplast repositioning apparently occurring during S phase (Matthews et al., 
1995) but not requiring DNA synthesis (Matthews and Gull, 1994b).
After a few days procyclic cells begin to move to the ectoperitrophic space, the
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route taken in returning to the midgut again being controversial. This space becomes 
packed with parasites which continue to migrate towards the proventriculus. 
Proventricular forms are even more elongate than the early procyclics and have a smaller 
mitochondrial volume. How these cells then reach the salivary gland is not well 
understood (see review by Ellis, 1986), but proliferative epimastigote cells in the salivary 
glands attach themselves through the flagellum to the microvilli of the cells lining the 
lumen (Tetley and Vickerman, 1985). Genetic exchange occurs in the tsetse but is not an 
obligatory part of the life cycle (reviewed by Sternberg and Tait, 1990; Tait and Turner,
1990). Further differentiation processes eventually produce the mature metacyclic forms 
which are non-dividing and have a VSG coat, although these VSGs are distinct from 
those in the bloodstream forms (Graham et al., 1990). This is the form that is infective to 
the mammal.
For experimental purposes bloodstream form T. brucei can be obtained from 
infected laboratory rodents. Stocks described as pleomoiphic produce infections 
apparently similar to those of trypanosomes in their natural hosts. Many stocks that have 
been highly passaged have lost the ability to produce short stumpy forms and are 
described as monomorphic; these stocks rapidly kill their hosts due to very high 
parasitaemias of dividing slender forms. It is possible to induce some of these stocks to 
produce morphologically stumpy forms by the administration of the trypanocide DFMO 
to the rodent host. The differentiation of slender bloodstream or short stumpy 
bloodstream forms through to procyclic forms can be induced by incubation at 27 °C in 
medium containing citrate and cis-aconitate (Bran and Schonenberger, 1981; Bass and 
Wang, 1991). Cells morphologically and biochemically similar to dividing procyclic 
forms can be satisfactorily grown in culture.
1.1.2 Genome and gene expression
T. brucei is diploid with a haploid genome size estimated at 3-4 x 107 bp (Tait, 1980; 
Borst et al., 1980; Borst et al., 1982). The chromosomes do not undergo condensation 
at any life cycle stage but can be analysed by pulsed field gel electrophoresis and three 
size classes of chromosomes can be recognised. The large chromosomes range in size 
from 800 kb to 6 Mb (Van der Ploeg et al., 1989), the intermediate chromosomes from 
150 kb to 700 kb and minichromosomes from 50 kb to 150 kb (Van der Ploeg et al.,
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1984a). The diploid genome contains at least eighteen of these large chromosomes and 
probable homologous pairs have been identified, although these are not all of the same 
size (Gottesdiener et al., 1990; Bastian et al., 1995). The number of minichromosomes in 
T. brucei was estimated at about 100 (Van der Ploeg et al., 1984b), while T. vivax has 
very small numbers (Dickin and Gibson, 1989). The fimction of minichromosomes seems 
to be as a reservoir of VSG genes (Van der Ploeg et al., 1984b). The number of 
intermediate sized chromosomes (which also contain VSG genes) is small, but variable, 
and rearrangements in these chromosomes have been detected (Van der Ploeg et al., 
1984c). Intermediate and minichromosomes do not show Mendelian inheritance (see 
Sternberg and Tait, 1990).
The mitochondrial (kinetoplast) genome of T. brucei, as of other kinetoplastids, 
is highly unusual and consists of a concatenated network of DNA circles (Simpson, 
1987; Chen et al., 1995). In T. brucei there are 25-50 maxicircles and 5000-10000 
minicircles. The 22 kb maxicircle encodes at least 13 proteins and the 9S and 12S 
mitochondrial RNAs, while the minicircles are about 1 kb in size and probably do not 
encode proteins. The production of a number of the mature mitochondrial mRNAs 
involves a process known as RNA editing in which maxicircle transcripts (precursor 
mRNAs) are modified by the insertion or deletion of uridines. Transcripts from both 
maxicircles and minicircles, known as guide RNAs (gRNAs), act as templates directing 
these reactions (Seiwert and Stuart, 1994). Differential RNA editing between life cycle 
stages could contribute to the developmental regulation of the mitochondrion (Priest and 
Hajduk, 1994).
Nuclear gene structure and expression in T. brucei is markedly different from that 
of higher eukaryotes (see reviews by Pays et al., 1994; Graham, 1995; Vanhamme and 
Pays, 1995). The great majority of T. brucei genes for which genomic organisation and 
production of primary transcripts has been studied in detail are clustered in the genome 
in polycistronic transcription units with each unit being under the control of a 5' 
promoter. The only known exceptions to this rule are the transcription units for 
metacyclic VSGs which appear to be either monocistronic or contain a single gene in 
addition to the metacyclic VSG gene, and are probably transcriptionally regulated 
(Graham and Barry, 1991; Graham et al., 1993). The genes of each polycistronic 
transcription unit are separated by intergenic regions, but T. brucei protein coding genes
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do not contain introns. The processing of polycistronic precursor RNAs into 
monocistronic mRNAs involves the trans-splicing of a leader sequence (which caps the 
mRNA) at the 5' end of each message (Parsons et al., 1984; DeLange et al., 1984) and 
the addition of a 3' poly(A) tail. The spliced leader sequence added to the 5' end of each 
precursor RNA is 39 bp long but originates from a 141 bp SL RNA (Milhausen et al., 
1984). Trans-splicing is not unique to kinetoplastids but they are unusual in processing 
all pre-mRNAs in this way. Polyadenylation in T. brucei is directed by a very different 
mechanism to that of higher eukaryotes. Polyadenylation of one gene appears to be 
linked to the addition of the spliced leader to the next gene downstream in the 
transcription unit, and is at least partly directed by polypyrimidine tracts in the intergenic 
region (Hug et al., 1994). Gene expression in T. brucei has been most intensively studied 
for the bloodstream VSG genes and for the procyclic PARP genes, and these are the only 
protein-coding genes for which promoters have been identified. However, it is not clear 
to what extent the control mechanisms identified for these transcription units are typical, 
especially since the polymerases that transcribe the surface antigen genes are a-amanitin 
resistant (like poll), while most T. brucei genes are transcribed by a-amanitin sensitive 
polymerases. An important consequence of the organisation of T. brucei genes into 
polycistronic transcription units is that the rate of transcriptional initiation at the 
promoter cannot result in differential expression of genes within a transcription unit. 
However, many examples of differential expression of genes from within an individual 
transcription unit are known. It seems likely that in many cases the regulation is at the 
level of mRNA maturation or stability, although evidence has also been presented for the 
regulation of gene expression at the levels of translation (Gale et al., 1994b) and protein 
stability (T orrid  al., 1993).
In summary both genome structure and the regulation of gene expression are 
unusual in T. brucei compared to higher eukaryotes. The great majority of T. brucei 
genes appear to be clustered in polycistronic transcription units but differential 
expression of the genes within a transcription unit is common and T. brucei has to 
radically change the expression of a large number of genes in undergoing differentiation 
between life cycle stages. The expression of a number of genes, and particularly those 
encoding the bloodstream and procyclic surface antigens, has been studied in some detail 
but little is known about the DNA and RNA binding factors that must be involved in
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regulating gene expression.
1.1.3 Energy metabolism
T. brucei bloodstream forms have access to an abundant supply of glucose and convert 
this into pyruvate at an extremely high rate. A high glycolytic rate is essential because 
there is no Krebs cycle or mitochondrial ATP-synthesising respiratory chain (at least in 
slender forms) and only 2 moles of ATP are produced per mole of glucose consumed. 
The pyruvate produced is excreted into the host bloodstream In the procyclic forms 
proline is the preferred substrate (Evans and Brown, 1972) and the mitochondrion is 
active. Acetate and succinate are the metabolic products excreted (reviewed by Turrens, 
1991). The glycolytic enzymes of higher eukaryotes are cytoplasmic but, in all 
kinetoplastids that have been examined, the majority of the glycolytic enzymes are 
contained in a unique organelle, the glycosome. The glyco somes of T. brucei contain 
nine enzymes responsible for the conversion of glucose to 3-phosphoglycerate and 
glycerol, and in the bloodstream stage these account for over 90% of the organelle’s 
protein content (reviewed by Hannaert and Michels, 1994). The glycolytic reactions 
occurring in the glycosome result in no net ATP gain or loss but net ATP production 
occurs in the cytoplasm in the pyruvate kinase reaction. Under aerobic conditions the 
NADH produced is reoxidised via the glycerol-3-phosphate/di-hydroxyacetone 
phosphate shuttle linking glycolysis to a mitochondrial alternative oxidase without ATP 
synthesis, while under anaerobic conditions glycerol is excreted as well as pyruvate. The 
compartmentalisation of glycolytic enzymes in glycosomes, which occupy less than 5% 
of cellular volume, probably partly explains how bloodstream T. brucei sustain such high 
glycolytic rates. Glycosomes have a number of features in common with peroxisomes 
and glyoxysomes found in other eukaryotes (Sommer and Wang, 1994) and Michels and 
Hannaert (1994) have proposed that these microbodies may have a common 
endosymbiont ancestor.
In the procyclic insect stage a number of the glycosomal glycolytic enzymes are 
repressed and reoxidation of NADH produced by glycolysis uses a different pathway 
involving the fixation of CO2 in a reaction catalysed by phosphoenolpyruvate 
carboxykinase. The mitochondrion in the procyclic insect stage is cristate and has both 
cytochrome-mediated electron transport using a conventional cytochrome c oxidase and
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a complete citric acid cycle (see reviews by Turrens, 1991; Priest and Hajduk, 1994). 
Energy metabolism in the salivary gland forms is not well understood, but it is thought 
that mitochondrial activity is down-regulated in the mature metacyclics. The short 
stumpy bloodstream forms metabolise glucose to pyruvate and reoxidise NADH using 
the same pathway as long slender cells, but pyruvate dehydrogenase and a-ketoglutarate 
dehydrogenase are found while the mitochondrion is larger than in the slender forms and 
is cristate. Evidence has been presented that stumpy forms are able to generate an 
electromotive force across the inner mitochondrial membrane using NADH 
dehydrogenase which might be used for ATP production (Bienen et al., 1991). These 
changes are consistent with the short stumpy forms representing a pre-adaptation for 
transmission to the insect.
1.1.4 Cytoskeleton and cell cycle, cell surface, and flagellar pocket
The morphology of the procyclic form of T. brucei has been examined in some detail 
(see Sherwin and Gull, 1989a+b; Robinson and Gull, 1991; Robinson et al., 1995). T. 
brucei has a well defined shape which is determined by a subpellicular “corset” of 
microtubules running along the length of the cell. This cytoskeleton is very stable 
compared to that of many eukaryotes and the microtubules are cross-linked both to each 
other and to the cell membrane. It does not undergo extensive disassembly during the 
cell cycle and cell division in T. brucei is not symmetrical. The T. brucei cell cycle is also 
unusual in that as well as the nucleus the flagellum, basal body and mitochondrion are 
present in single copies and therefore have to be segregated accurately at cell division.
Fig. 1.3 panel A (from Sherwin and Gull, 1989a) summarises schematically the 
morphological changes occurring during the procyclic cell cycle as determined by 
electron and fluorescent microscopy (Sherwin and Gull, 1989a). Cells at the earliest 
stage of the cell cycle (I) have a single flagellum emerging from the cell body at a 
posterior position, with a pro-basal body lying next to the mature flagellar basal body. 
The nucleus is round in shape and is in the centre of the cell, while the kinetoplast is 
adjacent to the basal body. The next stage (II) is marked by the development of the pro- 
basal body which lies adjacent and posterior to the mature basal body. This is followed 
by the appearance of two new pro-basal bodies and the partial elongation of the daughter 
flagellum from the posterior basal body (stage HI). The daughter flagellum continues to
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elongate and, in the stage IV cell, its anterior end extends out of the flagellar pocket and 
possesses a paraflagellar rod (which runs alongside the flagellar axoneme) but has not 
reached its final length. In stage V the two basal bodies begin to move apart. Mitosis 
then begins while the nucleus still lies anterior to both basal bodies (VI), but the elongate 
nucleus later comes to he across the axis of the parent flagellum (VH). Stage V m  is 
marked by the completion of mitosis with the separated nuclei occupying very specific 
positions within the cell. A cleavage furrow then begins to form running towards the 
posterior of the dividing cell (IX) which elongates until the daughter cells are connected 
only at their posterior ends (X) before their final separation. It has been shown that the 
kinetoplast is physically linked to the basal body and that the movement apart of the old 
and new basal bodies is responsible for kinetoplast segregation (Robinson and Gull,
1991). In a study of various morphological parameters of the procyclic cell cycle 
Robinson et al. (1995) found that all of the increase in cell length occurring during cell 
cycle progression could be accounted for by an increase in the inter basal body distance 
(see Fig. 1.3 panel B). A number of other aspects of the cellular structure and cell cycle 
of T. brucei have also been examined including the elongation, nucleation and polarity of 
microtubules within the subpellicular array and flagellum (Sherwin and Gull, 1989b; 
Robinson et al., 1995), the repositioning the kinetoplast during in vitro differentiation of 
stumpy forms to procyclic forms (Matthews et al., 1995) and the timing of cell cycle 
events (Woodward and Gull, 1990). In summary a number of the basic features of the 
morphology of the procyclic form of T. brucei have been quite well studied and many of 
the findings described above are also likely to apply to other life cycle stages. The cell 
surface and flagellar pocket of the bloodstream forms of T. brucei are described in the 
next few paragraphs, in relation to the selective pressures imposed by the mammalian 
immune system
The cell surface of T. brucei is completely covered in a dense coat of VSG 
glycoproteins in the bloodstream and metacyclic stages. The VSG proteins consist of 
about 500 amino acids of which the first 20-40 amino acids are a signal sequence, the 
next 360 amino acids are the variable region, while the C-terminus of 110-120 amino 
acids is less variable (see Blum et al., 1993). The signal peptide and the C-terminal 17-23 
amino acids are cleaved off in the mature protein and a glycoconjugate, the GPI anchor, 
is added at the C-terminus (GPI anchors are reviewed by McConville and Ferguson,
10
1993 and Ferguson, 1994). In the membrane the VSG molecules associate as 
homodimers with the N-terminal end facing outwards and the GPI anchor inserted in the 
membrane bilayer. It is thought that the glycan part of the anchor lies across the 
membrane to form a “glycocalyx” which may play a part in determining the barrier 
properties of the surface coat. While the surface of the bloodstream T. brucei cell is 
covered by the VSG coat, bloodstream T. brucei are highly dependent on uptake of 
nutrients such as glucose (ter Kuile, 1993) and low-density lipoprotein (Coppens et al.,
1988), and these functions are known to involve specific cell surface receptors of which 
at least part of the extracellular domains must have invariant structure essential to ligand 
binding. Because of this, these receptors have to be “hidden” from the host immune 
system There is evidence that at least some invariant surface proteins fail to provoke a 
powerful immune response by virtue of being hidden beneath the protruding and tightly 
packed VSG proteins. Two proteins (ISG 65 and ISG 75) which are probably the most 
abundant surface proteins after VSG, are dispersed over the cell surface and, in spite of 
large predicted extracellular domains, are not readily accessible to antibodies (Overath et 
al., 1994). The idea that the lack of immune reactivity is due to the packing of the 
surface coat is consistent with the finding that the accessibility of these proteins to the 
small protease trypsin varied between clones expressing different VSGs. In spite of the 
shielding of invariant surface proteins beneath the VSG coat, it is possible that in a 
chronic infection an immune response to invariant surface proteins can be mounted. One 
strain of T. brucei has been found to have seven genes for ISG 75 with two isoforms 
being co-expressed. Overath et a l  (1994) have suggested that a possible reason for this 
might be to keep the concentration of identical ISG 75 molecules at a low level thereby 
reducing the chance of bivalent antibody binding. Slightly different variants of surface 
molecules such as nutrient receptors might also be expressed at different times and most 
of the genes that are co-transcribed with VSG genes (expression-site associated genes - 
ESAGs) encode known or putative surface proteins with the corresponding ESAGs of 
different expression sites being slightly variant. Borst (1991) proposed that the 
differences between corresponding ESAGs in different expression sites represents a 
mechanism for varying the cell surface in addition to and alongside VSG switching.
The greatest variety and concentration of invariant surface molecules are located 
in a particular cellular structure known as the flagellar pocket. This is the sole site of
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endocytosis in T. brucei (reviewed by Webster and Russell, 1993) and is buried in the 
cell body at the base of the flagellum. Individual proteins and protein complexes from the 
host have access to the walls of the flagellar pocket, but its structure ensures that while 
antibodies have access to proteins located in the pocket, antibodies bound at this site will 
not be able to stimulate macrophage killing of the parasite. In addition any antibodies 
that do bind will be rapidly endocytosed and so only a very strong antibody response is 
likely to activate host effector mechanisms (such as complement) or kill the parasite by 
preventing nutrient uptake. Bastin et al. (1994) found that one monoclonal antibody 
raised against a fragment of the T. brucei LDL-receptor could cause trypanosome lysis 
through activation of complement and its binding was inhibited by LDL. The flagellar 
pocket also appears to be the site targeted by a component of human serum that kills T. 
b. brucei species (Hajduk et al., 1994; Smith etal., 1995).
1.1.5 Chemotherapy of African trypanosomiasis
The current strategies for prevention and treatment of African trypanosomiasis are 
unsatisfactory. No vaccines have been developed that can defeat the ability of T. brucei 
to vary its surface coat, although as described above, some experiments in mice suggest 
that a vaccine against flagellar pocket components may not be completely out of the 
question (Bastin et a l, 1994). It might also be possible to develop a vaccine blocking 
transmission from the mammalian host to the tsetse since T. brucei ingested by the insect 
will differentiate to procyclic forms that express a number of invariant surface antigens 
while still exposed to the blood meal. A number of drugs are available for the treatment 
of African trypanosomiasis but these all have significant side effects.
The treatment of African trypanosomiasis has been recently reviewed (Pepin and 
Milord, 1994; Jemigan and Pearson, 1993). The aromatic diamidine pentamidine has 
been used in treating human trypanosomiasis for over 50 years and is still an important 
trypanocide. Its mode of action is unknown although a number of enzymes have been 
suggested as targets (see Berger et al., 1995). In in vitro experiments, T. brucei was 
found to rapidly accumulate the drug to a level much higher than the surrounding 
medium but the parasites were only killed relatively slowly (Berger et al., 1995). 
Pentamidine has been found to be effective in treating early-stage T. b. gambiense 
disease, especially in combination with suramin, but it is less effective in treating T. b.
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rhodesiense. A number of side-effects of pentamidine treatment can occur including 
hypotension, vomiting, rashes, and hypoglycaemia and when it was used on a large scale 
as a chemoprophylactic the estimated death rate due to the drug was 1 per 300,000. 
Another aromatic diamidine, diminazene, may be an effective treatment for disease 
caused by both T. b. gambiense and T. b. rhodesiense if used in the early stages of 
disease (see references in Pepin and Milord, 1994), but very little data is available on its 
effectiveness in humans.
Suramin is a sulphated naphthylamine which, like pentamidine, was developed 
more than half a century ago. Its mechanism of action is poorly understood since it 
inhibits a large number of enzymes (see Pepin and Milord, 1994) and it is unclear which 
of these are relevant to its action as a trypanocide. Suramin has two clusters of negative 
charges about 4 nm apart and it has been proposed that its inhibition of the glycosomal 
phosphoglycerate kinase is due to its interaction with two positively charged clusters in 
separate domains of the enzyme (Hart et al., 1989). Similar electrostatic interactions 
might explain its effects on other enzymes. It binds plasma proteins and persists in the 
body for some time. Suramin is used for early stage rhodesiense disease for which it is 
more effective than pentamidine but is also used in combination with pentamidine for 
treating early stage gambiense disease. Like pentamidine, it is not effective in treating 
late-stage disease when the parasites have entered the central nervous system, although 
the combination of suramin and eflomithine has been tested for the treatment of late- 
stage rhodesiense disease (Kuzoe, 1993). The possible side effects of suramin include 
fever, renal toxicity, and very occasionally anaphylactic shock.
Melarsoprol (Mel B) is a trivalent arsenical and is the most powerful trypanocide 
available. The predominant trypanocidal action of melarsoprol seems to be through its 
strong binding to trypanothione, a low molecular weight thiol compound unique to the 
kinetoplastids, which is involved in regulating intracellular thiol/disulphide redox balance 
(Henderson and Fairlamb, 1987; Fairlamb et al., 1989 Cunningham et al., 1994). 
However, exactly how interference with trypanothione metabolism kills the trypanosome 
is not folly understood. The importance of melarsoprol is in treating the later stages of 
disease where it has the advantage of being able to clear parasites from the central 
nervous system This may be due more to its strongly trypanocidal activity than to 
efficient crossing of the blood-brain barrier. Before the availability of melarsoprol there
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was no drug effective against the late stages of either form of human trypanosomiasis 
and the great majority of patients with infection in the central nervous system died. 
Unfortunately, melarsoprol has severe side effects, the most serious of which is an 
invariably fatal reactive encephalopathy occurring in 5-10% of cases. It is possible that 
some side effects of melarsoprol are due to immune responses to antigens released when 
the parasites die and it may be possible to reduce the likelihood of encephalopathy by co­
administration of other drugs (see Pepin and Milord, 1994), but this increases the 
complexity and cost of treatment. Because of its severe side effects the use of 
melarsoprol is avoided if possible, although for late-stage rhodesiense disease there is 
currently no other drug available.
Eflomithine (DFMO) reduces trypanosome polyamine synthesis by irreversibly 
inhibiting ornithine decarboxylase (see Schechter and Sjoerdsma, 1986; Wang, 1991). 
Administration of putrescine, spermidine, and spermine with the drug to experimentally 
infected animals prevents its curative effect. The drug crosses the blood-brain barrier and 
is effective against early and late-stage gambiense trypanosomiasis, often proving 
successful in patients infected with parasites resistant to arsenicals. Limited trials of 
eflomithine against late stage T. b. rhodesiense were not encouraging but its use in 
combination with suramin for treating this form of the disease has been investigated (see 
Kuzoe, 1993). The drug has unpleasant side-efifects but these are generally much less 
severe than those caused by arsenicals. A serious barrier to its widespread use is its high 
cost (~ $500 per patient) and melarsoprol is still the drug most commonly used to treat 
the later stages of disease.
In summary, the currently available drugs for the treatment of African 
trypanosomiasis are unsatisfactory. When trypanosomiasis is diagnosed early the 
combination of suramin and pentamidine for treating T. b. gambiense disease or suramin 
monotherapy for treating T. rhodesiense can be used (Pepin and Milord, 1994) but are 
quite toxic. However, the situation is much worse when the disease has spread to the 
central nervous system since one of the two drugs available, melarsoprol, is extremely 
toxic while the other, eflomithine, is too expensive for most African countries to be able 
to afford and is less effective against T. b. rhodesiense. Unfortunately, the diagnosis of 
African trypanosomiasis in its early stages is difficult and therefore there is a great need 
for new drugs effective against the later stages of disease.
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1.1.6 Summary
T. brucei has been the subject of intensive research and many of the basic features of its 
biology have been elucidated. Unusual features of its biology which are now reasonably 
well understood include polycistronic transcription and the processing of precursor 
RNAs by trans-splicing, the genetic control of VSG switching (see Pays et al., 1994), the 
structural organisation of the cell surface and underlying cytoskeleton, the 
compartmentalisation of glycolysis in glycosomes, the presence of the mitochondrial 
DNA as a concatenate of maxicircles and minicircles and the process of RNA editing. 
The differentiation events that T. brucei undergoes in adapting to different host 
environments have also received considerable research attention. This is particularly true 
for the transition from stumpy or slender bloodstream forms to the procyclic form for 
which both differentiation protocols and markers for following the progress of 
differentiation have been developed. However, very little is known about what signals 
initiate differentiation in vivo and how these are processed by the cell. By analogy with 
higher eukaryotes it would be expected that T. brucei might utilise signalling pathways 
involving protein phosphorylation in controlling such events. In higher eukaryotes the 
cell cycle is also controlled by regulatory networks involving protein phosphorylation 
and again by analogy the same might be true in T. brucei. As in many higher eukaryotes 
cellular differentiation and cell cycle progression can be controlled coordinately in T. 
brucei and both of the transmission competent forms (stumpies and metacyclics) are cell 
cycle arrested (see Mottram, 1994). Protein kinases in T. brucei are the general theme of 
the present work. However, since very little is known about protein kinases and protein 
phosphatases in T. brucei, while protein phosphorylation has been intensively researched 
in other biological systems, the next section is a general introduction to the field of 
protein phosphorylation in eukaryotes.
1.2 Protein phosphorylation in eukaryotes
Protein phosphorylation was first recognised as a mechanism for regulating enzyme 
activity in the 1950’s in work on the control of glycogen synthesis and breakdown. In 
characterising an enzyme that converts muscle glycogen phosphorylase from an inactive 
b form to an active a form, Krebs and Fischer (1956) found that its activity was
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dependent on ATP and Mg2+ or Mn2+ ions. When they used radiolabelled ATP in the 
reaction mixture, activation of glycogen phosphorylase was accompanied by its 
concomitant phosphate labelling. They also found that another enzyme, that inactivated 
glycogen phosphorylase, removed the radiolabel incorporated during activation. Since 
these early experiments, protein phosphorylation has been found to be one of the most 
common post-translational protein modifications that occurs in eukaryotes. Enzymes that 
catalyse the transfer of phosphate groups from a nucleotide donor to amino acids in 
proteins are known as protein kinases while enzymes catalysing the removal of such 
phosphate groups are known as protein phosphatases. The effects of phosphorylation on 
target proteins varies and multi-site phosphorylation can lead to combinatorial effects. In 
the case of a bacterial isocitrate dehydrogenase, which is inhibited by phosphorylation at 
a single serine, it has been shown that the phosphorylated residue is a substrate binding 
residue and that enzyme inhibition is due only to local effects (Hurley et al., 1990). 
However, for glycogen phosphorylase, the activating phosphorylation occurs away from 
the active site and causes significant conformational shifts in the enzyme dimers (Barford 
and Johnson, 1989). In higher eukaryotes, at least, protein phosphorylation is involved in 
regulating all kinds of cellular activities and many protein kinases and phosphatases are 
linked into networks. This control mechanism, involving distinct forward and backward 
reactions, has particular advantages where a protein’s activity has to be switched 
independent of large changes in the concentration of an effector molecule binding to that 
protein (see review by Hardie, 1995). The three major roles for protein phosphorylation 
pathways in higher eukaryotes are in the processing of extracellular signals such as 
hormone binding, the control of the cell cycle and the coordination of cellular responses 
to environmental stress.
Cloning of the genes for a large number of protein kinases and comparisons 
between the predicted peptide sequences has shown that nearly all known eukaryotic 
protein kinases belong to a single superfamily in which members are known to 
phosphorylate proteins on either serine, threonine, or tyrosine residues, or a combination 
of these. There are eukaryotic protein kinases that are not members of this main 
superfamily, but the term ‘^ protein kinase” will be used to mean a member of this 
superfamily unless otherwise stated. In mammals it has been estimated that the protein 
kinase genes collectively make up at least 1% of the coding capacity of the genome
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(Hunter, 1987; Hanks and Hunter, 1995a+b) and that there may also be several hundred 
protein phosphatase genes (Hunter, 1995).
Protein phosphatases are not considered below except in Section 1.3 (Protein 
phosphorylation in T. brucei). Briefly, the original classification of protein 
serine/threonine phosphatases was on the basis of biochemical properties (reviewed by 
Cohen, 1989), but it is now clear that protein phosphatases of classes 1, 2A, and 2B 
belong to the same superfamily while protein phosphatase 2C is either unrelated or very 
distantly related to PP1, PP2A, and PP2B (see review by Wera and Hemmings, 1995). 
Protein tyrosine phosphatases (PTPs) were reviewed by Stone and Dixon (1994), and 
dual-specificity protein phosphatases by Keyse (1995). Recently, crystal structures were 
published for mammalian PP1 (Goldberg et al., 1995), PP2B (Griffith et al., 1995) and 
PTP1B (Barford et al., 1994).
1.2.1 Protein kinase classification
Protein kinases cannot satisfactorily be classified on the basis of their substrate specificity 
since most protein kinases will phosphorylate a number of substrates which may or may 
not be physiologically relevant. Protein kinases have been grouped in a number of 
different ways, but now that many protein kinase sequences are available a phylogeny 
based on sequence comparisons can be used (see below). A more general system that 
includes all protein kinases of both eukaryotic and prokaryotic origin uses specificity for 
the acceptor amino acid as the basis for classification (see Hunter, 1991). The separate 
categorisation of protein kinases into those that phosphorylate on serine/threonine (E.C. 
2.7.10), and those that phosphorylate on tyrosine (E.C. 2.7.11) is now out of date as a 
number of protein kinases are known that phosphorylate on serine/threonine and tyrosine 
(dual-specificity protein kinases). However, the conventional protein tyrosine kinases 
remain a valid protein kinase family, the members of which phosphorylate exclusively 
tyrosine residues, possess particular catalytic domain sequence motifs (see Section 
1.2.2), and cluster as a group in catalytic domain phylogenetic analyses (Hanks and 
Hunter, 1995a+b). In addition to the protein kinases that phosphorylate on serine, 
threonine or tyrosine residues, a eukaryotic example of another class of protein kinases, 
defined originally in prokaryotes and known as “two-component systems”, has been 
identified in S. cerevisiae (Maeda et al., 1994; Chang et al., 1993; reviewed by Swanson
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et al., 1994). In these enzymes, an environmental stimulus causes a histidine kinase 
domain to autophosphorylate. The phosphate is then transferred to an aspartate in 
another domain, resulting in the activation of downstream events. While these kinases are 
unrelated to the main family of eukaryotic protein kinases, the S. cerevisiae two- 
component system is linked to a signalling cascade involving conventional protein 
kinases (Maeda et al., 1994).
Hanks et al. (1988) produced a phylogenetic tree of the protein kinase 
superfamily based on catalytic domain peptide sequence comparisons and this has since 
been updated to include new protein kinase sequences (Hanks and Quinn, 1991; Hanks 
and Hunter, 1995a+b). In their latest analysis, which was performed using a parsimony 
method (see Hanks and Hunter, 1995a+b for more details), 99 protein kinase catalytic 
domain peptide sequences were used in the construction of a “skeleton” tree in which 
only representative members were included from each of four major groups of protein 
kinases. Separate trees were then constructed for these four major groups that included a 
larger number of sequences. The skeleton tree is reproduced in Fig. 1.4 with the four 
major groups of protein kinases that were subsequently analysed in more detail indicated 
by dashed boxes. The numbers indicate the number of amino acid substitutions required 
to reach hypothetical common ancestors while the asterisks indicate recognised protein 
kinase families. Original references for each of the sequences used in the phylogenetic 
analysis can be found in Hanks and Hunter (1995a). The AGC, CaMK, CMGC, and PTK 
groups of protein kinases which account for a large proportion of the known protein 
kinases and the more closely related families of protein kinases within them are described 
briefly below.
The first group of protein kinases (labelled as the AGC group) includes the 
cyclic-nucleotide-dependent protein kinases (PKA and PKG) and the protein kinase C 
(PKC) family. The cyclic-nucleotide binding domains of PKA (cAMP-dependent) and 
PKG (cGMP-dependent) are related to each other (Shabb and Corbin, 1992) but in PKA 
the cAMP-binding domains and the protein kinase catalytic domains are located in 
different polypeptides (Corbin et al., 1978) while in PKG, two cGMP-binding domains 
are contained within the same polypeptide as the protein kinase catalytic domain (Takio 
et al., 1984). The protein kinase C enzymes are best known as protein kinases activated 
by diacylglycerol and calcium released after agonist-induced stimulation ofphospholipase
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C (Nishizuka, 1984). The calcium and diacylglycerol binding domains are both within the 
same polypeptide chain as the protein kinase catalytic domain. Since the discovery of the 
first protein kinase C enzymes, new members of the family with different modes of 
activation have been identified (Nishizuka, 1992; Dekker and Parker, 1994). In addition 
to the PKA, PKG and PKC families there are a number of other families of protein 
kinases belonging to the AGC group which have different modes of regulation. A feature 
common to several of the protein kinase families in the AGC group is a preference for 
basic residues surrounding the phosphate acceptor amino acids (Pearson and Kemp,
1991).
The second group (labelled as the CaMK group) includes the protein kinases 
regulated by interaction with Ca2+/calmodulin. Many members of this group, including 
CaMKI, CaMKH, CaMKTV, PhK-y (phosphorylase kinase y) and skMLCK (skeletal 
muscle myosin light chain kinase) are known to be activated by the binding of 
Ca2+/calmodulin at a domain slightly C-terminal to the catalytic domain. As well as the 
protein kinases regulated by Ca27calmodulin, there is a family of protein kinases isolated 
from plants (calcium-dependent protein kinases, CDPKs) that are regulated by calcium 
binding to an intrinsic calmodulin-like domain (Harper et al., 1991). The Ca2+/calmodulin 
dependent protein kinases and the CDPKs form a major branch of the CaMK group. The 
other major branch of the CaMK group is the Snfl/AMPK family of protein kinases. 
Protein kinases of this family are involved in regulating cellular responses to stress (see 
review by Hardie, 1994). They are not regulated by calmodulin but have similar substrate 
recognition motifs to CaMKI (Dale et al., 1995).
The third group of protein kinases (designated the CMGC group) includes the 
cyclin-dependent protein kinases, the MAP kinases, the glycogen-synthase kinase 3 
family and the family of protein kinases related to the human protein kinase Clk (“Cdc- 
Uke kinase”). The cyclin-dependent protein kinases are protein kinases whose activity 
depends on binding regulatory subunits known as cyclins. The protein kinase cdc2 of S. 
pombe and functional homologues in other organisms play a critical role in controlling 
cell cycle progression. The MAP kinases are protein kinases activated by 
phosphorylation on tyrosine and threonine and are involved in signalling cascades (see 
review by Neiman, 1993). The glycogen-synthase kinase 3 (GSK3) family are protein 
kinases regulated by phosphorylation on tyrosine and serine (Wang et al., 1994). In
19
mammals the targets for GSK3 include the transcription factor Jun and GSK3 
homologues are imphcated in control of development in Drosophila (Siegfried et al.,
1992) and Dictyostelium (Harwood et al., 1995). The casein kinase II (CK2) family of 
protein kinases are most closely related to the GSK-3 family (casein kinase I is not in the 
same family as casein kinase II) and members of this family are found in highly divergent 
eukaryotes. They are protein kinases with multiple substrates in both the nucleus and 
cytoplasm and may be constitutively active (Allende and Allende, 1995). The majority of 
members of the CMGC group recognise proline-rich phosphorylation site motifs.
The fourth major group of protein kinases (labelled as the PTK group) are the 
conventional protein tyrosine kinases which are known only in metazoans and exclusively 
phosphorylate tyrosine residues. The members of this group have distinctive peptide 
sequence motifs in catalytic subdomains VTb and VDI (see Section 1.2.2). A number of 
protein tyrosine kinases are transmembrane receptors with intracellular protein kinase 
domains, such as the EGF, PDGF and insulin receptor protein tyrosine kinase families. 
Several other families in this group are protein kinases with an intracellular location that 
lack membrane-spanning domains, an example being the Src family of protein tyrosine 
kinases. A number of protein tyrosine kinases phosphorylate sites with at least one acidic 
residue adjacent to the phosphorylated tyrosine (Pearson and Kemp, 1991).
The protein kinase families identified by Hanks and Hunter (1995a+b) that fall 
outside the four largest groups are not described here for reasons of space, although 
some are considered in Section 1.3 in relation to protein kinase genes identified in T. 
brucei.
Many of the protein kinases grouped together by catalytic domain sequence 
comparisons are similar in other ways such as their modes of regulation and substrate 
specificity, indicating that the catalytic domain sequence comparisons are valid in 
indicating evolutionary relatedness in a large number of cases. As a whole, the 
evolutionary origin of the superfamily is uncertain. No gene encoding a eukaryotic-like 
protein kinase has been discovered in E. coli despite the sequencing of a significant 
proportion of its genome (Hanks and Hunter, 1995a) and a eukaryotic protein kinase 
homologue from the bacterium Yersinia pseudotuberculosis (Galyov et al., 1993) is 
carried on a plasmid and may well have been transferred from a eukaryote. However, the 
myxobacterium, M. xanthus, which undergoes complex differentiation events has a
20
number of eukaryotic type protein kinase genes, and gene disruption experiments have 
shown that one is essential for normal development while another affects spore formation 
(Zhang et al., 1992; Udo et al., 1995). Nucleotide sequences that predict (very 
divergent) eukaryotic type protein kinases have also been identified in archaebacteria 
(Smith and King, 1995). On this basis the protein kinases may have a very ancient 
evolutionary origin.
1.2.2 Catalytic domains
The catalytic domain of protein kinases is highly conserved and the key residues were 
originally identified on the basis of multiple sequence alignments and by mutational 
analysis (Hanks et al., 1988 and references therein). Eleven subdomains were defined by 
Hanks et al. (1988) as regions containing conserved residues that are not interrupted by 
large insertions although, more recently, subdomain VI was redefined as Via and VTb 
(Hanks and Quinn, 1991). The publication of crystal structures for a number of protein 
kinases has shown a conserved bilobar catalytic domain structure in which the smaller N- 
terminal lobe is mainly responsible for binding the nucleotide substrate and the cleft 
between the two lobes is the catalytic site. The great majority of protein kinase catalytic 
domains contain between 250 and 300 amino acids (most are about 260 amino acids), 
although that of CDC7 contains 437 amino acids. However, the catalytic domain is 
found in different positions in the primary structure in different protein kinases. Some 
protein kinase catalytic subunits (e.g. that of cdc2) have very little peptide outside the 
boundaries of the catalytic domain and are regulated by association with separate 
polypeptides. Other protein kinases have large N- and/or C-terminal non-catalytic 
domains with regulatory and targeting function which may include membrane spanning 
portions.
The first protein kinase catalytic subunit structure to be solved by X-ray 
crystallography was that of PKA (Knighton et al., 1991a+b; Zheng et al., 1993; 
Bossemeyer et al., 1993). Crystal structures have also been published for the catalytic 
subunits of human cyclin-dependent kinase CDK2 (De Bondt et al., 1993), the rat MAP 
kinase ERK2 (Zhang et al., 1994) and a fission yeast casein kinase I (Xu et al., 1995). 
Crystal structures that include the catalytic domain have been published for recombinant 
fragments of the C. elegans twitchin kinase (Hu et al., 1994) and the human insulin
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receptor protein tyrosine kinase (Hubbard et al., 1994). Protein kinase structure was 
reviewed by Taylor et al. (1992), Taylor and Radzio-Andzelm (1994), Wei et al. (1994) 
and Morgan and De Bondt (1994).
Fig. 1.5 (slightly modified from Taylor and Radzio-Andzelm, 1994) shows an 
alignment of the sequences of three protein kinase catalytic domains that have been 
analysed by X-ray crystallography (PKA, ERK2 (MAPK) and CDK2). The twelve 
catalytic subdomains are indicated by roman numerals with very highly conserved 
residues marked by asterisks; the peptide sequences that form a-helices and p-strands are 
shaded and labelled. Fig. 1.6 (from Taylor and Radzio-Andzelm, 1994) shows a ribbon 
diagram of the structure of PKA with bound ATP and a naturally occurring 
pseudosubstrate inhibitor (PKI). The p-strands are labelled 1-9, of which strands 1-8 
superimpose on p-strands in CDK2 and ERK2 while P-strand 9 is not present in CDK2. 
The a-helices that superimpose between all three structures are D, E, F, and H, while a- 
helices C, G, and I are conserved but displaced and a-helix B is not conserved. The ATP 
and the side-chains of some of the essential catalytic residues are shown in black and the 
magnesium ion is represented by a black dot. The inhibitor peptide PKI is darkly shaded 
while a threonine residue that is phosphorylated shortly after protein synthesis (Shoji et 
al., 1979) is indicated by an arrow.
The function of some of the most highly conserved residues is summarised in 
Table 1.1. The dominant feature of the minor lobe (uppermost in Fig. 1.6) is a five- 
stranded p-sheet structure that is largely conserved between all of the protein kinases for 
which crystal structures have been determined. The glycine rich loop of subdomain I that 
is involved in anchoring the P-phosphate of ATP (reviewed by Bossemeyer, 1994) is 
found between P-strands 1 and 2, while the conserved lysine of subdomain II is in the 
third p-strand, and the conserved glutamate of subdomain m  is in a conserved a-helix 
between p-strands 3 and 4. The residues listed for subdomains I-DI are highly conserved 
among all protein kinases although the third glycine and the valine of subdomain I are 
somewhat less highly conserved than the other residues. Subdomains IV and V do not 
contain any invariant or nearly invariant residues but correspond to p-strand 4 
(subdomain IV) and P-strand V and a-helix D (subdomain V), the latter two structural 
elements forming the link between the small and large lobes.
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In the larger lobe, subdomain Via forms a long a-helix that appears to have a 
mainly structural role while subdomain VIb forms two short P-strands with an 
intervening loop (the catalytic loop) that contains an invariant aspartate and asparagine. 
The aspartate is a catalytic base while the asparagine stabilises the loop by hydrogen 
bonding to the backbone carbonyl of the aspartate. The consensus sequence for the 
catalytic loop among serine/threonine kinases is H/Y-R-D-L-K-X-X-N (where X is any 
amino acid) while that for the protein tyrosine kinases is H-R-D-L-R-A-A-N (Src family) 
or H-R-D-L-A-A-R-N (other protein tyrosine kinases). The lysine in serine/threonine 
kinases helps to neutralise charge and makes a hydrogen bond to a serine or threonine 
located seven residues N-terminal of the subdomain VUI glutamate. In protein tyrosine 
kinases the arginine appears to play a similar role in charge neutralisation but also 
hydrogen bonds to the catalytic base (Hubbard et al., 1994). The serine/threonine residue 
seven amino acids N-terminal of the subdomain VIII glutamate is replaced in protein 
tyrosine kinases by a proline. The aspartate of the “DFG” motif of subdomain VII 
chelates the Mg2+ ion that aids phosphate transfer and this motif is highly conserved 
among all protein kinases, however, there are differences in secondary structure between 
CDK2, PKA and ERK2 in this region. In many protein kinases, including PKA, ERK2 
and CDK2, there are phosphorylation sites between the conserved motifs of subdomains 
VII and Vm , the phosphorylation state of which affects enzyme activity. The “APE” 
motif of subdomain VIII is highly conserved among both serine/threonine and tyrosine 
kinases, the glutamate being most highly conserved. Ion-pairing between the glutamate 
and the conserved arginine of subdomain XI helps to stabilise the large lobe. Casein 
kinase I lacks both the “APE” and the arginine in subdomain XI but the triplet “SIN” at 
the equivalent position to “APE” appears to adopt the same secondary structure but 
makes a different set of interactions that stabilise the large lobe (Xu et al., 1995). 
Subdomain IX, which includes several highly conserved residues and an almost invariant 
aspartate, forms an a-helix in which the aspartate contacts the highly conserved arginine 
that lies immediately N-terminal to the catalytic base in subdomain VIb. As can be seen 
in the sequence alignments, subdomain X includes a small conserved helix but is also a 
site at which there are significant differences between the three aligned sequences; large 
insertions at similar positions to those in CDK2 and ERK2 are found in many protein
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kinases of the CMGC group. Subdomain XI includes a nearly invariant arginine that lies 
between two a-helices and which contacts the conserved glutamate in subdomain VEIL 
Many other features of the function of the protein kinases, for which structures are 
known, can be at least partly explained in structural terms and are dealt with in the 
original references and reviews cited. To summarise, the essential catalytic domain core 
structure is common to all protein kinases but this large structural element can 
accommodate significant insertions at particular positions.
1.3 Protein phosphorylation in T. brucei
1.3.1 Biochemical studies
The study of protein phosphorylation in T. brucei and other kinetoplastids is at an early 
stage and it is only recently that the first sequences for T. brucei protein kinases have 
been reported (Gale and Parsons, 1993; Hua and Wang, 1994; Mottram and Smith, 
1995). The predicted catalytic domains of these protein kinases have a subdomain 
structure similar to that defined by Hanks et al. (1988). T. brucei genes encoding protein 
phosphatases with strong catalytic domain homology to mammalian protein phosphatases 
of classes 1 and 2A have also been isolated (Evers and Comelissen, 1990; Erondu and 
Donelson, 1991). In addition to these protein kinase and protein phosphatase coding 
sequences, a number of protein kinase activities have also been defined biochemically and 
show similarities to particular classes of mammalian protein kinases. The available data 
on protein phosphorylation in T. brucei is reviewed below. Biochemical studies aimed at 
characterising protein kinase activities are described first while studies based on the 
cloning of protein kinase or protein phosphatase genes are described in Section 1.3.2. 
Protein phosphorylation in protists has been reviewed by Fazio et al. (1994).
Early evidence for the presence of protein serine/threonine kinases in T. brucei 
came from studies of protein kinase activity in extracts of bloodstream T. b. gambiense 
(Walter, 1976; Walter, 1978; Walter, 1980) and T. b. brucei (Walter and Opperdoes, 
1982). In the first of these studies a protein kinase activity was partially purified from the 
soluble fraction of trypanosome extracts by sequential ammonium sulphate precipitation, 
size exclusion chromatography and isoelectric focusing. The molecular weight of the 
kinase activity was estimated at 95 kDa by size-exclusion chromatography and at 88 kDa 
by sucrose gradient sedimentation while its isoelectric point was estimated at 4.85.
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Protein kinase activity was greatest with basic histone and protamine substrates with 
little activity detected with acidic casein and phosvitin. Phosphorylation of histones was 
predominantly on serine but phosphothreonine was also detected. Magnesium and 
manganese were both found to be acceptable as divalent cation co-factors. The protein 
kinase activity was unaffected by the cyclic nucleotides cAMP and cGMP but the 
nucleosides adenosine, guanosine, inosine, uridine and cytidine each stimulated the 
reaction rate about two-fold at a concentration of 0.1 mM. Two further protein kinase 
activities from the soluble fraction of bloodstream T. b. gambiense extracts were 
detected in a later study (Walter, 1978). These had apparent molecular weights of 200 
kDa and 37 kDa in size-exclusion chromatography. One (PKI) preferred the acidic 
substrate phosvitin but phosphorylated lysine-rich histones and protamine (basic) as 
effectively as acidic casein, while the other (PKm) used only the basic substrates tested. 
Phosphorylation of phosvitin (PKI) or protamine (PKIII) was predominantly on serine (> 
95%). Cyclic nucleotides had no effect on PKI and PK m  as had been shown for the 
previously identified protein kinase (PKII). In a comparison of the effects of the 
trypanocide suramin on the three protein kinase activities, it was shown that PKII and 
PKIH were only slightly inhibited at a drug concentration of 0.1 mM but PKI activity 
could be inhibited by 1 pM suramin (Walter, 1980). Activities apparently similar to PKI 
and PKII and a protein phosphatase activity were also identified in T. brucei (Walter and 
Opperdoes, 1982).
Keith et al. (1990) performed experiments to determine whether enzyme 
activities similar to those of mammalian protein kinase C could be detected in T. brucei. 
Five protein kinase activities from bloodstream form T. brucei were identified in assays 
of anion-exchange fractions in which histone m S was the substrate and Ca2+, 
diacylglycerol (DAG) and phosphatidylserine (PS) were added to each assay. Protein 
kinase activities PKm, PKIV and PKV were strongly stimulated by Ca2+, DAG and PS 
together, but not by Ca2+ or DAG/PS alone. Phosvitin was demonstrated to be the 
preferred substrate for PKIV and a Ca2+/DAG stimulated protein kinase from the 
procyclic stage suggesting that these kinases were not protein kinase C like activities as 
mammalian protein kinase C does not use phosvitin. In addition PKIV was only slightly 
inhibited by the protein kinase C inhibitor H7 at 1 tiM, while PKV was unaffected and
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PKm was inhibited. PKV was found to phosphorylate histone HIS, phosvitin, and 
protamine to equal extents. Overall, of the protein kinase activities identified, PKm was 
found to be most similar to mammalian protein kinase C in its stimulation by the 
combination of Ca2+, DAG, and phospholipid, its preference for the basic substrates 
histone and protamine and its sensitivity to H7. All of the other activities had properties 
distinct from those of mammalian protein kinase C. Protein kinase activities stimulated by 
Ca2+ and DAG were also detected from crude extracts using an IEF gel in situ assay and 
these activities were inhibited by H7. However, it was not determined whether these 
were the same as any of the activities characterised in the assays of anion-exchange 
fractions. An antibody raised against an epitope from a mammalian PKC was also shown 
to recognise a 95 kDa protein from T. brucei bloodstream forms by Western blotting.
An alternative approach to studying protein phosphorylation in T. brucei was 
adopted by Aboagye-Kwarteng et al. (1991) who compared SDS-PAGE phosphoprotein 
profiles from the high speed supernatants of total extracts of slender and stumpy 
bloodstream T. brucei labelled with [y-32P]ATP in vitro, in the absence of exogenous 
substrate. Trypanosomes were sampled over a time course of infection at the start of 
which all cells were slender form while at the end 95% of cells were short stumpy form. 
Among the phosphoproteins detected it was observed that an 80 kDa phosphoprotein 
(pp80) became progressively less prominent over this time, while two phosphoproteins, 
pp42 and pp37, became more prominent. The same phosphoproteins were also found to 
be more prominent in T. brucei that was induced to become morphologically stumpy by 
administration of the trypanocide DFMO to the rodent hosts. In order to characterise the 
protein kinases phosphorylating pp42 and pp37, labelling reactions were performed in 
vitro under different conditions. It was found that both ATP and GTP were acceptable 
phosphoryl donors for the labelling of pp42 and pp37 but the phosphorylation of these 
proteins was differentially affected by the concentration of KC1 in the labelling buffer. A 
number of activators of some of the main families of protein kinases in higher eukaryotes 
(cAMP, cGMP, Ca2+/calmodulin, Ca2+/phospholipid) showed no effect on activity but the 
negatively charged compounds heparin and suramin inhibited phosphorylation of all the 
phosphoproteins detected. Positively charged polylysine and polyarginine inhibited 
phosphorylation of pp42 and pp37 while having little effect on the phosphorylation of 
other proteins. Since the properties of the protein kinase activities that phosphorylate
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pp42 and pp37 were in some ways similar to those of mammalian casein kinase II (ability 
to utilise GTP and inhibition by heparin) extracts of the slender and stumpy cells were 
tested for their ability to phosphorylate exogenous casein and phosvitin. In spite of the 
increased phosphorylation of pp42 and pp37 in extracts of stumpy bloodstream forms, 
the extracts of slender bloodstream forms were found to be more active in 
phosphorylating these substrates. However, the results of experiments in which heat- 
denatured extracts were used as substrates suggested that pp42 was more abundant in 
stumpy cells while pp80 was less abundant, and although phosphorylation of pp37 from 
heat-treated extracts could not be shown, the results of a Western blot analysis with an 
antiserum against pp37 indicated that pp37, like pp42, is also present at a higher level in 
the stumpy cells.
Parsons et al. (1993) used a protein kinase renaturation assay (Ferrell and Martin,
1989) to examine protein kinase activities from different T. brucei life cycle stages. 
Multiple protein serine/threonine kinase activities were detected from slender, stumpy 
and procyclic forms with apparent molecular weights ranging from 43 kDa to 181 kDa. 
A protein kinase with an apparent molecular weight of 71 kDa (PK71) showed highest 
activity in slender bloodstream forms, protein kinases PK181, PK123 and PK43 showed 
highest activity in stumpy forms while PK52 showed highest activity in procyclic forms. 
Only one of the eight activities analysed showed no stage specific differences in the level 
of activity (PK97). Stumpy bloodstream forms are cell cycle arrested while the slender 
bloodstream and procyclic forms are proliferative. Therefore, differences in protein 
kinase activities between the stumpy forms and the slender and procyclic forms might be 
due to protein kinases involved in cell cycle control. In order to address this question the 
comparison of the protein kinase activities was extended to include samples from 
stationary phase procyclic cells. None of the activities that were upregulated in stumpy 
forms were also upregulated in stationary phase procyclics, but a number of differences 
were found between the two procyclic samples. In particular PK89, which had much 
lower activity in stumpy forms than in slender and proliferating procyclic, was found to 
have very low activity in stationary phase procyclic forms (see below).
These experiments demonstrated the existence of a number of renaturable protein 
kinases in T. brucei with the activities of most being stage specific. While only trace 
amounts of phosphotyrosine were detected in the kinase renaturation assay (on PK97),
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tyrosine phosphorylation was demonstrated in T. brucei (and in Crithidia fasciculata, 
Trichomonas vaginalis, and Giardia lamblia) by Western blotting with a previously 
characterised anti-phosphotyrosine serum (Parsons et al., 1991). A reason suggested for 
the lack of protein tyrosine kinase activity in the kinase renaturation assay is that these 
protein kinases may not renature well. The kinase renaturation assay was also used to 
investigate protein kinase activities from different life cycle stages of T. congolense 
grown in culture or in rodents (Parsons et al., 1995). As observed previously for T. 
brucei, there were significant differences in the protein kinase activities detected between 
the life cycle stages. Several of the activities were of similar size and showed similar 
stage regulation to protein kinases detected in the earlier study of protein kinase 
activities in T. brucei, but there were also a number of activities detected in one species 
and not in the other. Phosphoamino acid analysis showed that the proteins labelled in the 
kinase denaturation assay were only labelled on serine and threonine, although multiple 
tyrosine-phosphorylated proteins were demonstrated in extracts of all stages by Western 
blotting. Protein kinase activities were also assayed over a time course from cells 
stimulated to differentiate from bloodstream to procyclic forms by the addition of citrate 
and cis-aconitate to their culture medium and a temperature shift to 24 °C. The profiles 
of protein kinase activities were different within 24 hours between the stimulated and 
unstimulated cells and further differences were found at later time points.
The 89 kDa protein kinase activity from T. brucei, identified in the study of 
Parsons et al. (1993) as being potentially specific to proliferating forms, was investigated 
further in studies with cultured procyclic cells (Gale et al., 1994a). It was first shown 
that stationary phase procyclics stimulated to proliferate by fresh culture medium 
underwent one cell cycle in a semi-synchronous manner. Induction of the 89 kDa protein 
kinase (named SPK89 in this study) in the first cell cycle occurred at a time 
corresponding to S phase (5 hours); levels remained high at the time when the proportion 
of cells in G2/M was high (8 hours), but was lower at the 12 hour time point by which 
time the parasites had undergone one division cycle. There was rapid loss of synchrony 
after this time, but in accordance with the results of the earlier study, SPK89 activity in 
stationary phase procyclics was very low. To test whether the pattern of expression of 
SPK89 activity observed was specific to previously quiescent cells re-entering the first 
dividing cell cycle, or whether the same pattern would be repeated in subsequent cycles,
28
SPK89 activity was measured in cells from an asychronous culture sorted into 
populations at different cell cycle stages by flow cytometry. SPK89 activity was highest 
in the S phase population, lower in the G2/M population and lowest in the G1 
population, supporting the idea that SPK89 activity is S-phase specific. The effects of 
protein kinase inhibitors and cycloheximide on induction of SPK89 in stationary phase 
procyclic cultures placed in fresh medium were also investigated in this study. The 
protein kinase inhibitors genistein and staurosporine added at the same time as fresh 
medium blocked induction of both S phase and SPK89 activity, but had no direct effect 
on the protein kinase activity when added to the kinase renaturation assay. 
Cycloheximide also blocked induction of S phase and the appearance of SPK89 activity 
if added within 3 hours of the addition of fresh medium, but not at subsequent times. The 
gene encoding SPK89 has not yet been identified but some similarities of the protein’s 
properties and pattern of expression to those of the S. cerevisiae protein kinase Spkl 
(Zheng, P. et al., 1993) were noted.
Wheeler-Alm and Shapiro (1992) investigated protein tyrosine kinase activity in 
T. brucei. An activity that could phosphorylate a synthetic glutamate/tyrosine polymer 
was detected in extracts of bloodstream forms and could be heat-inactivated. A number 
of endogenous proteins also became phosphorylated when these extracts were incubated 
with [y-32P]ATP in a buffer containing Mn2+ ions without exogenous substrate. A 
comparison of the autoradiograph of an SDS-PAGE gel lane containing the labelled 
extract that had been treated with alkali, with that of an equivalent untreated lane 
showed that a number of bands were more prominent after alkali treatment. Ap 
phosphotyrosine is more resistant to alkaline hydrolysis than phosphoserine and 
phosphothreonine this result suggests that the more prominent bands (resistant to alkali 
treatment) were labelled on tyrosine. The compound genistein which inhibits a number of 
mammalian protein tyrosine kinases was found to inhibit both phosphorylation of the 
glutamate/tyrosine polymer and to inhibit multiplication of T. brucei grown in culture. 
However, a later study (Gale et al., 1994a) showed marked effects of cell treatment with 
genistein on protein synthesis and on protein serine/threonine phosphorylation, and while 
these could have been downstream effects of inhibition of protein tyrosine kinases it is 
not clear that the effects of genistein on the proliferation of T. brucei actually result from 
inhibition of protein tyrosine kinase activity.
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As well as the studies described above in which protein kinase activity was 
assayed in vitro in whole cell extracts or after partial protein kinase purification and 
addition of exogenous substrates, a number of studies have been performed to detect T. 
brucei proteins phosphorylated in living cells. In some of these studies cultured procyclic 
forms or bloodstream forms isolated from laboratory rodents were metabolically labelled 
in culture, while in other experiments to examine tyrosine phosphorylation 
phosphotyrosine antisera were used to detect tyrosine-phosphorylated proteins without 
the requirement for prior 32P labelling. In a further experiment described below, the 
phosphorylation state of T. brucei RNA polymerase II was examined after photoaffinity 
labelling of the active form of the enzyme in isolated nuclei
Clayton and Fox (1989) examined the phosphorylation of the glycosomal enzyme 
fructose bisphosphate aldolase in T. brucei bloodstream cells isolated from rats and then 
maintained in culture for metabolic labelling and pulse-chase experiments. Phosphate 
labelling of immunoprecipitated aldolase could usually be detected from cells lysed after 
a 30 minute labelling period, and was reliably detected after a 90 minute labelling period. 
The kinetics of phosphate labelling of VSG (not due to protein kinase activity) which 
was to be used as a control proved to be poorly reproducible. Pulse-chase experiments in 
which parasites were labelled with both [3H]leucine and [32P]orthophosphate were 
performed to assess the stability of the phosphate labelling of aldolase. Tritium labelling 
of both VSG and aldolase did not change significantly after chase periods of up to 19 
hours but, while the ratio of tritium to phosphate label incorporated into aldolase did not 
vary during this time, the amount of phosphate label incorporated into VSG increased 
dramatically. Two hypotheses were proposed to explain the results, one being that 
phosphate labelling of aldolase is stable and that the cytoplasmic or glycosomal 
phosphate pool equilibrates rapidly but the endoplasmic reticulum and golgi phosphate 
pool (responsible for phosphate labelling of VSG) equilibrates much more slowly. 
Alternatively, the aldolase phosphate groups might be continually turned over with the 
constant level of aldolase phosphorylation being explained by very slow removal of 
phosphate from the cells during the chase period. The phosphorylation of aldolase was 
found to be solely on serine but the phosphorylation site was not determined. No studies 
were performed to determine whether the phosphorylation of aldolase in T. brucei has 
functional significance.
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Parsons et al. (1991) investigated tyrosine phosphorylation in different T. brucei 
life cycle stages using a polyclonal anti-phosphotyrosine serum. Proteins were identified 
in all life cycle stages that reacted with the serum, and specificity for phosphotyrosine 
was indicated by the fact that this could be blocked by phenyl phosphate. Phosphoamino 
acid analysis of immunoprecipitates from procyclic cells metabolically labelled with 
[32P]orthophosphate showed that immunoprecipitated proteins contained phosphoserine 
and phosphothreonine as well as phosphotyrosine. In an examination of stage specific 
tyrosine phosphorylation by Western blot analysis of total cell extracts, it was found that 
the profiles of reacting proteins were fairly similar between life cycle stages, except that a 
set of strongly-labelled bands of about 40 kDa and 42 kDa in procyclic, intermediate and 
stumpy forms were much more weakly labelled in the slender bloodstream forms. Similar 
results were obtained for the slender and procyclic forms of a monomorphic stock. 
However, induction of stumpy forms by the trypanocide DFMO did not induce a 
stronger signal from the 40/42 kDa proteins compared to that from slender forms. 
Monoclonal antibodies were raised against the 40/42 kDa tyrosine phosphorylated 
proteins (Parsons et al., 1994) and used for further investigations. Two monoclonal 
antibodies were each found to recognise both of the proteins at 40/42 kDa (although the 
size estimates were changed to 44/46 kDa) suggesting that 44/46 kDa phosphoproteins 
(pp44/46) are related. The possibility that the common epitope was phosphotyrosine was 
ruled out by the fact that recognition of pp44/46 in Western blots by the antibodies was 
not blocked by phosphotyrosine. The two antibodies were used in addition to the anti- 
phosphotyrosine serum to determine the levels of pp44/46 in different stages and their 
tyrosine phosphorylation levels. For a naturally differentiating stock, the abundance of 
pp44 was low in slender bloodstream forms while almost no signal was observed for 
pp46. The protein level of pp44 was 3-4 fold higher in stumpy and procyclic forms than 
in slender forms, while the stoichiometry of phosphate labelling was 9-fold higher in 
procyclic forms compared to slender forms and higher still in stumpy forms. The 46 kDa 
protein was partially induced in stumpy forms but was most abundant in procyclic forms 
and there was no detectable tyrosine phosphorylation of this protein in slender forms. 
The two immunoprecipitated proteins were found to have associated protein serine and 
tyrosine kinase activity, but no stoichiometric association with other proteins was 
observed. Reactivity with antisera to MAP kinases could not be demonstrated. To
31
summarise, these two studies provided firm evidence that protein tyrosine 
phosphorylation does occur in T. brucei and that, as in other eukaryotes, at least some 
tyrosine phosphorylated proteins are also phosphorylated on serine and threonine. 
Additionally, clear stage-specific differences in the abundance and extent of tyrosine 
phosphorylation of two related proteins was shown, and less dramatic stage-specific 
differences in reactivity of other proteins with an anti-phosphotyrosine serum were also 
found.
In order to investigate microtubule-associated proteins in T. brucei, Woods et a l
(1989) raised monoclonal antibodies against the whole trypanosome cytoskeleton. 
Characterisation of a protein recognised by one of these antibodies showed it to be 
distributed at low abundance (relative to tubulin) over the entire surface of the 
cytoskeleton, but not the flagellum (Woods et a l , 1992). Immunogold microscopy 
showed the protein localised mainly on the exterior face of the subpellicular cytoskeleton 
and to the side of the microtubules. However, experiments performed to test for 
microtubule binding gave inconclusive results. The apparent molecular weight of the 
protein in SDS-PAGE was 210 kDa, while sucrose gradient density sedimentation 
suggested that it was globular, unlike many other cytoskeletal proteins. Since a low- 
abundance globular microtubule-associated protein might play a regulatory role in 
cytoskeletal function, an analysis was performed to test whether the protein was 
phosphorylated in cultured procyclic forms metabolically labelled with 32P 
orthophosphate. A number of proteins were labelled from different cytoskeletal fractions, 
and in 2-D gel analysis it was shown that one of these was the 210 kDa antigen. 
Therefore, while the role of the 210 kDa antigen has not been determined, there is at 
least preliminary evidence that in T. brucei, as in many other eukaryotes, the function of 
cytoskeletal proteins may be regulated by phosphorylation.
As discussed in Section 1.1.2, transcription and other aspects of gene expression 
in T. brucei have been found to have a number of unusual features. One unusual feature 
relates to the large subunit of T. brucei RNA polymerase n. In organisms ranging from 
S. cerevisiae to mammals the C-terminus of the large subunit of RNA polymerase II is 
made up of tandemly repeated heptapeptide sequences (e.g. 25 repeat units in S. 
cerevisiae, 52 in mouse) that are phosphorylated as the polymerase activity changes from 
initiation to elongation (Cadena and Dahmus, 1987). In T. brucei there are two genes
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encoding the large subunit of RNA polymerase II and both of the predicted proteins lack 
C-terminal heptapeptide repeats (Evers et al., 1989; Smith et al., 1989). In order to 
investigate whether T. brucei RNA polymerase II large subunits were nevertheless 
phosphorylated, Chapman and Agabian (1994) used antisera to identify RNA polymerase 
II large subunits that had been labelled by an affinity technique specific to elongating 
complexes. It was found that treatment of the immunoprecipitated RNA polymerase II 
with calf intestinal phosphatase led to its faster migration in SDS-PAGE (consistent with 
dephosphorylation), and this did not occur in a control experiment in which a 
phosphatase inhibitor was included in the incubation buffer. Experiments in which the 
polymerase large subunits were partially protease digested before or after phosphatase 
treatment and then detected with a C-terminus specific antiserum indicated that despite 
the lack of heptapeptide repeats the C-termini were extensively phosphorylated. In 
addition, when the phosphatase treatment was applied to total RNA polymerase II large 
subunits rather than those specifically engaged in transcriptional elongation, the C- 
termini of higher mobility forms were unaffected by phosphatase treatment. Thus the 
results of Chapman and Agabian (1994) indicate that despite the lack of heptapeptide 
repeats, phosphorylation of the C-termini of RNA polymerase II large subunits is 
associated with the change from a transcription initiation complex to an elongation 
complex in T. brucei, as in higher eukaryotes.
1.3.2 Protein kinase and protein phosphatase genes
Protein kinases and phosphoproteins can often be studied biochemically even when they 
are present at very low abundance because of the high sensitivity of assay techniques 
based on the use of 32P. However, obtaining the sequence of the gene encoding a specific 
protein kinase through techniques that depend on prior protein purification is often 
extremely difficult. An alternative approach to the study of protein kinases is to begin 
with gene cloning using one of a number of techniques based on the sequence homology 
between different protein kinases (see Hanks and Lawton, 1993), and a number of 
workers have used the polymerase chain reaction (PCR) with primers based on 
conserved protein kinase catalytic domain sequence motifs in the isolation of protein 
kinase genes from T. brucei. The various investigations into protein phosphorylation in 
T. brucei that have begun with gene cloning are described below.
33
1.3.2.1 Nrk (Nekl and NimA related kinase)
Gale and Parsons (1993) used PCR with degenerate primers based on protein kinase 
catalytic subdomains VTTT and IX to amplify T. brucei gene fragments similar to protein 
kinase genes. A gene-specific primer, based on the sequence of one of the clones 
obtained that was similar to protein kinase genes, was then used with a primer based on 
the T. brucei spliced leader to PCR amplify a longer fragment from cDNA. This 
fragment was cloned and used to screen genomic and cDNA libraries. Sequence analysis 
of one genomic clone, pNrkA, obtained by this approach showed that it contained an 
open reading frame encoding a putative protein kinase in which all of the conserved 
protein kinase catalytic subdomains could be recognised. Sequencing of the single cDNA 
clone obtained (pNrkB) showed that it contained a region of 97% nucleotide sequence 
identity to pNrkA across the coding region and into the 3' untranslated region, and also 
included a poly(A) tail. However, the open reading frame in this clone was terminated by 
a stop codon before catalytic subdomain Vm , and any protein product would therefore 
not be expected to be active. This clone also contained sequence 5' of the spliced leader 
acceptor site and was therefore assumed to be a precursor mRNA. The 5' sequence of 
this clone was very divergent from that of pNrkA suggesting that there might be more 
than one genetic locus for the putative protein kinase Nrk. It was shown by Southern 
blotting that T. brucei has two nrk loci (named nrkA and nrkB) and it was also shown 
that in two different T. brucei stocks transcripts could be detected from both loci, but 
that stock IsTAR 1 was homozygous for the truncated pseudogene at nrkB while stock 
TREU667 had one pseudogene allele, and one allele encoding a potentially functional 
protein at this locus. No significant difference was found between the level of expression 
of each mRNA between slender, stumpy and procyclic forms. Database searches showed 
that the Nrk catalytic domain sequence was most closely related to that of the murine 
dual-specific protein kinase Nekl and of the Aspergillus protein serine/threonine kinase 
NimA. (Letwin et al., 1992; Pu and Osmani, 1995; Ye et al., 1995). However, Nrk is not 
similar to either of these protein kinases outside the catalytic domain, and the C-terminus 
of Nrk has similarity to pleckstrin homology domains (Gale and Parsons, 1993; reviewed 
by Musacchio et al., 1993) which are not found in either Nekl or NimA.
In a later study (Gale et al., 1994b) the expression of the Nrk protein was 
analysed using an antiserum raised against a NrkA fusion protein which was shown to
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specifically immunoprecipitate Nrk from T. brucei extracts. The ability of Nrk 
immunoprecipitated from stumpy bloodstream cells to phosphorylate various substrates 
was tested. Nrk was found to be capable of phosphorylating both histone H -l (basic) and 
(3-casein (acidic) to some extent, but showed higher activity with myelin basic protein. 
Enolase, poly(glu-tyr), immunoglobulin heavy chain and heat-denatured T. brucei 
extracts were poor substrates and no autophosphorylation of Nrk was observed. 
Phosphoamino acid analysis of myelin basic protein and p-casein phosphorylated by Nrk 
showed that labelling was on serine and serine and threonine respectively. Nrk was able 
to use both Mg2+ and Mn2+ and its activity against myelin basic protein was significantly 
enhanced by the addition of 100 mM NaCl to the reaction buffer.
An analysis of the expression of Nrk and its activity during the procyclic cell 
cycle was performed using stationary phase cultured procyclic cells stimulated to re-enter 
a dividing cell cycle by dilution into fresh medium Levels of both Nrk protein and its 
activity were similar throughout the first cell cycle after stimulation, during which time 
there was a reasonable degree of synchrony. The level of Nrk protein during the cell 
cycle was also examined in cells from exponential cultures sorted by flow cytometry and 
again there was no evidence for cell cycle regulation of Nrk abundance. The levels of 
Nrk protein were also examined in different T. brucei life cycle stages. While in the 
earlier study it was shown that the expression of Nrk mRNAs was constitutive during the 
life cycle, it was found by immunoblot analysis that the level of the protein was highly 
regulated during the life cycle with lowest expression of Nrk in slender bloodstream 
forms, somewhat higher expression in procyclics, but much higher expression in stumpy 
forms. It was shown by analysing bloodstream cells from a naturally differentiating stock 
harvested at different time points during differentiation from slender to stumpy form that 
Nrk protein expression increased early in the differentiation process. The expression of 
Nrk was also examined in the monomorphic IsTAR 1 stock which can be induced to 
differentiate to morphologically stumpy forms by DFMO treatment, and which had been 
previously shown to have truncated pseudogenes at both nrkB alleles. Nrk protein was 
expressed at a low level in the slender bloodstream forms of this stock, but was strongly 
induced by DFMO treatment, indicating that the upregulation of the level of Nrk protein 
is at least partly due to the nrkA locus. The level of Nrk protein kinase activity from the 
different life cycle stages was found to parallel that of the protein’s abundance. The
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results of biosynthetic labelling experiments indicated that developmental regulation of 
Nrk abundance is primarily due to changes in the rate of its biosynthesis rather than its 
degradation. It was also shown that while stumpy forms showed the highest rate of Nrk 
synthesis, during the labelling period these forms synthesised 11 and 7 times less total 
protein than the slender and procyclic forms respectively. The Nrk proteins synthesised 
by slender, stumpy and procyclic cells had identical mobilities in SDS-PAGE when 
analysed after a 1 hour labelling period. However, when samples were analysed following 
a 1-4 hour chase period the labelled Nrk protein from procyclic forms had the same 
mobility in SDS-PAGE as when analysed at the earlier time point, but Nrk from stumpy 
forms had a slightly lower mobility. Therefore, it seems that Nrk is subject to a post- 
translational modification (perhaps phosphorylation) in stumpy forms but not in procyclic 
forms. The lack of developmental regulation of Nrk transcript abundance found in the 
earlier study was confirmed, and it was also determined that in slender, stumpy and 
procyclic forms all of the Nrk transcripts were polyadenylated and in each stage the same 
spliced leader acceptor site was used. The conclusion reached was that developmental 
regulation of Nrk expression is at the translational level, a level of control which is 
unusual in T. brucei.
1.3.2.2 cdc2-related protein kinases
Three genes encoding protein kinases with homology to the cdc2 family of protein 
kinases have been isolated from T. brucei {tbcrk 1-3) and there is evidence for further 
cdc2-related protein kinases in this organism (Mottram and Smith, 1995; Mottram, 
1994). The genomic organisation of the three genes was analysed by Southern blotting of 
genomic digests and T. brucei chromosomes separated by pulse-field gel electrophoresis. 
The results of this analysis indicated that each gene is single copy and that the genes are 
not closely linked although tbcrkl and tbcrk2 could be on the same chromosome. All of 
the tbcrk genes are located on large chromosomes (>3 Mb). A polyclonal antiserum 
against a peptide corresponding to the conserved PSTAIR box of cdc2 kinases reacted 
with a major protein band of 32 kDa and minor bands of 43, 65, and 90 kDa in blots of 
extracts from slender, stumpy and procyclic T. brucei, and the recognition of each 
protein was blocked by a PSTAIR peptide. This result is consistent with there being a 
family of cdc2-related protein kinases in T. brucei. The 32 kDa polypeptide could be
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TbCRKl since the antiserum used in the blotting cross-reacted strongly with a TbCRKl 
fusion protein, and TbCRKl has a calculated molecular weight of 34 kDa.
The proteins have been named cdc2-related protein kinases (CRKs) since they 
have not yet been shown to associate with cyclin partners. Each of the TbCRKs has the 
PSTAIR box domain which is implicated in cyclin binding (Ducommun et al., 1991), and 
sites of regulatory phosphorylation in cdc2 are also conserved (see review by Dunphy, 
1994), although in TbCRKl and TbCRK2 the residue in the equivalent position to T14 
in cdc2 is substituted by a serine. The conservation of these features suggests that 
TbCRKs 1-3 may well be cyclin-dependent kinases also regulated by phosphorylation, 
and a question of obvious interest is whether any of the TbCRKs might be a functional 
homologue of cdc2 acting as the key regulator of entry into mitosis. TbCRKl, TbCRK2 
and TbCRK3 are respectively 54%, 49% and 53% identical in amino acid sequence to 
HsCDC2. TbCRKl is most closely related (88% and 72% identity respectively) to cdc- 
related kinases from T. congolense and Leishmania mexicana (Mottram, 1994; Mottram 
et al., 1993) while TbCRK2 and TbCRK3 are both most closely related to human CDK2 
(52% and 59% identity respectively). The three T. brucei protein kinases are less closely 
related to each other than to HsCDC2. A phylogenetic analysis of the TbCRK sequences 
with those of other cdc2-related protein kinases showed that TbCRKl and the 
leishmanial cdc-related protein kinase (LmmCRKl) form an independent outgroup while 
TbCRK2 and TbCRK3 group with human cyclin-dependent protein kinases CDK4 and 
CDK5. Thus, by this criterion, none of the TbCRKs seems likely to be a functional cdc2 
homologue. LmmCRKl which groups with TbCRKl has also been shown to be a poor 
candidate for a cdc2 functional homologue by various criteria including its failure to 
complement an S. pombe cdc2 temperature sensitive mutant, and its lack of activity 
towards histone HI in amastigotes (which are dividing) when this activity could be 
readily detected in both proliferative and stationary promastigotes (Mottram et al.,
1993). It is possible that a primitive eukaryote such as T. brucei does not have a 
functional homologue of cdc2. However, there is evidence for further genes encoding 
cdc2-related protein kinases in T. brucei (see Mottram, 1994; Mottram and Smith, 1995) 
and a histone HI protein kinase activity distinct from LmmCRKl has been detected in 
Leishmania mexicana (Mottram et al., 1993). This kinase binds to pl3sucl beads as 
well as having greater activity in proliferating Leishmania forms than in non-proliferating
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forms, and is therefore a candidate leishmanial cdc2 homologue. Aflfanchino et al. 
(1993) have isolated a T. brucei cDNA clone encoding a protein (CYC1) with 
approximately 25% amino acid identity to human cyclins of A and B classes. Expression 
of CYC1 rescued an S. pombe cyclin mutant and in procyclic T. brucei the protein’s 
abundance was found to be cell cycle regulated in a manner consistent with it acting as a 
mitotic cyclin. An antiserum against CYC1 co-immunoprecipitated a 34 kDa protein that 
reacted with an anti-PSTAIR serum and a histone HI kinase activity could also be 
precipitated by this serum. To summarise, T. brucei has a family of cdc2-related protein 
kinases and although it is not clear whether any of the TbCRKs isolated so far plays a 
similar role to that of cdc2 in regulating entry into mitosis there is, however, indirect 
biochemical and immunochemical evidence suggesting that T. brucei may have such a 
protein kinase.
1.3.2.3 A MAP kinase homologue
Hua and Wang (1994) isolated seven amplified cDNA fragments similar to protein kinase 
coding sequences from T. brucei using primers based on conserved catalytic domain 
peptide sequences. One of these fragments (TbPK-Al) was used to screen a T. brucei 
cDNA library and hybridising clones were isolated. The sequence of the clone with the 
largest insert contained an open reading frame encoding a putative protein kinase of 350 
amino acids, with the catalytic domain extended at the N-terminus by 13 amino acids and 
at the C-terminus by 51 amino acids. Database searches with the predicted peptide 
sequence showed that the protein kinase was most closely related to the MAP kinases 
(MAPKs) KSS1 and FUS3 from S. cerevisiae (42% and 40% identity respectively 
excluding the C-terminal 40 amino acids) and was also similar to the rat MAP kinase, 
ERK1 (37% identity). No significant similarity was found between the C-terminal 40 
amino acids and any sequences in the databases. In addition to the significant overall 
homology to MAPKs, the T. brucei protein kinase has the sequence “TEY” in 
subdomain VH3. This sequence (sometimes with a different central residue) is 
characteristic of MAPKs and in other eukaryotes is known to be the site of activating 
phosphorylations on the threonine and tyrosine catalysed by dual-specificity MAPK 
kinases (Davis, 1994). Thus on the basis of its sequence the T. brucei protein kinase 
(named KFR1) is a putative MAPK.
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KFR1 was shown to be a single copy gene by Southern blotting while Northern 
blot analysis showed a single hybridising RNA species from both bloodstream and 
procyclic T. brucei of about 1.4 kb that was 3-4 fold more abundant in the bloodstream 
stage. The level of expression of the protein in these life cycle stages was also examined 
by Western blotting with an antiserum raised against the C-terminal sequence and it was 
found that the protein was about twice as abundant in the bloodstream forms compared 
to the procyclic forms.
1.3.2.4 Partial cDNAs for T. brucei protein kinases
The predicted peptide sequences of the remaining six amplified fragments (TbPK-A2-A5; 
TbPK-Bl and TbPK-B2) isolated by Hua and Wang (1994) were used in database 
searches for similar sequences. TbPK-A2 was found to be most similar to a protein 
kinase from Drosophila named polo and to a mammalian PKC, which overall are not 
closely related to each other. A cDNA that includes TbPK-A2 was cloned as part of the 
present study (Chapter 5) and it is clear from the more complete sequence that the 
putative protein kinase corresponding to TbPK-A2 is in fact a polo-like kinase.
The assignment of the other sequences to particular protein kinase subgroups is 
less certain because the cDNA fragments are short, and because the region of the 
catalytic domain they cover is significantly conserved between even divergent protein 
kinases. The closest matches found in the original database searches with the predicted 
peptide sequence for TbPK-A3 were to SNF1 of S. cerevisiae (49% identity); a protein 
kinase of the same family from Arabidopsis and to a Dictyostelium myosin fight chain 
kinase. TbPK-A4 and TbPK-A5 both showed most similarity to YAK1 of S. cerevisiae 
(53% and 48% identity respectively). TbPK-Bl was most similar to a Drosophila 
member of the protein kinase C family (47% identity) and TbPK-B2 was most similar to 
COT-1 of Neurospora (34% identity). In a Northern blot analysis of T. brucei poly(A)+ 
mRNA probed with the various PCR clones it was shown that transcripts for TbPK-A2, 
TbPK-A5, TbPK-B2, TbPK-A4 and TbPK-Bl are present at similar levels in 
bloodstream and procyclic forms (though the signals from the latter two are weak in both 
fife cycle stages), while TbPK-Al mRNA is 3-4 fold more abundant in the bloodstream 
forms. In the case of TbPK-A3 a 7.4 kb transcript was common to bloodstream and 
procyclic forms while two transcripts of 2.2 and 2.5 kb were only found in the
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bloodstream forms.
1.3.2.5 Protein phosphatase genes from T. brucei
T. brucei has two almost identical genes encoding the RNA polymerase II large subunit, 
which are located on different chromosomes (Evers et al., 1989). Evers and Comelissen
(1990) found, in a study of the 5' flanking regions in the two loci, that in both cases the 
genes immediately 5' of the large subunit genes encode putative protein phosphatases. 
The predicted peptide sequences from the two loci are 96% identical to each other. The 
protein phosphatase peptide sequence from one locus was found to be 56% identical to 
rat protein phosphatase 1 (a  isoform) and 40% identical to rat protein phosphatase 2A, 
and removal of 50 N- and C-terminal amino acids from the comparison increased the 
homology with P P -la  to 64%. It was therefore concluded that the putative T. brucei 
enzymes were of the protein phosphatase 1 family although neither sequence was 
classified as being of a particular isoform The sequences immediately 5' and 3 ' of the 
protein phosphatase coding regions from the two loci were found to be quite different 
from each other, but it was shown that the overall homology between the two loci 
extended several kb further 5' of the protein phosphatase genes. Using a different 
approach Erondu and Donelson (1991) cloned two different cDNAs from T. b. 
rhodesiense encoding putative protein phosphatase 1 homologues which had 3' 
untranslated regions almost identical to the previously described flanking sequences 5' to 
the two RNA polymerase II loci, suggesting that these cDNAs are transcribed from the 
previously described protein phosphatase genes (Evers and Comelissen, 1990). The 
results of an SI nuclease mapping analysis by Evers and Comelissen (1990) showed that 
both protein phosphatase 1 genes were co-transcribed with the RNA polymerase II large 
subunit genes and Erondu and Donelson (1991) were able to detect precursor mRNAs 
that hybridised to probes from both protein phosphatase and RNA polymerase coding 
sequences. As described above, the C-terminal domain of the RNA polymerase large 
subunit is known to be extensively phosphorylated in actively transcribing complexes 
from T. brucei (Chapman and Agabian, 1994) and an endogenous activity 
dephosphorylating the C-terminal domain was also detected in this study. However, this 
activity was not characterised, and it is not known whether the T. brucei protein 
phosphatase 1 can dephosphorylate the polymerase large subunit.
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Erondu and Donelson (1991) also cloned a further cDNA from T. b. rhodesiense 
with an open reading frame predicting a protein phosphatase 55% identical to 
mammalian protein phosphatase 2A and with a lower degree of identity (39%) to 
mammalian protein phosphatase 1. Southern blotting showed that the gene was single 
copy. One of the protein phosphatase 1 homologues and the protein phosphatase 2 
homologue were expressed as fusion proteins. An antiserum against the protein 
phosphatase 1 fusion protein cross-reacted with mammalian protein phosphatases of the 
1, 2A and 2B classes, and with the protein phosphatase 2A fusion protein, while the 
antiserum against the T. brucei protein phosphatase 2A only cross-reacted with the 
mammalian enzyme of the same class. The native enzyme was shown to have an apparent 
molecular weight of 35 kDa agreeing with its predicted molecular weight of 34.5 kDa. 
However, the fusion proteins were not active and the biochemical properties of the 
enzymes have not been characterised.
1.3.3 Conclusions
The biochemical studies of protein kinase activities in T. brucei have shown that many 
protein kinase activities are developmentally regulated and that, as in higher eukaryotes, 
phosphorylation on serine and threonine residues is more common than phosphorylation 
on tyrosine. However, in most cases the initial identification of a protein kinase activity 
or phosphoprotein has not been developed further. The application of homology based 
approaches (mainly PCR) to the cloning of protein kinase and phosphatase genes from T. 
brucei and other kinetoplastids has recently yielded results (the first T. brucei protein 
kinase sequence was published in 1993), details of which are summarised in Table 1.2. 
The identification of cdc2-related protein kinases in T. brucei, Leishmania mexicana and 
Crithidia fasciculata, a putative mitotic cyclin in T. brucei, and a T. brucei polo-like 
kinase (see Chapter 5) strongly suggests that kinetoplastids share with other eukaryotes 
much of the molecular machinery involved in cell cycle regulation. Similarly the isolation 
of genes for MAPK and MAPKK homologues from T. brucei and Leishmania 
respectively suggest that kinetoplastids have MAP kinase cascades. In higher eukaryotes 
such cascades transduce signals from the cell surface to the nucleus. The T. brucei PKAs 
also show strong homology to PKAs from higher eukaryotes and adenylate cyclase 
homologues have been identified in both T. brucei and Leishmania (Alexandre et al.,
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1990; Sanchez et al., 1995), while a cAMP phosphodiesterase homologue has also been 
identified from T. brucei (M. Boshart, personal communication). It seems reasonable to 
conclude that T. brucei and other kinetoplastids have many of the protein 
phosphorylation pathways that have been identified in higher eukaryotes and that many 
more protein kinase genes will be identified in the fixture, either through fiirther studies 
using homology based approaches to gene cloning or through large scale genome 
sequencing. Although the protein kinases of T. brucei now appear to be quite 
conventional considering the early evolutionary divergence of this organism there are 
likely to be some differences between the roles of protein phosphorylation in T. brucei 
and in higher eukaryotes. For instance, in higher eukaryotes, including unicellular 
eukaryotes such as yeasts, the downstream targets of many protein phosphorylation 
cascades are transcriptional regulators. In T. brucei most genes are organised in 
polycistronic transcription units within which differential gene expression (which is 
common) cannot result from regulation of the rate of transcriptional initiation. It 
therefore seems likely that if protein phosphorylation cascades are involved in controlling 
gene expression in T. brucei then the downstream targets will be DNA and RNA binding 
proteins responsible for RNA maturation and stability.
Given the high level of interest in understanding the differentiation events that T. 
brucei undergoes during its complex life cycle (and in the development of ways of 
interfering with them) research into protein phosphorylation in this organism is likely to 
expand at an increasing rate. In other organisms the cloning of protein kinase genes has 
not necessarily rapidly led to an understanding of their cellular role, and the identification 
of substrates has been a long-standing problem in protein phosphorylation research. 
However, transfection methods have been developed for T. brucei and the application of 
reverse genetic methods should help greatly in the study of the fimction of protein 
kinases and phosphatases in this organism The large amount of background information 
available about protein kinases is also helpftd in this respect. In summary, the study of 
protein phosphorylation in T. brucei to date has yielded very little information about the 
parasite’s biology, but with the recent isolation of a number of protein kinase and protein 
phosphatase genes from T. brucei and other kinetoplastids, it has become clear that these 
organisms have many of the protein phosphorylation pathways that operate in higher 
eukaryotes. The availability of T. brucei protein kinase coding sequences allows new
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approaches to be taken to the further study of protein phosphorylation in this organism
1.4 Overview of thesis
It is clear that the combination of biochemical, biological, and molecular research is the 
most powerM combination in terms of understanding the function and properties of 
specific protein kinases in any organism At the time that the work reported in this thesis 
was initiated, very little was known about protein kinases in trypanosomatids hut two 
sets of protein kinase activities from T. brucei had been partially characterised at the 
biochemical level in this laboratory. The first of these protein kinases had been found to 
be expressed in a stage specific manner with much greater activity in the slender 
bloodstream forms than in the procyclic forms and furthermore had the interesting 
property of undergoing apparent autophosphorylation. It was decided to characterise this 
protein kinase activity in more detail and to develop purification methods so that the 
purified protein could be microsequenced, or used to raise antibodies which could then 
be used in screening expression libraries. Chapter 3 describes work performed to extend 
the earlier characterisation of the activity using the original protein kinase assay system 
while Chapter 4 describes the partial purification of the protein kinase by liquid 
chromatography. This work involved both the development of new assays for the protein 
kinase activity and some further characterisation of the protein kinase.
The second protein kinase activity or set of activities were those with properties 
suggesting a similarity to PKC (Keith et al., 1990; see Section 1.3.1). These had been 
more completely characterised and because of their reported instability were not 
considered suitable for the purification approach taken with the autophosphorylating 
protein kinases. However, when the sequence of an amplified cDNA fragment predicting 
peptide sequence similar to PKC catalytic domains became available it was decided to 
clone the full length gene to complement the earlier biochemical characterisation of T. 
brucei PKC-like activities. This work is described in Chapter 5. Each of the three results 
chapters has its own discussion which is supplemented by an overall discussion (Chapter 
6).
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Page 44 became empty following corrections
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Kingdom: Protista (Unicellular eukaryotes)
Phylum: Kinetoplastida
Order: Trypanosomatida
Genus: Trypanosoma
Section: Salivaria
Subgenera: Duttonella Nannomonas Trvpanozoon
Species: T. vivax T. congolense T. brucei brucei
T. simiae T. b. rhodesiense
T. b. gambiense 
T. equiperdum 
T. evansi
Fig. 1.1 Classification of Salivarian trypanosomes
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Fig. 1.2 Developmental cycle of Trypanosoma brucei (from Vickerman, 1985)
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Fig. 1.3 Morphological changes occurring in the cytoskeleton of the procyclic form of T. 
brucei during the cell cycle. Panel A (from Sherwin and Gull, 1989a) shows a schematic 
diagram representing the complete cell cycle as deduced from electron micrographs. 
Panel B (from Robinson et al., 1995) shows procychc cells at different stages in the cell 
cycle. Cells at the earhest stage of the cell cycle have 1 flagellum and 1 nucleus (IF  IN), 
the daughter flagellum then begins to lengthen before nuclear division (2F1N). Following 
mitosis (M) the 2F2N cell continues to elongate before the two cells finally separate. A, 
B, C, D and E refer to positional descriptors analysed by Robinson et al. (1995). Note 
that the total increase in cell length during cell cycle progression can be accounted for by 
the increase in inter-basal body distance.
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Fig. 1.4 Phylogenetic tree o f the eukaryotic protein kinase superfamily inferred from 
catalytic domain amino acid sequence alignments (from Hanks and Hunter, 1995a+b). 
Only representative members have been included for the AGC, CaMK, CMGC and PTK 
groups of protein kinases (separate trees are given for each o f these groups in the 
references quoted above). Branch lengths indicate the number o f amino acid substitutions
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to reach hypothetical common ancestors at internal nodes. Asterisks indicate branches 
leading to defined protein kinase families.
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Fig. 1.5 (opposite) Sequence alignment o f PKA, MAPK, and CDK2 (slightly adapted 
from Taylor and Radzio-Andzelm, 1994). Secondary structure motifs are indicated by 
shading as shown in the key. Highly conserved residues are marked by asterisks, 
phosphorylation sites in the activation loops are marked by filled arrows, and ligands or 
potential ligands to the phosphorylation site are marked by open arrows. Roman 
numerals indicate conserved catalytic subdomains as defined by Hanks and Quinn (1991).
Fig 1.6 Ribbon diagram of the catalytic subunit of PKA (from Taylor and Radzio- 
Andzelm, 1994). Only the core o f the catalytic subunit (residues 40-300) is shown. ATP 
and the side chains o f Asp 166, Asp 184, Arg280 and Glu208 are shown in black. The 
magnesium ion binding the (3- and y-phosphates is shown as a black dot. Phosphorylated 
Thrl97 is indicated by the arrow. PKI (to the right o f the figure, labelled) is a small 
naturally occurring peptide inhibitor of PKA.
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Conserved residue 
PKA Cdk2 ERK2
Subdomain Function
G50 G11 G30 I Loop anchoring the P-phoq>hate of ATP
G52 Gl3 G32 I
Gi5 G16 Gl5 I
V57 y l8 V37 I Lines the adenine binding pocket
K72 K52 n Contacts the a- and p-phosphates of ATP
E91 E51 E69 m Ion pairs with K72
Dl66 D117 D147 VIb Catalytic base
K'68 Kli9 k 149 Vlb Interacts with y-phosphate
N171 N132 N147 VIb Stabilises catalytic loop
D184 dT45_ D165 vn Chelates Mg2+
Elbs E172 E195 vm Ion pairs with R in subdomain XI
Di20 Dl85 d 5M IX Stabilises catalytic loop
Ri„o R174 Rto XI Forms ion pair with E in subdomain VIE
Table 1.1 Highly conserved residues of the protein kinase catalytic domain
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Protein kinases
Name Organism Class of kinase Size/ Comments Reference
kDa
NrkA T. brucei NimA-related kinase 48 41% identity with murine N ekl, Gale and Parsons, 1993
30% identity with Aspergillus NimA, Gale et al., 1994b
stage-regulated kinase activity
NrkB T. brucei NimA-related kinase 48 97% identity with Nrk A Gale and Parsons, 1993
KFR1 T. brucei MAP kinase 40 42% identity with KSS1 Hua and Wang, 1994
(S. cerevisiae)
T. brucei MAP kinase Different from KFR1 Accession number
Z54341
LdLPK L. chagasi MAP kinase kinase 42 37% identity with Xenopus MAPKK Accession number
U16029
TbCRKl T. brucei cdc2-related kinase 34 54% identity with Hscdc2, Mottram et al., 1993;
homologue of LmmCRK 1 Mottram and Smith,
1995
TbCRK2 T. brucei cdc2-related kinase 39 49% identity with Hscdc2 Mottram and Smith,
1995
TbCRK3 T. brucei cdc2-related kinase 35 54% identity with Hscdc2, Mottram and Smith,
homologue of LmmCRK3 1995
LmmCRKl L. mexicana cdc2-related kinase 35 54% identity with Hscdc2 Mottram and Smith,
1995
CfCRK4 C.fasciculata cdc2-related kinase 54 ~49% identity with Hscdc2, Brown et al., 1992
2 large kinase domain insertions
TbPK-A3- T. brucei 3 unidentified kinases ? PCR products from cDNA, Hua and Wang, 1994
TbPK-A5 amplified using primers based on
kinase subdomains VI and IX
TbPK-Bl- T. brucei 2 unidentified kinases ? PCR products from cDNA, Hua and Wang, 1994
TbPK-B2 amplified using primers based on
kinase subdomains VI and VTTT
TbPLK T. brucei Polo-like kinase ? 53 % identity with CDC5 over see Chapter 5
kinase domain (TbPK-A2 from Hua
and Wang, 1994)
TbPKAa T. brucei Protein kinase A 38 51 % - 59% identity with PKAs M  Boshart, personal
from yeast to human communication
TbPKAp T. brucei Protein kinase A 38.5 52% - 60% identity with PKAs M  Boshart, personal
from yeast to human communication
TbPKAy T. brucei Protein kinase A 39 51% - 62% identity with PKAs M  Boshart, personal
from yeast to human communication
TbZFK T. brucei Protein kinase C? 97 N-terminal Zn2+-finger, M  Boshart, personal
24% identity over > 500 amino acids communication
with human PKCv
Protein phosphatases
Name Organism Class of kinase Size/ Comments Reference
kDa
TbPPla T. brucei Protein phosphatase I 39 Type 1 class of catalytic subunit, Evers and Comelissen,
66% identity with mammalian PP1 1990
Erondu and Donelson,
1991
TbPPlb T. brucei Protein phosphatase I 39 Type 1 class of catalytic subunit, Evers and Comelissen,
> 95% identical with TbPPla 1990
Erondu and Donelson,
1991
TbPP2 T. brucei Protein phosphatase 2A 35 Type 2A class of catalytic subunit, Erondu and Donelson,
55% identity with mammalian PP2A 1991
LcPP2C L. chagasi Protein phosphatase 2C 42 Type 2C class of catalytic subunit, Bums et al., 1993a
30.8% identity with rat 42 kDa
PP2C over 302 amino acids
Table 1.2 Protein kinase and protein phosphatase genes from kinetoplastids
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Chapter 2
Materials and Methods
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2.1 Protein methods
2.1.1 T. brucei stocks and preparation of cell extracts
Bloodstream form T. brucei were prepared from Sprague-Dawley or Wistar rats 
inoculated with a T. b. brucei cloned monomorphic stock TREU 869, originally isolated 
in Kiboko, Kenya in 1969. Procyclic T. brucei were of the cloned stock EATRO 1125 
isolated in Uganda (see Hide et al., 1990 for details of these stocks) and were grown in 
culture in SDM-79 medium (Brun and Shoenenberger, 1979). Bloodstream T. brucei 
were separated from host blood by anion-exchange chromatography (Lanham and 
Godfrey, 1970), and were then washed twice in phosphate buffered saline pH 8.0 
containing 1% glucose (PBSG) before being frozen as a packed cell pellet at -70 °C until 
use. Cultured procyclic T. brucei were washed twice in PBSG and then frozen as a 
packed cell pellet at -70 °C.
T. brucei extracts were made by resuspending the cells (after thawing at room 
temperature) in ice-cold 20 mM Tris-HCl pH 7.5, 2 mM EDTA, 0.5 mM EGTA with 
leupeptin and aprotinin added to a final concentration of 25 fig/ml (3 ml buffer/1 ml 
packed cells). Triton X-100 and NP40 were then added to a final concentration of 0.1%, 
and a glass homogeniser was used to break up the cells. Crude extracts were stored at - 
70 °C until use. In order to prepare clarified extracts to load onto chromatography 
columns, crude extracts were centrifuged at 100 000 g for 45 minutes in a Beckman VTI
65.2 rotor at 4 °C. After centrifugation the supernatant was removed using a syringe and 
was stored at -70 °C.
2.1.2 Isoelectric focusing and in situ protein kinase assay
Gels consisted of 0.3 g Agarose IEF (Pharmacia), 3.6 g sorbitol, 27 ml distilled water 
and 0.38 ml each of ampholines pH 3.5-10 and pH 5-7. The agarose, sorbitol and water 
were heated in a boiling waterbath until dissolved and the ampholines added immediately 
before gel pouring. Gels were poured onto the hydrophilic side of Gelbond (EMC) in an
18.5 x 11.3 cm frame and allowed to set for at least 30 minutes before use. For 
electrophoresis the gels were placed over a thin film of water on the glass cooling plate 
of a Multiphor II apparatus (Pharmacia). Electrode strips were wetted in 1 M freshly 
prepared sodium hydroxide (cathode), and 0.05 M sulphuric acid (anode), and laid on 
the long edges of the gel. Sample papers were soaked in 50 pi or more of sample and
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placed on the gel surface 3 cm from the cathode. EEF markers (Pharmacia) were applied 
to the gel in the same way. Gels were run at a constant 5 W with voltage limited to 1000 
V, current to 20 mA, for 1 hour. After electrophoresis, gels were removed from the 
apparatus and the electrode strips and underlying gel were removed. Gels were then 
soaked in cold 50 mM Tris-HCl pH 7.5 for 2 x 10 minutes before being placed in 50 ml 
of 30 mM Tris-acetate pH 7.4, 4 mM magnesium acetate, 10 mM sodium fluoride for 10 
minutes at 37 °C. The labelling reaction was then started by the addition of 50 jnCi of [y- 
32P]ATP (6000 Ci/mmol, New England Nuclear) and 2.5 pi of 2 mM ATP and allowed 
to continue for 15 minutes at 37 °C before the labelling solution was poured off. Gels 
were fixed in 10% trichloroacetic acid, 1% phosphoric acid and then soaked in this 
solution for two hours or more before being rinsed again and left overnight in 30% 
methanol, 10% acetic acid. The gels were then partially dried by blotting with filter paper 
and tissues, and finally dried completely at 60 °C. The dried gels were exposed to X- 
Omat-S film (Kodak) at -70 °C
To obtain molecular weights for radiolabelled proteins separated in IEF gels, the 
relevant gel bands were located using the autoradiograph, and cut out of the dried gel 
with scissors. Gel bands were cut into smaller pieces and re-hydrated in separate tubes by 
soaking in 50 mM Tris-HCl pH 7.2, 3% SDS, 10% glycerol for 1-2 hours. Prior to gel 
loading SDS-PAGE sample buffer was added and samples were boiled for five minutes 
before removal of Gelbond fragments and loading onto a SDS-PAGE gel while the 
agarose was still liquid.
Alternatively the separated proteins were analysed by blotting. Following the 
labelling step of the assay, gels were rinsed in 50 mM Tris-HCl pH 7.5 and then soaked 
in a fresh change of this solution for 15 minutes. Gels (still attached to Gelbond) were 
then taped around the circumference onto a plastic tray. A piece of PVDF paper 
(previously dipped in methanol and soaked in 50 mM Tris-HCl pH 7.5 for 10-15 
minutes) was laid on top of the gel and then overlaid with 1 sheet of 3MM (Whatman) 
paper moistened in 50 mM Tris-HCl pH 7.5, two sheets of dry 3MM paper, a block of 
tissues, and finally a weight. The stack was left overnight to allow proteins to transfer to 
the PVDF, the sheet of PVDF was then rinsed 5 x with distilled water and air-dried 
before autoradiography.
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2.1.3 Phosphoamino acid analysis
Bands of phosphate labelled protein were located on PVDF blots by overlaying the 
autoradiograph on the blot and were then cut out with scissors. Each labelled band was 
cut up into small pieces that were dipped briefly into methanol, rinsed in water, then 
placed in separate screw-capped microcentrifuge tubes. A minimal volume of 5.7 M HC1 
sufficient to cover the PVDF strips was added and the tubes were then heated for 1 hour 
at 110 °C with the caps tightly closed. The PVDF strips were then removed from the 
tubes which were then centrifuged briefly to collect the liquid. The tubes were then 
placed in a vacuum oven at 80 °C without lids until the liquid had evaporated.
The samples were then analysed by 2-dimensional electrophoresis on thin-layer 
chromatography plates according to the method of Cooper et al. (1983). Buffer 1.9 was
4.4 ml 100% formic acid, 15.6 ml glacial acetic acid made up to 200 ml with distilled 
water. Buffer 3.5 was 1 ml pyridine and 10 ml glacial acetic acid made up to 200 ml with 
water. Each dried sample was re-suspended in 2 pi of Buffer 1.9 containing 10 mg/ml 
each of phosphoserine, phosphothreonine, and phosphotyrosine as internal standards. 
The samples were spotted onto cellulose thin-layer chromatography plates (four evenly 
spaced sample origins/plate) with care being taken to minimise the spreading of each 
sample. For the 1st dimension electrophoresis each TLC plate was wetted with Buffer
1.9 by blotting with 3MM paper soaked in the buffer. The plate was then placed on the 
aluminium cooling plate of a Multiphor II apparatus (Pharmacia) and run at 1400 V 
(limited to 40 W) for 22 minutes with water-cooling. The TLC plate was then dried with 
a stream of warm air and wetted with Buffer 3.5. It was then placed back in thp 
apparatus at 90° to its previous orientation and electrophoresed for 30 minutes at 1000 
V. Following the second dimension run the plate was again dried, and then sprayed with 
0.5% ninhydrin in butan-l-ol to develop the internal standards, and then 
autoradiographed for 1-3 weeks at -70 °C.
2.1.4 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE was performed using the discontinuous buffer system of Laemmli (1970). 
Large format gels were run in Bio-Rad Protean II vertical slab gel apparatus, while 
minigels were run in Bio-Rad Mini-Protean II apparatus. The gels poured were 1.5 mm 
thick in both cases. Initially, 12% polyacrylamide gels were prepared using bis-
55
acrylamide as the crosslinking agent but in some experiments 7.5% gels were prepared 
using piperazine di-acrylamide as the crosslinker.
Stock solutions made up were 1.5 M Tris-HCl pH 8.8, 10% w/v SDS, and 3% 
w/v polyacrylamide. A commercial 30% acrylamide/bis-acrylamide (37.5:1) stock 
(Northumbria Biologicals) was stored in the dark at 4 °C. To prepare 30 ml of a 12% 
resolving gel, 12 ml of acrylamide stock, 6.9 ml distilled water, 7.5 ml 1.5 M Tris-HCl 
pH 8.8, 300 pi of 10% SDS, 3 ml of 3% polyacrylamide, and 300 jxl of fresh 10% 
ammonium persulphate were mixed before addition of 12 pi of tetra-methyl-1,2- 
diaminoethane (TEMED, Sigma) immediately before pouring. Resolving gels were 
overlaid with water-saturated 2-butanol and allowed to set for about 1 hour. The top of 
the resolving gel was washed with distilled water before the stacking gel was applied. 
The mixture used for 10 ml of stacking gel (4%) was 1.7 ml acrylamide stock, 5.8 ml 
distilled water, 1.25 ml 1 M Tris-HCl pH 6.8, 1 ml 3% polyacrylamide, 100 pi SDS, 100 
pi 10% ammonium persulphate, and 10 pi TEMED.
For acrylamide/piperazine di-acrylamide gels a 30% acrylamide/piperazine di- 
acrylamide stock solution (reagents from Bio-Rad) was made up in distilled water 
according to the manufacturer’s instructions, filtered and stored in the dark at 4 °C. For 
30 ml of a 7.5% resolving gel mixture, 7.5 ml of the acrylamide stock, 14.5 ml of 
distilled water, 7.5 ml of 1.5 M Tris-HCl, 0.3 ml of 10% SDS and 150 pi of freshly 
prepared 10% ammonium persulphate were mixed before the addition of 15 pi of 
TEMED to start the polymerisation reaction. For 10 ml of a 4% stacking gel, 1.3 ml of 
acrylamide solution, 6.1 ml of distilled water, 2.5 ml of 0.5 M Tris-HCl pH 6.8, 100 pi of 
10% SDS and 50 pi of 10% ammonium persulphate were mixed before addition of 10 pi 
of TEMED.
Samples were prepared for SDS-PAGE by addition of SDS-PAGE sample buffer 
and then boiling for 5 minutes, before gel loading or storage at -20 °C. Radiolabelled 
protein molecular weight markers (14.3 kDa-200 kDa) were from Amersham, while non­
radioactive markers were from Sigma (29 kDa-205 kDa and 14.2 kDa-66 kDa). The 4 x 
sample buffer stock consisted of 200 mM Tris-HCl pH 6.5, 8% w/v SDS, 8 mM EDTA, 
20% v/v 2-mercaptoethanol, and 40% v/v glycerol, with bromophenol blue added to 
0.002%. The running buffer was 50 mM Tris, 384 mM glycine, 2 mM EDTA, and 0.1% 
SDS. Large gels were electrophoresed overnight at 50-60 V and run at 100 V the next
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day until the bromophenol blue band had reached the desired position. Minigels were run 
at 100 V for approximately 2 hours with the position of the bromophenol blue band 
again being used to judge the progress of electrophoresis. Polyacrylamide gels were 
silver stained using a commercial silver stain kit (Sigma) following the manufacturer’s 
instructions. Following any post-electrophoresis process, such as silver staining, gels 
were either dried onto 3MM paper in a Bio-Rad vacuum gel dryer, or between 
cellophane sheets in a Hoefer Easy-breeze gel dryer. Gels containing radioactive material 
were exposed to film (Kodak X-Omat S) in a gel cassette at -70 °C.
2.1.5 2-dimensional protein electrophoresis
1st dimension gels for 2-dimensional protein electrophoresis were prepared in glass tubes
7.5 cm long with an internal diameter of 1.5 mm using a Hoefer apparatus according to 
the manufacturer’s instructions. The gels contained (per 3.5 ml): 1.95 g urea, 467 pi 
30% acrylamide solution (37.5:1 acrylamide.bis-acrylamide, Northumbria Biosciences), 
700 pi 10% NP-40, 177 pi 40% ampholines (50:50 mixture of ampholines of pH ranges 
3.5-10 and 5-7, Pharmacia), 800 pi distilled water, 10 pi ammonium persulphate, 7 pi 
TEMED. Samples (10-30 pi) were resuspended in 9.8 M urea, 4% NP-40, 2% 
ampholines (pH 3.5-10), 100 mM DTT (final concentrations). The electrode buffers 
were 20 mM NaOH (cathode) and 0.085% phosphoric acid (anode). Gels were prerun at 
a constant 250 V for 30 minutes before sample loading and were then run at 500 V for 3 
hours. Gels were extruded from the tubes using a syringe and adaptor (Hoefer), 
equilibrated in 0.25 M Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 50 mM DTT and frozen 
until use. 2nd dimension gels were 7.5% SDS-PAGE minigels prepared using piperazine 
di-acrylamide as crosslinker as described in Section 2.1.4
2.1.6 Liquid chromatography
The HPLC system used was a Waters 625 LC system with a single wavelength (280 nm) 
UV absorbance spectrophotometer and an automatic fraction collector (Gilson). This 
system can accurately mix buffers from four components and can be programmed to mix 
buffer gradients (all gradients used were linear). Following each chromatography 
experiment, the system was flushed out with water and then filled with 10% isopropanol
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to prevent bacterial contamination. Tris and NaCl stock solutions were stored at 4 °C 
and all solutions were filtered through 0.22 pm filters shortly before use.
Anion-exchange chromatography was performed using a Waters AP-1 (1 cm 
internal diameter) glass column pre-packed with Protein-Pak DEAE 8HR resin at a flow 
rate of 0.8 ml/min and fractions were collected every half minute. Buffers used for anion- 
exchange chromatography were mixed by the HPLC fluid handling system from separate 
bottles containing 100 mM Tris-HCl, 100 mM Tris-base, 1 M NaCl and distilled water. 
Size-exclusion chromatography was performed using a Waters Protein Pak 300SW glass 
column (8 x 300 mm). The flow rate was 0.8 ml/minute and fractions were collected 
every 30 seconds. In order that HPLC could be performed using H-9 Sepharose 
(prepared as described in Section 2.1.8) a Waters AP minicolumn (5 cm long, 5 mm 
internal diameter) was filled using the manufacturer’s method for slurry packing. 
Separations were undertaken using flow rates of up to 0.5 ml/minute.
2.1.7 Slot blot kinase assay
Suitably sized pieces of PVDF to fit into the slot blot apparatus (Gibco BRL 24-well 
filtration manifold) were soaked in methanol for 15 minutes and then left submerged in 
30 mM Tris-acetate, 4 mM magnesium acetate, 10 mM sodium fluoride until use. 
Immediately before sample blotting, a PVDF sheet was removed from the soaking buffer 
and placed on the lower bed of the apparatus. The upper plate of the blotter was then 
screwed down and each slot was loaded with an aliquot from a single HPLC fraction 
(usually 100 pi). A vacuum was then applied briefly to draw the liquid through the 
PVDF but without causing excessive drying. After blotting the PVDF sheets were 
removed from the apparatus and were returned to a solution of 30 mM Tris-acetate, 4 
mM magnesium acetate, 10 mM sodium fluoride to keep the membrane wet. All 
procedures between sample blotting and the labelling step were performed as rapidly as 
possible to minimise protein denaturation or diffusion. The blots were then transferred to 
plastic bags containing 10 ml of 30 mM Tris-acetate, 4 mM magnesium acetate, 10 mM 
sodium fluoride and incubated at 37 °C for 10 minutes before a comer was cut off each 
bag to allow the addition of the label (0.5 pi 2 mM ATP/1 pi [y-32P]ATP 6000 Ci/mmol 
in labelling buffer). After re-sealing, the bags were incubated for a further 15 minutes at 
37 °C. Following the labelling step, the labelling solution was poured away and the blots
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were rinsed 3 times in distilled water and then air dried. The dried membranes were 
exposed to Kodak X-Omat S film at -70 °C.
2.1.8 Liquid kinase assay for column fractions
Column fractions (usually 25 pi aliquots in 20 mM Tris-HCl pH 5.7, with varying NaCl 
concentrations) were mixed with an equal volume of 60 mM Tris-HCl pH 7.4, 8 mM 
MgCl2. An ATP labelling mix was prepared by adding 1 pi [y-32P]ATP (6000 Ci/mmol, 
NEN) and 0.5 pi 2 mM ATP to 198.5 pi water, and 1 pi of this was added per 50 pi of 
1:1 diluted column fractions. Reactions were incubated for 15 minutes at 37 °C, the 
reaction stopped by addition of SDS-PAGE sample buffer and boiling (5 minutes). 
Samples were then loaded onto SDS-PAGE gels or stored at -20 °C until use. In some 
experiments the 2x Tris-HCl/MgCl2 buffer normally used was substituted by 5x or lOx 
buffer with appropriate adjustment to the volume of column fraction used. The labelling 
step of the liquid kinase assay was also used to prepare pre-labelled 
(autophosphorylated) protein kinase for experiments to test the binding of the 60 kDa 
protein kinase to chromatography matrices (Sections 4.2.2 and 4.2.4). Following the 37 
°C incubation, buffer exchange was performed on the samples using Centricon 30 
concentrators (see Section 2.1.9) to remove excess unincorporated labelled ATP and, if 
necessary, to change the buffer conditions. Following the Centricon step the samples 
were either used immediately or frozen at -20 °C.
2.1.9 Preparation of H-9 Sepharose
H-9 Sepharose 4B was prepared essentially according to the method of Inagaki et al. 
(1985). Cyanogen bromide-activated Sepharose 4B (Sigma) was washed with distilled 
water and re-suspended in 50 mM borate buffer pH 8.0, 0.5 M NaCl. H-9 (Biomol) 
dissolved in the borate buffer (10 pmol in 250 pi) was added to 0.9 ml of the settled 
Sepharose which was then made up to a total volume of 2.5 ml with 50 mM borate 
buffer pH 8.0, 0.5 M NaCl. The reaction was allowed to proceed for 2 hours at 30 °C 
with regular mixing by inversion of the tube. After incubation, the Sepharose was washed 
with 30 ml of the borate buffer, re-suspended in excess 1 M ethanolamine pH 8.0 and 
incubated for 8 hours at room temperature with regular mixing. The Sepharose was then 
washed extensively in distilled water and stored in 25 mM Tris-HCl pH 7.0 containing 2
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mM EGTA and 50 mM 2-mercaptoethanol. A control Sepharose matrix was prepared 
similarly except that borate buffer without H-9 was used in the initial incubation before 
blocking with ethanolamine.
2.1.10 Protein concentration/buffer exchange
Centricon 30 concentrators (Amicon) were used for concentration and buffer exchange 
of column fractions and Hquid kinase assays according to manufacturer’s instructions.
2.2 Nucleic acid techniques
2.2.1 Growth and transformation of E. coli
E. coli strains used for plasmid work were either XL-1 Blue or INVccF' (Invitrogen) and 
were grown in LB medium or on LB agar plates (Sambrook et al., 1989). Ampicillin was 
added to a final concentration of 50 fig/ml for cells transfected with ampicillin resistant 
plasmids. XL-1 Blue cells were made competent by treatment with 50 mM CaCl2 and 
were transformed according to standard protocols. Manufacturer’s instructions were 
followed for transformation of INVaF' supercompetent cells. E. coli strain Y1090(f) 
were used for growth of Xgtl 1 and was cultured in LB media containing ampicillin. LB 
agar plates used for growth of Y1090 cells infected with phage contained 10 mM 
M gS04.
2.2.2 Bacterial vectors and preparation of vector DNA
Bacterial vector pCRU (Invitrogen) was used for cloning of PCR products according to 
the manufacturer’s protocol. pGEM7Zf(+) (Promega) or Bluescript II SK(+) 
(Stratagene) were used for all other DNA cloning. Cells containing these plasmids were 
grown as 10 ml cultures in LB media containing 50 pg/ml ampicillin in 20 ml plastic 
universal tubes which were incubated overnight at 37 °C with vigorous shaking. Wizard 
Minipreps (Promega) were used for the extraction of plasmid DNA (3 ml cell culture per 
miniprep) according to the manufacturer’s protocol.
2.2.3 Manipulations of plasmid DNA
DNA restriction digests were performed using enzymes and buffers from Gibco BRL or 
from Boehringer Mannheim according to manufacturer’s instructions. Ligations were
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performed using T4 ligase and ligase buffer from Gibco BRL and were incubated 
overnight at 16 °C, except for ligations performed in the construction of deletion sets 
using the Erase-A-Base kit (Promega), where the manufacturers’ reagents (containing 
polyethylene glycol) and protocols were used to allow shorter incubation times. When 
required, the ends of linear vector DNA were dephosphorylated to prevent vector self­
ligation using calf intestinal phosphatase (Boehringer Mannheim) according to standard 
protocols (Sambrook et al., 1989).
2.2.4 Electrophoresis of DNA in agarose gels
Gels were prepared with electrophoresis grade agarose from Gibco BRL and were run in 
40 mM Tris-acetate, 1 mM EDTA (TAE) buffer prepared according to Sambrook et al. 
(1989) containing 0.5 pg/ml ethidium bromide in apparatus from Pharmacia or BRL. 
Type I sample loading buffer was prepared and used according to Sambrook et al. 
(1989). DNA size markers (1 kb ladder) were from Gibco BRL. DNA bands were 
visualised by UV transillumination and gels were photographed using a Polaroid camera. 
The Geneclean II kit (Bio 101) was used for all DNA extraction from agarose gels 
according to the manufacturer’s protocol.
2.2.5 Southern blotting of agarose gels
Agarose gels were washed twice (15 minutes per wash) in denaturing solution (0.5 M 
NaOH, 1.5 M NaCl) and then twice (15 minutes per wash) in neutralising solution (0.5 
M Tris-HCl pH 7.5, 3 M NaCl). Gels were then placed, inverted, on 3MM paper 
(Whatman) on a platform with the ends of the paper immersed in 20x SSC (175.3 g 
NaCl, 88.2 g sodium citrate made up to 1 litre in distilled water with the pH adjusted to
7.0 with sodium hydroxide). A sheet of Hybond-N membrane of the same size as the gel 
was then placed on top of the gel and this was then covered by 3 sheets of 3MM paper 
soaked in 3x SSC, a block of paper towels and finally a weight. Transfer was allowed to 
proceed overnight. Blots were dried in an oven at 80 °C for 10 minutes and the DNA 
was cross-linked to the membrane by placing on a UV transilluminator (DNA side down) 
for 7 minutes. Hybridisations using 22mer oligonucleotide probes prepared by end- 
labelling or larger random primed DNA fragments (see Section 2.2.6) were performed as 
follows. Blots were prehybridised in 0.5 M Phosphate buffer pH 7.0, 1% SDS (prepared
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by adding equal volumes of 1 M Phosphate buffer and 14% SDS; 1M phosphate buffer 
was prepared by titrating 1 M Na2HP0 4  with 1 M NaH2PC>4 to pH 7.0) for 30 minutes at 
65 °C in a rotating bottle in a hybridisation oven. The buffer was then poured off and 
replaced by 10 ml of the same buffer containing the labelled probe (denatured by boiling 
immediately before use). Hybridisation was allowed to proceed overnight at 65 °C. Blots 
were then rinsed in 2x SSC, 0.1% SDS and then washed 3 times (15 minutes per wash) 
at 65 °C in the same solution before being either dried or sealed wet in a bag for 
autoradiography. When required blots (kept wet after hybridisation) were stripped by 
immersion in 500 ml of 0.1% SDS and heating in a microwave oven at full power for 15 
minutes. This step was then repeated with fresh 0.1% SDS, and the blot then transferred 
to prehybridisation buffer.
2.2.6 Labelling of oligonucleotide and DNA probes
Short oligonucleotides (22mers) were prepared as probes by end-labelling with T4 
polynucleotide kinase (Gibco BRL) according to the protocol described in Sambrook et 
al. (1989) and were then ethanol precipitated before use. Larger DNA fragments 
contained in LMP agarose were labelled with [a-32P]dCTP by random priming using a 
kit (Boehringer Mannheim) according to manufacturer’s instructions.
2.2.7 Polymerase chain reaction
Oligonucleotide primers were supplied by the oligonucleotide synthesis service of the 
University of Glasgow Biochemistry Department in a solution of ammonium hydroxide. 
Primers were de-salted by ethanol precipitation according to standard protocols. PCR 
reactions were prepared according to the instructions in the Perkin-Elmer GeneAmp kit, 
using polymerase, buffer, and dNTPs from Perkin-Elmer or Advanced Biotechnologies. 
In all reactions a “hot-start” was performed by denaturing at 94 °C for 5 minutes before 
addition of the polymerase. In all PCR reactions the denaturation step was 94 °C for 1 
minute and the annealing step was also for 1 minute. A temperature of 72 °C was used 
for the extension step. Annealing temperatures, extension times, and cycle numbers 
specific to particular reactions are described in Section 5.2. A Hybaid thermal cycler was 
used.
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2.2.8 DNA sequencing
Deletion sets for DNA sequencing were prepared using the'Erase-A-Base kit (Promega) 
according to the manufacturer’s protocol. Sequencing reactions were performed on 
double-stranded plasmid DNA using the Sequenase kit (USB) with [a-35S]-dATP as the 
label according to manufacturer’s instructions. Sequencing products were analysed by 
vertical polyacrylamide gel electrophoresis using 8% gels prepared in the BRL S2 
apparatus and were run in 45 mM Tris-borate, 1 mM EDTA (TBE) buffer prepared 
according to Sambrook et al. (1989) at a constant 65 W. The migration of “Sequenase” 
tracking dyes was used to judge the run length required. Gels were fixed for 20 minutes 
in 10% methanol/10% acetic acid, were then rinsed briefly with water and blotted to 
3MM paper (Whatman) before vacuum drying in a Bio-Rad gel dryer. Gels were then 
exposed to Kodak X-Omat S film overnight or longer at room temperature. Sequences 
were read manually and were analysed using the Wisconsin GCG software package.
2.2.9 Isolation of T, brucei genomic DNA and RNA, purification of poly(A)+ RNA 
and synthesis of 1st strand cDNA
T. brucei genomic DNA was isolated from bloodstream form cells using a standard 
procedure (Borst et al., 1980). T. brucei total RNA was isolated from bloodstream 
forms using the RNAgents kit (Promega) and the manufacturer’s protocol was followed. 
T. brucei poly(A)+ RNA was purified from T. brucei total RNA using the Poly(A) Quik 
kit (Stratagene) according to the manufacturer’s instructions. First strand cDNA was 
prepared using the Riboclone cDNA synthesis kit (Promega) according to the 
manufacturer’s instructions, except that the second strand cDNA synthesis step was 
omitted.
2.2.10 Screening of a A, cDNA library
E. coli strain Y1090 were prepared as plating cells from a 50 ml culture grown in LB 
medium containing 50 pg/ml ampicillin to an optical density (650 nm) of 0.5. The cells 
were pelleted by centrifugation and re-suspended in 5 ml SM buffer (5.8 g NaCl, 2 g 
M gS04.7H20 , 50 ml 1 M Tris-HCl pH 7.5, 5 ml 2% gelatin made up to 1 litre with 
distilled water) and stored at 4 °C for up to 1 week. To prepare plates (8.5 cm diameter) 
of bacteria infected with phage, serial dilutions of the phage stock were prepared in SM
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buffer and 100 pi of each phage dilution were mixed with 100 pi of plating cells and 
incubated at 37 °C for 10-15 minutes. After incubation, 2.5 ml of top agarose 
(containing 50 pg/ml ampicillin) at 55 °C was added to each tube and the agarose 
containing the infected bacteria was poured immediately onto pre-warmed LB agar 
plates. The plates were then incubated overnight at 37 °C and plaques were counted the 
next day to titre the phage stocks.
Plaques were blotted to nylon filters (GeneScreen Plus, NEN) and DNA was 
immobilised according to the method described in Sambrook et al. (1989). Filters were 
hybridised to a 171mer oligonucleotide probe prepared from a PCR product similar to 
TbPK-A2 (Section 5.2.1) by a random priming labelling method (Section 2.2.6). The 
hybridisation solution used was (per 100 ml): 50 ml Phosphate buffer stock solution (71 
g Na2HPC>4, 2 ml 85% orthophosphoric acid made up to 1 litre with distilled water), 35 
ml 20% SDS, 0.2 ml 0.5 M EDTA pH 8.0, 14.8 ml distilled water. Filters were 
prehybridised in the hybridisation solution at 65 °C in a hybridisation oven for 30 minutes 
before addition of the probe (denatured immediately before use by boiling). The 
hybridisation reaction was allowed to proceed overnight at 65 °C. Filters were then 
rinsed in preheated 1 x SSC/5% SDS and were then washed 3 times (15 minutes per 
wash) in the same solution at 65 °C. Filters were then dried and autoradiographed. 
Agarose plugs from hybridising plaques were picked using a glass pasteur pipette. The 
agarose from each plaque was placed in a microcentrifuge tube containing 1 ml SM 
buffer and a small volume of chloroform. Tubes containing X stocks were stored at 4 °C.
2.2.11 Isolation of X DNA
DE-52 cellulose (Whatman) was prepared for use by addition of several volumes of 0.05 
M HC1 until the supernatant was below pH 4.5. Concentrated NaOH was then added 
with gentle stirring of the suspension until the pH reached 7.0. The supernatant was 
poured off and several volumes of LB medium were added. This was repeated with fresh 
LB medium until there was no pH difference between the LB medium and the DE-52 
slurry. The slurry was adjusted to approximately 75% resin/25% LB medium and stored 
at -20 °C until use.
Bacteria were infected with phage from plaques picked as described in Section
2.2.10 at a phage concentration known to give confluent lysis from previous titrations,
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and were spread in 0.3% top agarose onto LB agar plates containing 10 mM magnesium 
sulphate. After overnight incubation, 2 ml of SM buffer was added to each plate and the 
top agarose was scraped off into a tube and centrifuged to pellet the solid material. The 
supernatant was then added to the equilibrated DE-52 resin in microcentrifuge tubes (0.8 
ml of supernatant to 0.5 ml of slurry) and the tubes were inverted about 50 times. The 
tubes were then centrifuged for 5 minutes and the supernatant from each was put in a 
fresh tube. Extraction buffer (0.5 M Tris-HCl pH 8.0, 0.25 M EDTA, 2.5% SDS was 
added (150 pi to 800 pi of supernatant) and the tubes were heated at 65 °C for 15 
minutes. After cooling to room temperature, 200 pi of 8 M ammonium acetate was 
added to each tube and the tubes were left on ice for 15 minutes to precipitate the phage 
proteins and RNA. The tubes were then centrifuged for 10 minutes at 10 000 g, the 
supernatant removed and extracted twice with phenol/chloroform. Isopropanol was 
added to the aqueous supernatant from the second extraction and the tubes were 
incubated for 10 minutes at room temperature. The DNA was then pelleted by 
centrifugation at 10 000 g for 10 minutes and washed with 1 ml 70% ethanol before 
being resuspended in a small volume of 10 mM Tris-HCl pH 7.4, 1 mM EDTA.
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Chapter 3
Identification of an autophosphorylating protein kinase from
Trypanosoma brucei
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3.1 Introduction
To investigate protein kinase activities in T. brucei, Keith et al. (1990) adapted an 
isoelectric focusing gel in situ protein kinase assay (Grove and Mastro, 1987). When the 
procedure was modified for the investigation of autophosphorylating protein kinase 
activities by the exclusion of exogenous substrates, up to eight gel bands containing 
phosphate labelled proteins were detected from total extracts of bloodstream T. brucei. 
Furthermore, when these bands were individually cut out of the dried gels, re-hydrated, 
and run in SDS-PAGE, it was found that the predominant phosphate labelled protein 
from each IEF gel band migrated with an apparent molecular weight of 60 kDa. Thus it 
seemed that all of protein kinase activities detected might be isoenzymes of each other. 
When identical conditions were used to detect protein kinase activities in extracts of 
procyclic T. brucei only two bands containing protein kinase activity were detected 
which had isoelectric points identical to those of two of the bloodstream activities, 
although the phosphate labelling was considerably weaker (see below and Hide et al., 
1994).
The apparent stage-specificity of these protein kinase activities was very 
interesting. In higher eukaryotes, cellular growth and differentiation are partly controlled 
by protein kinases and phosphatases, often acting in cascades. Far less is known about 
the role of protein phosphorylation in evolutionarily primitive eukaryotes such as T. 
brucei, but a stage-regulated protein kinase activity might play a role in controlling the 
transition from one life-cycle stage to the next. Based on these initial results, it was 
decided to perform experiments to confirm the profile of protein kinases obtained for 
bloodstream and procyclic T. brucei and then undertake a more extensive 
characterisation of these activities.
The procedure for the IEF gel in situ assay and subsequent analysis of labelled 
proteins is summarised in Fig. 3.1 (described in detail in Chapter 2). As depicted in panel 
A, electrophoresis is performed in a thin horizontal IEF gel with samples and isoelectric 
point markers loaded onto the gel surface soaked into sample application papers. 
Following electrophoresis the gel is washed to remove ampholines and other 
contaminants and is then equilibrated in a protein kinase assay buffer at 37 °C before the 
kinase reaction is started by addition of [y-32P]ATP. As shown in panel B, the steps 
subsequent to the labelling reaction depend on the nature of the analysis required. The
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gel is either washed under protein fixing conditions and dried or is washed briefly under 
non-fixing conditions and capillary blotted to PVDF. The dried gel or blot is then 
autoradiographed to reveal the positions of proteins that have become phosphate 
labelled. Molecular weight estimates for phosphate labelled proteins were obtained by 
cutting out the agarose containing the labelled proteins and loading it into SDS-PAGE 
gels. Phosphoamino acid analysis was performed on labelled proteins which were 
capillary blotted onto PVDF membranes from IEF gels.
3.2 Analysis of autophosphorylating protein kinase activities in Trypanosoma 
brucei using the IEF gel in situ assay
T. brucei extracts were prepared and assayed for autophosphorylating protein kinase 
activity (see Materials and Methods). Fig. 3.2 panel A depicts an autoradiograph of a 
dried-down IEF gel used in the in situ protein kinase assay with [y-32P]ATP as the label, 
and in the absence of exogenous substrate. Equal amounts of procyclic (P) and 
bloodstream (BS) T. brucei total extracts were loaded at the origin (O). The positions 
and isoelectric points of markers used to calibrate the gel are shown to the right of the 
figure. Two labelled bands were detected in the assay of procyclic T. brucei extracts and 
up to eight in the assay of bloodstream extracts. Six of the bloodstream bands (1-6) form 
a cluster with isoelectric points between 5.2 and 6.5, of which bands 1 and 2 were the 
most strongly labelled and reproducibly detected in subsequent assays. The activity at 
isoelectric point 7.1 was always lower than the activity of bands 1 and 2 but was 
routinely detected unless the overall activity of the extract was low. The activity at 
isoelectric point 9.25 was often low but was seen in the majority of the assays. The 
isoelectric points of the procyclic bands 1 and 2 are 7.1 and 9.25 respectively, and these 
bands were always weakly labelled. These possibly represent the same activities as those 
of bloodstream bands 7 and 8 at the same isoelectric points. However, procyclic band 1 
and bloodstream band 8 both focus near the cathode and it is possible that they are at a 
pH discontinuity in the gel.
The molecular weights of proteins in 32P-labelled IEF gel bands were determined 
by SDS-PAGE under reducing conditions. Individual bands were cut out of dried IEF 
gels, re-hydrated in SDS-PAGE sample buffer and fractionated by SDS-PAGE. Fig. 3.2 
panel B shows the autoradiograph of an SDS-PAGE gel used to analyse phosphate
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labelled proteins from a bloodstream T. brucei extract. Lanes 1-6 contain bands 1, 2, 3, 
4, 7, and 8 respectively. The positions and sizes (in kDa) of protein molecular weight 
markers are indicated on the left of the figure. It can be seen that the predominant 
phosphate labelled protein in each lane has an apparent molecular weight of 60 kDa, 
although lane 3 clearly has a labelled band below 60 kDa in size, and the main band could 
be a doublet. It was found consistently in many experiments that a 60 kDa band 
accounted for almost all of the labelling of any of the IEF bands and was frequently the 
only phosphate labelled protein present. Similarly, the two IEF bands from procyclic 
extracts were also found to migrate with an apparent molecular weight of 60 kDa 
confirming the earlier results.
To investigate whether the autophosphorylating protein kinase activities are 
cytosolic or membrane associated, the T. brucei total extracts were fractionated by 
ultracentrifugation. Following extraction with TX-100 and NP-40 a total extract was 
centrifuged at 100 000 g to spin down membrane fractions. Fig. 3.3 shows the 
autoradiograph of an IEF gel used in an assay to compare a total extract and the 100 000 
g supernatant fraction of an extract. Lanes 1 and 2 are loaded with duplicate samples of 
total extract, lanes 3 and 4 (also duplicates) are loaded with the high speed supernatant 
fraction. There is high background labelling around the origin (O) but the pattern of 
labelled bands migrating towards the anode side of the origin is clearly very similar 
between the two pairs of samples. This result suggests a cytoplasmic rather than a 
nuclear or membrane location for the protein kinase activity.
3.3 Phosphoamino acid analysis
Serine, threonine and tyrosine are the residues phosphorylated by members of the main 
eukaryotic protein kinase superfamily. In order to determine whether the 
autophosphorylating activity was a serine/threonine or tyrosine kinase, an analysis was 
carried out to determine which phosphoesters of these amino acids could be detected in 
preparations of the 60 kDa protein. The method used was essentially that of Cooper et 
a l (1983) in which protein hydrolysates are analysed by 2-dimensional electrophoresis 
on thin-layer chromatography plates except that proteins were hydrolysed directly from 
PVDF blots of IEF gels rather than from solution. A description of the methods used for 
both blotting of the IEF gels and phosphoamino acid analysis is given in Chapter 2.
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Fig. 3.4 panels A and B show areas of a ninhydrin stained thin-layer 
chromatography plate used in the analysis of the phosphate labelled proteins from 
bloodstream bands 1 and 2 respectively while panels C and D show the corresponding 
autoradiographs. The large arrows indicate the direction of electrophoresis in buffers of 
pH 1.9 and pH 3.5. The identities of the three ninhydrin-stained internal standards are 
marked on panels A and B while the arrows on panels C and D mark the positions of 
phosphate labelled spots that match with the ninhydrin stained spots on the plates. The 
nature of the other radiolabelled sample components detected in the autoradiographs is 
not known but it is normal to detect phosphopeptides as well as free phosphoamino 
acids. The marked phosphate labelled spots in both C and D have the same positions as 
the phosphoserine and phosphothreonine standards of panels A and B but in neither case 
is there phosphate labelling at a position corresponding to that of the phosphotyrosine 
standard. As discussed below, the phosphoamino acid analysis performed on the IEF 
bands is incomplete but phosphoserine and phosphothreonine were detected in each of 
four separate analyses of bloodstream bands 1 and 2. IEF bands 3 and 6 were not 
sufficiently well resolved from blots of IEF gels to be separately analysed, while single 
analyses on bands 4, 5, and 7 showed labelling of serine and threonine. The results of 
three analyses of band 8 showed labelling only on serine.
3.4 Discussion
The profile of labelled bands obtained using the IEF assay to detect autophosphorylating 
activities and the SDS-PAGE analysis of the labelled bands confirmed the earlier results. 
The phosphoamino acid analysis confirmed that phosphate had been covalently 
transferred to protein and, for the bands where thorough analysis was possible, 
phosphate transfer was either to serine and threonine residues or only to serine. The 
combined results of the earlier analyses and of the work reported here are published in 
Hide etal. (1994).
The original finding that the predominant phosphate labelled protein in each 
labelled IEF gel band migrated at 60 kDa in SDS-PAGE was surprising but was 
confirmed by the work described here. The common size of the labelled proteins 
suggests that they are related and while some proteins are substrates for many protein 
kinases the separation of proteins in the T. brucei extracts by isoelectric focusing would
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be expected to separate most protein kinases from their substrates. Two possible trivial 
explanations of the results were addressed in controls experiments performed previously 
and not repeated here. These were: 1) that the 60 kDa band protein was a contaminant of 
the agarose used to form the gels; 2) that the 60 kDa protein was the VSG or another 
major protein coincidentally co-migrating with multiple protein kinase activities. The first 
of these possibilities was ruled out by experiments in which the assay was performed in 
polyacrylamide gels. The results obtained using these gels were very similar results to 
those obtained using agarose gels. The 60 kDa protein was shown not to be VSG by its 
lack of reactivity with anti-VSG antibodies in a Western blot of an SDS-PAGE gel 
containing the 60 kDa protein. Staining for total protein showed no major protein band 
at the position of the 60 kDa labelled band indicating that the 60 kDa protein is not 
highly abundant in T. brucei. Thus while the possibility that the 60 kDa labelled proteins 
co-migrate with unassociated protein kinase activities cannot be absolutely ruled out, by 
far the most likely explanation is that the labelling of the 60 kDa protein is due to an 
autophosphorylating protein kinase activity. The simplest case for this type of protein 
kinase activity in which the substrate and protein kinase are physically associated is that 
of autophosphorylating protein kinases where the protein kinase catalytic subunit 
phosphorylates its own amino acids in an intramolecular reaction. This type of activity is 
very common among protein kinases, but trans-autophosphorylation is also consistent 
with the results since identical molecules of a protein kinase will have the same 
isoelectric point and focus to the same region of the gel. It is also possible that the 60 
kDa protein is not itself a protein kinase catalytic subunit but is a substrate that co- 
migrates with one or more types of catalytic subunit due to a physical association with 
the catalytic subunit. Most protein kinase substrates would only transiently associate with 
a protein kinase but a protein kinase regulatory subunit, for instance, could be much 
more strongly associated.
There were obviously differences between the labelled proteins (or between 
oligomeric complexes that included the labelled protein) detected in the IEF gels since 
there were multiple bands of different isoelectric point. If the 60 kDa polypeptide is part 
of an oligomeric complex, the 60 kDa polypeptide itself could be identical in each of the 
IEF gel bands detected, since the charge differences could be explained by the 
association of the 60 kDa polypeptide into different homo- or hetero-oligomers. The
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denaturation of the proteins before SDS-PAGE (and reduction of any disulphide bonds) 
would separate the components of the oligomers allowing common subunits to run 
similarly in the SDS-PAGE gels.
If the differences in isoelectric point between the IEF bands are due to differences 
between the 60 kDa polypeptides, the differences must affect the isoelectric points much 
more than the mobilities in SDS-PAGE, unless protein modification during the IEF assay 
is responsible for the similar mobilities of the labelled proteins in SDS-PAGE (see 
below). There was no clear evidence for more than one band near 60 kDa when the 
SDS-PAGE analysis of the IEF bands was undertaken (the lower mobility SDS-PAGE 
band from seen in gel lane 3 in Fig. 3.2 panel B (from IEF band 3) was not reproducibly 
detected) but it is possible that small mobility differences could have been missed. The 
procedure for transferring protein contained in the agarose of the IEF gels to SDS- 
PAGE can lead to adjacent wells being loaded with slightly different amounts of sample 
buffer which is not ideal when comparing bands of very similar or identical mobility. 
Also, long exposures of autoradiographs were often necessary for detection of the 
weaker bands so that the stronger bands were overexposed, possibly obscuring tightly 
spaced multimers. The simplest pre-translational mechanism for producing slightly 
different products is the expression of multiple closely related genes. There are many 
examples known of this and a small number of closely related gene products, if capable 
of forming oligomers, could produce a larger number of oligomeric isoenzymes. 
Alternate splicing is another pre-translational mechanism that could produce slightly 
different forms of a protein. Phosphorylation is one of the commonest post-translational 
modifications of proteins in higher eukaryotes. The addition of a phosphate to a protein 
makes the protein more acidic and shifts its position in isoelectric focusing towards the 
anode. The charge shift is typically about 0.3 pH units per phosphate in the pH 6-7 
region of the gel (Garrison and Wagner, 1982). It is quite possible that some of the 
different IEF gel bands reflect different levels of phosphorylation of the 60 kDa protein 
prior to IEF. Phosphorylation differences can lead to detectable differences in protein 
mobility in SDS-PAGE and the addition of phosphates at particular sites can lead to both 
increases and decreases in mobility, the latter being more common However, protein 
kinase activity during the labelling step in the IEF assay could have equalised the extent
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of phosphorylation of the 60 kDa protein. This is one possible explanation of the similar 
mobilities of the IEF bands when cut out and run in SDS-PAGE.
To summarise, based on their common 60 kDa molecular weights in SDS-PAGE 
the predominant phosphate labelled proteins in each of the labelled IEF gel bands appear 
to be related, while there is no reason to believe that a 60 kDa protein that might act as 
substrate for multiple protein kinases is distributed throughout the IEF gels. It therefore 
appears that the 60 kDa proteins are either protein kinase catalytic subunits or are quite 
strongly associated with protein kinase catalytic subunits and that they become labelled in 
an autophosphorylation reaction. The differences in isoelectric point between the IEF 
bands containing the 60 kDa proteins are unexplained, but a number of different 
mechanisms that might explain the observed results can be proposed. Because the results 
are most consistent with the various IEF gel bands representing different isoenzymes of a 
protein kinase that autophosphorylates on a 60 kDa polypeptide, the activities of 
different isoelectric point detected in the IEF assay are referred to below collectively as 
those of the 60 kDa autophosphorylating protein kinase.
The earlier work was also extended by phosphoamino acid analysis of the labelled 
IEF bands from bloodstream T. brucei. Labelling of serine and threonine was detected 
for IEF bands 1, 2, 4, 5 and 7 while band 8 was apparently labelled only on serine, but no 
phosphotyrosine was detected. It therefore appears that the protein kinase activity 
detected is that of a serine/threonine protein kinase. The phosphoamino acid analysis of 
the radiolabelled IEF bands was however found to be problematic and, despite a number 
of attempts, the data obtained was limited and no reliable estimate of the relative 
amounts of phosphoserine and phosphothreonine in each IEF gel band was obtained. A 
serious problem was the weakness of labelling of some of the IEF bands. The protein 
hydrolysis conditions are a compromise between incomplete hydrolysis of protein and 
excessive hydrolysis of phosphoamino acids so it is difficult to obtain results if very little 
radiolabelled phosphate is incorporated in the sample proteins. A possible solution to this 
problem would have been to use a much higher ratio of radiolabelled to non-radiolabelled 
ATP in the IEF assay. A further difficulty was the unreliability of the 2-D electrophoresis 
procedure. Many experiments were uninterpretable because the resolution of the 
phosphoamino acid spots was not good enough to allow unambiguous identification. A 
major problem was in wetting the plates evenly and then preventing uneven drying out of
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the plates during electrophoresis. Adjustments to the voltage applied and the technique 
for wetting the plates did not improve the results greatly. Purpose-built equipment is 
available that addresses the problem of unequal fluid distribution across the 
electrophoresis plate and use of this equipment would probably have given better results.
The IEF assay could have been used for further characterisation of the protein 
kinase activity detected but it was decided to purify the protein kinase before further 
characterisation was undertaken. The protein kinase activity was of interest because of 
the great differences observed between the activities in the bloodstream and procyclic 
extracts. Although any information that might have been gained about the properties of 
the 60 kDa autophosphorylating protein kinase in further studies using the IEF assay 
would have been potentially usefiil, there were problems with reproducibility both 
between batches of extract and between individual gels loaded with the same extract. 
This meant that not every band of activity could be reliably detected and resolution of the 
bands was also limited. This may have been more to do with diffusion during the various 
washes between electrophoresis and gel fixation or blotting than with the electrophoresis 
itself. For these reasons each experiment had to be repeated a number of times to give a 
reliable result and it seemed more promising to proceed directly to partial purification of 
the protein kinase before undertaking further characterisation.
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Fig. 3.1 Isoelectric focusing gel in situ protein kinase assay. Panel A shows 
schematically the arrangement of the gels used in the isoelectric focusing gel in situ 
protein kinase assay. The method is described in detail in Chapter 2. Panel B 
summarises the post-electrophoresis steps in the protein kinase assay.
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Fig. 3.2 Analysis of autophosphorylating protein kinase activities from bloodstream and 
procyclic T. brucei using the isoelectric focusing gel in situ protein kinase assay. Panel 
A shows the autoradiograph of a typical IEF gel used for in situ assay of protein kinase 
activity in the absence of added substrate. Procyclic (lane P) and bloodstream (lane BS) 
samples were loaded at the origins (0) and electrophoresed before assay. The positions 
of the anode (+) and cathode (-) are marked. Isoelectric points (pi) were determined by 
running pi markers alongside the samples. The phosphate-labelled bands are numbered 
1-2 for the procyclic samples and 1-8 for the bloodstream. Panel B shows the 
autoradiograph of an SDS-PAGE gel loaded with bands cut out from a dried down IEF 
gel containing autophosphorylating protein kinase activity from bloodstream T. brucei. 
Lanes 1-6 contain bands 1, 2, 3, 4, 7, and 8 respectively. The sizes and positions of 
protein molecular weight markers are indicated to the left of the figure.
Fig. 3.3 Autoradiograph of an IEF gel used to compare protein kinase activity in a 
bloodstream total extract and the 100 000 g supernatant of a total extract. Lanes 1 and 2 
are identical lanes loaded with a total extract, lanes 3 and 4 are identical lanes loaded 
with the supernatant of a total extract.
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Fig. 3.4 Phosphoamino acid analysis of the 60 kDa autophosphorylating protein kinase. 
Panels A and B show sections of a ninhydrin-stained thin-layer chromatography plate 
loaded with hydrolysates of bloodstream DEF bands 1 and 2 respectively (see Fig. 3.2) 
mixed with phosphoserine, phosphothreonine, and phosphotyrosine standards. Panels C 
and D show the autoradiographs corresponding to panels A and B respectively. Labelled 
spots corresponding to the phosphoserine and phosphothreonine standards are indicated 
by arrows. The directions of electrophoresis in buffers 1.9 and 3.5 are also indicated.
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Chapter 4
Purification of the 60 kDa protein kinase
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4.1 Introduction
4.1.1 Aims
As described in the previous chapter the 60 kDa autophosphorylating protein kinase 
identified using the IEF assay showed significant stage-specific differences in its 
expression. Up to eight bands of activity were detected from bloodstream forms while 
only two bands were detected from procyclic forms. Therefore, the study of the protein 
kinase was interesting from the point of view of defining biochemical differences between 
slender bloodstream and procyclic forms (no experiments had been performed to detect 
the protein kinase in stumpy bloodstream forms). Protein phosphorylation in T. brucei 
has only been studied to a limited extent (see Chapter 1) while in other eukaryotes major 
developmental changes such as those that T. brucei undergoes in its complex life cycle 
are co-ordinated by regulatory networks that include protein kinases. Therefore, in order 
to better understand differentiation in T. brucei there is a need for more research into 
protein kinases that are expressed at different levels between life cycle stages.
One major goal in characterising the 60 kDa protein kinase was to clone and 
sequence the gene encoding it; the approach chosen to achieve this was to purify the 
protein kinase in small quantities in order to determine the amino acid sequence by 
microsequencing and to use as an antigen for raising specific antibodies. With a small 
amount of known sequence, specific (although degenerate) oligonucleotides can be 
designed to allow gene cloning through PCR or library screening. If  antisera specific to 
the protein can be raised, expression library screening can be used to isolate clones from 
which the gene sequence can be determined, in addition, a specific antiserum could be 
used in the purification of greater quantities of pure protein for microsequencing. The 
development of methods for at least partial purification of the 60 kDa protein kinase 
would also simplify further biochemical characterisation. General considerations in 
protein purification are discussed in Section 4.1.2.1 while various chromatography 
techniques for protein purification are described in Sections 4.1.2.2-4.1.2.5. Affinity 
purification techniques specific to protein kinases are dealt with in Section 4.1.2.6.
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4.1.2 Approaches to protein purification
4.1.2.1 General considerations
Proteins are large molecules with complex three-dimensional structures, and a mixture of 
charged, polar and hydrophobic groups exposed at the surface. A wide range of 
techniques are therefore applicable to their purification, but protein purification also 
presents particular difficulties. For many purposes it is necessary that the protein being 
purified retains its folded structure throughout the purification and so gentle separation 
conditions are often necessary. Protein purification also requires specific means of 
detecting the protein of interest from a complex mixture of proteins. Because of the large 
number of proteins in a cell it is usually necessary to use several sequential purification 
steps in purifying an individual protein to homogeneity. In many cases the overall 
procedure is a combination of "classical" purification methods such as ion-exchange and 
size-exclusion chromatography and one or more affinity steps based on the reversible 
binding of the target protein to an immobilised ligand, such as a substrate, for which it 
has a specific binding site.
Liquid chromatography techniques are a part of most protein purification 
procedures and a range of chromatographic media designed for protein separations is 
available. In most cases the separation property is determined by a specific chemical 
group (e.g. a charged group for an ion-exchange medium) which is attached to an 
insoluble matrix. The support matrix for protein chromatography will generally be 
hydrophilic so that it can be wetted by an aqueous mobile phase but should not be 
charged or strongly polar as this will result in non-specific protein interactions with the 
matrix. It must also have mechanical strength and flow properties suitable for the 
conditions under which it will be used. The best resolution is obtained when the surface 
area is maximal and since proteins are large molecules the pore size of the support must 
be large enough that proteins can diffuse freely through the matrix (so that it does not 
become blocked or show undesirable size-exclusion properties). The best results will be 
obtained with column chromatography using a pump capable of operating at high 
pressure and a gradient forming system able to mix a mobile phase accurately from 
several solvents (HPLC). UV spectrophotometry at 280 nm is commonly used to give an 
estimate of overall protein concentration in the eluate.
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4.1.2.2 Ion-exchange chromatography
Ion-exchange chromatography depends on ionic interactions between charged groups on 
the chromatographic matrix and charged sample components. In a typical purification an 
ion-exchange matrix is equilibrated in a buffer that includes counter-ions with respect to 
the immobilised charged groups of the matrix. The sample is then applied. Molecules that 
are uncharged or that have the same charge as the ion-exchange matrix fail to bind while 
those of opposite charge may displace buffer counter-ions and bind reversibly to the 
chromatography matrix. After washing to remove unbound material, the conditions are 
changed to elute bound sample molecules. Two types of changes in the buffer are 
commonly used for elution in the case of protein mixtures: an increase in ionic strength 
leads to increased competition for binding sites by buffer ions, while a shift in buffer pH 
towards the isoelectric point of a protein weakens its interaction with an ion-exchange 
matrix. Once the target protein has been eluted under conditions that maximise 
separation, more stringent elution conditions may be employed to remove any strongly- 
bound material, before the matrix is re-equilibrated.
The strength of binding of a protein to an ion-exchanger depends on the number 
of charged groups interacting with the ion-exchanger and the charge density at the points 
of interaction. Very high resolution of proteins may be obtained because of their great 
diversity in charge properties. Proteins are amphoteric and both positively charged 
(anion-exchange) and negatively charged (cation-exchange) matrices may be used 
provided that the target protein is stable across the required pH range. Ion-exchangers 
may be described as strong or weak depending on whether they remain completely 
ionised over a very wide or a somewhat narrower pH range, respectively.
In developing an ion-exchange step for protein separation the pH chosen for 
protein adsorption will normally be about 1 unit above (anion-exchange) or below 
(cation-exchange) the isoelectric point of the target protein. Most proteins begin to elute 
from an ion-exchanger at 0.5 pH units from their isoelectric point at an ionic strength of 
0.1 M NaCl (Lampson and Tytell, 1965). However, it is usually necessary to refine 
binding and elution conditions empirically. A protein’s isoelectric point is a measurement 
of net charge while protein binding to an ion-exchange material is also dependent on the 
distribution of charge, so that some proteins will remain bound at their isoelectric points. 
Salt gradients are commonly used for protein elution and, while buffer pH changes are
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also quite commonly used, these are normally step changes since pH gradients are less 
reproducible.
The advantages of ion-exchange chromatography in protein separations are its 
wide applicability, the high resolution achievable, and the generally high capacity of ion- 
exchange media. Ion-exchange separations can usually be performed using “gentle” 
buffer conditions and recovery of native proteins retaining activity is generally good. It is 
often possible to elute the desired protein in a relatively small volume. For these reasons 
it is one of the most commonly used protein separation techniques. Ion-exchange 
chromatography may be used at any stage of a protein purification and it is not unusual 
for a protein purification procedure to include more than one ion-exchange step. 
However, because of the high capacity of ion-exchange matrices it is very frequently the 
first chromatography step used.
4.1.2.3 Size-exclusion chromatography
Size-exclusion chromatography (also known as gel filtration) separates molecules 
according to differences in their molecular size. The media used for size-exclusion 
chromatography contain pores filled by the liquid phase into which sample components 
can enter. A sample is applied to the top of a column in a small volume and is eluted by a 
flow of eluant of constant composition. As the sample zone moves down the column, the 
smallest sample molecules move freely into the pores of the matrix and are retarded in 
their movement down the column, larger molecules may be partially or completely 
excluded and travel faster down the column mainly or entirely in the spaces between the 
matrix particles. Sample molecules are therefore separated on the basis of size with the 
largest molecules eluting first although molecules of unusual shape may migrate 
anomalously.
Unlike ion-exchange chromatography which has wide applicability to protein 
separations, size-exclusion chromatography is limited to separating proteins that differ 
substantially in size. In a size-exclusion separation important considerations are the pore 
size of the chromatographic matrix and the column length as well as the sample volume 
and viscosity. The matrix used should be one that gives best resolution over the size 
range important for the separation being performed; if this is not known, a matrix with a 
wide fractionation range may be used initially. Resolution is proportional to the square
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root of the column length and so columns for size-exclusion chromatography tend to be 
relatively long. Sample volume is important since sample resolution depends on the ratio 
of sample volume to column volume. A sample volume 1-5% of the column volume is 
normally used for protein separations. Sample concentration does not affect size- 
exclusion chromatography provided that the viscosity of the sample does not differ from 
that of the eluant by more than a factor of two but this is a relatively stringent 
requirement given that sample volume must also be low. The separation achieved in size- 
exclusion chromatography does not fundamentally depend on eluant composition, 
although the buffer should have a high enough ionic strength to prevent ionic interactions 
between sample components and the chromatographic matrix. Because an eluant can be 
chosen to maximise protein stability, recovery of activity is usually good. It is also often 
possible to load samples from a previous step without buffer exchange. If the target 
protein interacts with other proteins in the sample, a buffer may be chosen to minimise or 
maximise the extent of interaction.
Size-exclusion chromatography is an attractive technique for protein separation 
provided that the target protein differs sufficiently in size from contaminants to make the 
technique applicable. The equipment needed is relatively simple, and the development of 
size-exclusion separations is usually uncomplicated. Recovery of native protein is usually 
good. The main disadvantages of size-exclusion chromatography, apart from its limited 
applicability, are the relatively low protein capacity of the technique (for this reason it is 
usually used in the later stages of protein purification) and its inevitable tendency to 
dilute the sample. Size-exclusion chromatography is often used for purposes other than 
protein separation. Particularly common applications are in determining protein 
molecular weights under non-denaturing conditions and for the de-salting of protein 
solutions, for which it is much quicker than dialysis.
4.1.2.4 Reversed-phase and Hydrophobic interaction chromatography
Reversed-phase chromatography (RPC) and hydrophobic interaction chromatography 
(HIC) are related techniques based on the partitioning of sample components between a 
polar mobile phase and a hydrophobic stationary phase. While the majority of 
hydrophobic groups will be buried in the core of a folded protein, the side chains of 
alanine, methionine, tryptophan and phenylalanine do occur at the surface (Hofstee,
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1975). The "hydrophobic interaction" between a protein leaving solution to adsorb to a 
hydrophobic matrix is due to the entropy increase that occurs as water molecules that 
were previously ordered through contact with the protein become less ordered, although 
van der Waal’s forces can also play a part.
RPC describes chromatography using strongly hydrophobic groups, usually 
aliphatic chains, attached to the support matrix at high density. In RPC there would 
normally be a significant organic component to the mobile phase and, with protein 
samples, denaturation would not be unusual. HIC refers to chromatography with a less 
hydrophobic stationary phase substituted with shorter chain alkyl groups or with phenyl 
groups, at a lower density. The mobile phase might include an organic component but 
could be entirely aqueous. Protein denaturation is less likely to be a problem than for 
RPC. A common way of performing HIC is to apply the protein sample in the presence 
of "salting out" salts which promote protein adsorption by trapping water molecules 
released on protein adsorption and then to elute with a decreasing salt gradient. If a drop 
in ionic strength is insufficient to elute the target protein an organic component might be 
added to the mobile phase. These promote elution by reducing the polarity of the 
solution or by competing more strongly than the protein for sites on the matrix. A 
reduction in temperature will also decrease the strength of interaction of a protein with a 
hydrophobic matrix.
Proteins vary widely in the hydrophobic groups exposed at their surfaces and 
HIC is therefore applicable to many protein separations. The protein capacity of HIC 
matrices is generally good and HIC, like ion-exchange, can be used in the early stages of 
a protein purification. An HIC step using salt-promoted adsorption can follow a salting- 
out step with little adjustment to the sample buffer. The main disadvantages of HIC are 
that the conditions used are more likely to denature proteins than those of most other 
chromatography techniques and the development of HIC separations often requires much 
experimentation.
4.1.2.5 Affinity chromatography
Many proteins interact very specifically with other biomolecules due to ligand binding 
sites on the protein which provide a surface complementary to the ligand. For instance, 
enzymes have specific sites which bind substrates. In affinity chromatography a ligand is
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immobilised on a support to make the affinity matrix. A protein mixture containing the 
target protein is passed over the matrix to allow adsorption and the matrix is washed. 
Elution is achieved either with a selective eluant (such as the free ligand) that competes 
for the binding site on the protein or by a change in conditions to weaken the binding 
between the target protein and ligand in a less specific way. For instance, if the binding 
between a protein and a ligand is mainly ionic then increasing the ionic strength to a high 
enough level will cause desorption.
Ligands that may be suitable for affinity chromatography include the cellular 
substrates and regulators of the target protein, natural and synthetic analogues of these 
and antibodies. A number of factors affect the choice of ligand for a particular 
application. Availability of the ligand may be a significant factor as a molecule that would 
otherwise be ideal for affinity chromatography might be very difficult or expensive to 
obtain in sufficient quantities. The affinity of the interaction between target protein and 
ligand must be high enough that the protein is adsorbed to a high degree but not so high 
that harsh conditions are needed for elution. In general, the affinity in solution of the 
ligand for the target protein should be in the range 10'4-10'8 M. A high degree of 
specificity for the target protein is desirable but ligands such as nucleotides have often 
been used for affinity chromatography despite the fact that they bind many proteins. In 
such cases affinity chromatography is best used after previous purification steps have 
removed most competing proteins.
A very important consideration in affinity chromatography is the coupling of the 
ligand to its support to make the affinity matrix. A range of support materials is available 
for immobilising ligands with different reactive groups but it is also essential that the 
linkage used is compatible with protein binding. If the ligand is immobilised through a 
group at, or close to, a part of the ligand that interacts with the target protein then 
protein binding may be sterically hindered. Therefore, it may be necessary to test 
matrices with the ligand bound through different groups. Spacer molecules between the 
support and the ligand may also be needed where the ligand is small and protein binding 
would otherwise be sterically inhibited by the support matrix. A possible problem 
associated with the use of spacer molecules is increased non-specific protein binding.
Affinity chromatography potentially gives the highest levels of protein separation 
of any of the chromatographic techniques. Provided that the affinity is not too strong,
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retention of biological activity is usually good and ligand binding stabilises most proteins, 
although selective eluants can be difficult to remove. The major limitation is that it is 
difficult to develop affinity chromatography for target proteins that have not been well 
characterised. Even if a potentially suitable ligand is available, it may not be easy to find a 
way of immobilising it to give a suitable matrix for purifying the target protein.
4.1.2.6 Purification approaches specific for protein kinases
General considerations in affinity chromatography have been discussed above. In this 
section affinity techniques applicable to protein kinases are considered in more detail. 
Protein kinase purification was reviewed in Methods in Enzymology 200: 159-178 and 
by Wang and Roach (1993). A number of features are common to many protein kinase 
purifications. The abundance of protein kinases varies widely (see Ferrari and Thomas, 
1991) but they are frequently low-abundance proteins and, if this is the case, it is 
important to maximise the efficiency of the purification techniques used and one or more 
affinity steps may be virtually essential. Protein kinases are often regulated by 
phosphorylation and dephosphorylation which can affect both their activity in assays and 
their properties in purification procedures. For this reason it may be necessary to 
homogenise the starting material rapidly in a buffer containing inhibitors of protein kinase 
and protein phosphatase activity and to keep the protein kinase in a buffer containing 
phosphatase inhibitors at all times. A lysis buffer would normally contain EDTA which 
will prevent protein kinase activity by chelating Mg2+. Sodium fluoride is commonly used 
as a protein phosphatase inhibitor and is cheap but, if it is necessary to avoid raising the 
ionic strength or if the protein kinase is targeted by a protein phosphatase not inhibited 
by fluoride, it may be necessary to include other inhibitors such as okadaic acid. 
Vanadate can be used to inhibit protein tyrosine phosphatases.
Possible affinity ligands for the purification of protein kinases are the nucleotide 
and peptide substrates and effector molecules such as activators and inhibitors. 
Immobilised adenosine nucleotides have been used in the purification of protein kinases 
as all use ATP as a substrate (some will also use GTP). ATP affinity chromatography 
matrices have been described as being of four types depending on whether the coupling 
is through the N-6 of adenine, the C-8 of adenine, the terminal phosphate or a ribose 
hydroxyl group (Jeno and Thomas, 1991). A ribose-coupled ATP agarose was used to
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give a 20-fold purification of a mitogen-activated S6 kinase (Jeno et al., 1989) although 
the same enzyme failed to bind ATP agaroses coupled through the N-6 and C-8 positions 
of adenine under the same conditions. Ribose-coupled ATP agarose was also used to 
purify CDK2 from insect cells over-expressing the protein (Rosenblatt et a l,  1993) while 
Seger et a l  (1992) used a C-8 coupled agarose in the purification of a MAP kinase 
kinase. However, despite the fact that all protein kinases bind ATP, the number of 
examples of the successful use of ATP affinity matrices for protein kinase purification is 
limited. The use of ATP affinity matrices for this purpose was recently re-examined by 
Haystead et a l  (1993) who pointed out that the structure published for PKA co­
crystallised with Mg2+ and ATP shows the adenine ring deeply buried in a hydrophobic 
pocket with the phosphates facing outwards. The ribose hydroxyls at the 2- and 3- 
positions hydrogen bond with the enzyme and all three phosphates are also involved in 
interactions with the enzyme. The ATP-binding sites in the other protein kinases analysed 
by X-ray crystallography are similar, although there are some differences (see review by 
Taylor and Radzio-Andzelm, 1994). On the basis of these considerations steric blocking 
of the interaction between protein kinase ATP-binding sites and immobilised ATP would 
be expected for N-6, C-8 and ribose-coupled ATP affinity matrices (purifications 
achieved in the past using these matrices might have been due to cation-exchange) but 
immobilisation of ATP through the terminal (y) phosphate would be expected to be the 
most suitable linkage. However, Haystead et a l  (1993) were unable to find any 
published work describing the use of such affinity matrices for protein kinase purification 
(or any source for a y-phosphate-linked ATP matrix) and decided to develop a y- 
phosphate-linked ATP Sepharose. The first matrix synthesised was a Sepharose with a 
non-hydrolysable ATP analogue (adenosine-5 -(y-4-aminophenyl) triphosphate) bound 
directly to reactive groups on the support through the phenylamino group without the 
use of a spacer. Although the ATP analogue had been previously shown to inhibit four 
different protein kinases in solution and several ATP-binding proteins were shown to 
bind to the matrix, none of the protein kinases tested were found to bind. However, 
when the same ATP analogue was linked to Sepharose in the same way but with an 
additional hexyl spacer, a matrix was obtained that was used to give a 31-fold 
purification of a mammalian MAPKK. ATP affinity matrices of this type have since been
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used in the purification of a rat liver AMP-activated protein kinase (Davies et al., 1994) 
and a human IL-1 activated protein kinase (Kracht et al., 1994).
A number of triazinyl dyes bind enzymes at sites naturally occupied by purine 
nucleotides. Cibacron blue F3GA has been shown by crystallography to bind alcohol 
dehydrogenase at the sites normally occupied by the adenine and ribose rings despite the 
dye’s general lack of structural similarity to NAD (Biellmann et al., 1979). Cibacron blue 
F3GA and other dyes of this group that act as ADP-ribose analogues have been used in 
the purification of protein kinases, although the structure of the nucleotide binding site in 
protein kinases is different from that in NAD binding proteins (see Bossemeyer, 1994), 
and it is not known whether the interaction between these dyes and protein kinases is at 
the protein kinase ATP-binding site. Protein binding to triazinyl dyes can involve both 
ionic and hydrophobic interactions, so unless a bound protein kinase elutes with a low 
concentration of a specific eluant such as ATP a range of elution conditions may have to 
be tested.
Protein and peptide substrates have been used as affinity ligands for the 
purification of a number of protein kinases. Specific protein substrates are likely to give 
highest binding affinity but are often difficult to obtain at high purity in sufficient 
quantities. The large size of proteins, and the variety of ionic, polar, and hydrophobic 
regions present at their surfaces can cause non-specific interactions with contaminating 
proteins as well as there being a higher probability of recognition sites for multiple 
protein kinases on a whole protein than on a peptide. An example of the use of a protein 
substrate affinity matrix was the 10-fold purification of glycogen synthase kinase-3 on a 
glycogen synthase-agarose (Hemmings et al., 1981). Matrices with immobilised model 
substrates, such as protamine, are commercially available and so are easy to test as 
affinity matrices. Protamine-agarose, for example, has been used in the purification of 
protein kinase C (Wooten et al., 1987). The use of peptides based on phosphorylated 
sites in protein kinase substrates for protein kinase affinity purification was reviewed by 
Woodgett (1991). Where the sequences at sites phosphorylated by the target protein 
kinase are known, similar peptides can be tested as substrates for the protein kinase in 
solution before being tested as affinity ligands. Peptides corresponding to protein kinase 
recognition motifs but with the phosphorylated residues replaced by residues that cannot 
accept phosphate groups have been used as protein kinase inhibitors and such motifs
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(pseudosubstrate domains) occur naturally in a number of protein kinases. A peptide 
corresponding to the pseudosubstrate domain of the naturally occurring peptide inhibitor 
of PKA (PKI) was effective as an affinity ligand for purification of this protein kinase 
(Olsen and Uhler, 1989). Compared to whole proteins, peptides are simple to obtain in 
large amounts and at high purity; they are small and are therefore less likely to bind non- 
specifically to proteins other than the target protein and can also be coupled to supports 
at higher density. For both proteins and peptides the coupling group used is important, 
and a spacer may also be needed although usefid affinity matrices can be obtained when 
only a proportion of the ligands are in the correct orientation.
As well as matrices with immobilised proteins and peptides, Sepharoses with 
immobilised threonine have been used in the purification of protein kinase C and 
ribosomal S6 kinase (Lane and Thomas, 1991; Koide et al., 1992). While threonine is 
one of the substrate amino acids of these protein kinases, it is not clear that threonine 
Sepharose acts as a true affinity matrix. Another type of matrix that may interact with 
sites on some protein kinases that are involved in peptide substrate recognition is 
phosphocellulose. This is an ion-exchange material that has been used for purifying a 
number of different types of protein but it may act as an affinity matrix for protein 
kinases such as casein kinase I (Xu et al., 1995) and glycogen synthase kinase. These 
protein kinases phosphorylate residues in peptide motifs that include phosphoserine, and 
might have sites that can specifically bind to the phosphorylated cellulose.
Various molecules that bind to protein kinases as regulators of enzyme activity 
can be used as ligands in affinity chromatography. Protein kinase regulatory subunits 
have been used in a number of cases. For example, calmodulin-Sepharose has been used 
for the purification of several calcium/calmodulin-dependent protein kinases (e.g. Naim 
et al., 1985) and a group of proteins that interact with cyclin-dependent protein kinases 
have proved extremely usefid as affinity ligands for their purification (Hindley et al., 
1987; Azzi et al., 1994). Immobilised EGF has also been used in purifying its receptor 
(Cohen et al., 1982) but the usefidness of peptide growth factors as affinity ligands for 
the purification of receptor protein kinases is limited by both cost and the fact that they 
may bind so strongly to their receptors that elution without loss of activity is impossible. 
Non-peptide effectors of protein kinase activity have also been used as affinity ligands. 
An example is the use of immobilised forms of cAMP and cGMP for the purification of
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the cyclic nucleotide dependent protein kinases. cAMP and cGMP bind to these protein 
kinases with high affinity and a very substantial level of purification can be achieved (e.g. 
Lincoln, 1983). Phosphatidylserine is a natural effector of protein kinase C that has been 
used as an affinity ligand for its purification (Wise et al., 1982). Heparin is an inhibitor of 
casein kinase II in vitro and immobilised heparin has been used for its affinity purification 
(Takio et al., 1987). Non-physiological protein kinase inhibitors can also be usefiil 
affinity ligands for protein kinase purification. The isoquinolinesulfonamide, H-9, inhibits 
PKA, PKG, and PKC. Inagaki et al. (1985) used an H-9 Sepharose in purifying PKC 
from rabbit brain to near homogeneity and were also able to elute PKC, PKA and PKG 
separately from the same column. Chijiwa et al. (1989) demonstrated binding of casein 
kinase I to Sepharoses to which two further isoquinolinesulfonamide inhibitors (CKI-7 
and CKI-8) had been attached and used the latter matrix in the purification of this protein 
kinase.
A significant proportion of protein kinases are themselves phosphoproteins and 
this property may be exploited in their purification. Phosphotyrosine antisera have been 
used in the purification of protein tyrosine kinases (e.g. Wedegaertner and Gill, 1989) 
although, the best known use of such antibodies, is probably in screening expression 
libraries to isolate genes for protein tyrosine kinases. Antibodies to phosphoserine and 
phosphothreonine are also available but are less likely to be usefid for protein kinase 
purification due to the presence of these phosphoamino acids on many proteins. 
Phosphoproteins can also show selective adsorption to iron (HI) metal chelate 
chromatography matrices (Muszynska et al., 1986). This technique appears to have been 
little used for protein kinase purification although it was used by Songyang et al. (1994) 
to select phosphopeptides from a peptide library.
4.1.2.7 Summary
The classical chromatography techniques described above are among the most commonly 
used techniques for protein purification that have general applicability. However, there 
are many other protein purification methods that have not been mentioned. Among these, 
an important technique is 2-D gel electrophoresis in which the first dimension is an IEF 
gel and the second dimension is SDS-PAGE. This technique can give extremely high 
resolution of complex protein mixtures so that even if the starting material has not been
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previously fractionated at least a proportion of proteins are likely to be resolved as 
individual spots free of contaminating protein. It is therefore potentially possible to 
isolate pure protein from the SDS-PAGE gel or from a blot of the gel. However, unless 
the resolution of the electrophoresis is very high, previous purification steps are likely to 
be required before a large proportion of proteins will be resolved as individual spots and 
considerable development may be needed if the technique is to be used preparatively 
rather than analytically.
A large number of affinity techniques have been used for the purification of 
protein kinases (Section 4.1.2.6), the main difficulty with the development of such 
methods being the requirement for some prior information about the properties of the 
protein kinase being purified. All protein kinases share the property of using ATP as 
substrate and Mg2+ as a co-factor but no affinity matrix with general applicability for 
protein kinase purifications has been available in the past. The recently developed y- 
phosphate-linked ATP Sepharose may prove to have such general applicability. Most 
protein kinase purifications are likely to involve both classical purification techniques and 
affinity techniques. It may sometimes be necessary to develop a partial purification 
procedure using classical techniques before performing further characterisation to assist 
in the development of affinity purification steps.
4.2 Results
4.2.1 Development of anion-exchange chromatography
As described in Chapter 3 a number of properties of the 60 kDa autophosphorylating 
protein kinase from bloodstream T. brucei had been determined. 1) The protein 
partitioned in the 100 000 g supernatant of T. brucei extracts. 2) The protein kinase 
activity from this supernatant was stable for at least 1 month at -20 °C or -70 °C. 3) The 
isoelectric points of the various isoenzymes were known. 4) The molecular size of the 
protein kinase had been determined by SDS-PAGE. 5) The protein kinase had been 
found to be able to utilise both ATP and GTP (data not shown) as the nucleotide 
substrate and to autophosphorylate on serine and threonine residues. Protein kinase 
activities that were apparently similar to two of the isoenzymes of the 60 kDa protein 
kinase from bloodstream forms were also detected from extracts of procyclic T. brucei 
but the activity was much lower. Based on these known parameters, the high speed
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supernatant of bloodstream T. brucei extracts was chosen as a suitable starting material 
for protein purification that was free of particulate matter and could be applied to 
chromatography columns. Ion-exchange chromatography was chosen for the first 
purification step because of its high protein capacity (the starting material had only been 
enriched for the 60 kDa protein kinase by removal of insoluble material) and because the 
estimation of the isoelectric points of the 60 kDa protein kinase isoenzymes from the IEF 
protein kinase assay could be used to judge the likely behaviour of the 60 kDa protein 
kinase in ion-exchange. A DEAE anion-exchange column (DEAE is a weak anion- 
exchanger) was available and appeared suitable.
4.2.1.1 Initial anion-exchange separation
In the initial anion-exchange separation using the DEAE column, a priority was to elute 
the protein kinase in a small volume at a predictable point in the chromatography run 
because only a small number of fractions (10) could be assayed immediately for the 60 
kDa protein kinase activity using the IEF gel in situ protein kinase assay. The protein 
kinase was known to be stable to freezing in extracts of high protein concentration but it 
could not be assumed that the same would be true in column fractions. The 
chromatography conditions used are shown in Fig. 4.1 panel B. The sample was loaded 
in 20 mM Tris-HCl pH 7.65 as the isoelectric points of the protein kinase isoenzymes 
that showed highest activity in the IEF assay are between 5.2 and 5.8. As described in 
Section 4.1.2.2 a starting pH of about 1 pH unit above the isoelectric point of the target 
protein is usually chosen in anion-exchange. Thus the lowest isoelectric point isoenzymes 
would be likely to bind quite strongly to the column under the starting conditions, and 
some of the other isoenzymes (isoelectric points between 5.8 and 7.1) should also bind. 
Co-elution of multiple isoenzymes in column fractions to give a pattern of labelled bands 
in the IEF assay similar to that seen when total extracts were assayed would aid 
identification of the 60 kDa protein kinase (although SDS-PAGE size data could also be 
used). It seemed unlikely that the isoenzyme of isoelectric point 9.25 would bind to the 
column under the buffer conditions chosen. Two buffer changes were introduced to elute 
the protein kinase. The first of these was a pH step to 20 mM Tris-HCl pH 5.7, and the 
second a salt step to 500 mM NaCl.
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The absorbance trace from the anion-exchange separation is shown in Fig. 4.1 
panel A with absorbance (at 280 nm) on the vertical axis and time on the horizontal axis. 
Absorbance units frill scale (AUFS) on the spectrophotometer was set initially to 0.2 but 
the spectrophotometer was rescaled for a short time following the NaCl step (indicated 
in the figure). The sample was loaded in multiple injections and the run was started at the 
time of the last injection. The times at which buffer changes were introduced are 
indicated on the horizontal axis. The trace shows a large absorbance peak following 
sample injection representing unbound protein and by 20 minutes into the run the 
absorbance had returned to near baseline level. The pH step introduced at 25 minutes did 
not lead to a significant increase in absorbance but the 500 mM NaCl step introduced at 
33 minutes was followed by a large absorbance peak. Because the pH step had failed to 
lead to an absorbance peak, it was decided to only analyse fractions following the salt 
step. Fig. 4.2 panel A shows the autoradiograph of the IEF gel used in the assay of 
fractions 40-44, which were the first few fractions to show elevated absorbance 
following the 500 mM NaCl step. The gel lanes are labelled with the fraction number 
loaded. The autoradiograph shows that there was no phosphate labelled protein in the 
lanes loaded with fractions 40-41.5 and 43.5-44 but there is labelling in the lanes loaded 
with fractions 42, 42.5, and 43. Because it was necessary to analyse as many fractions as 
possible on a single gel it was not possible to include lanes loaded with the 100 000 g 
supernatant used as the starting material for chromatography or with isoelectric point 
markers, so the identification of any of the phosphate labelled bands as being due to 
isoenzymes of the 60 kDa protein kinase from the autoradiograph of the IEF gel is 
tentative. However, comparison of the phosphate labelled bands from fraction 42 with 
the autoradiographs of IEF gels loaded with total bloodstream extracts (e.g. Fig. 3.2 
panel A) shows some similarity. In both cases the strongest labelling is of the bands 
focusing nearest the anode and the broad strongly labelled band from fraction 42 could 
represent bands 1 and 2 from assay of the total bloodstream extract. The very weak band 
of slightly lower isoelectric point could represent IEF band 6 while the slightly stronger 
band focusing nearest to the cathode could represent IEF band 7. Following 
autoradiography of the IEF gel, the gel bands containing the phosphate labelled protein 
were cut out from the dried gel, rehydrated, and loaded onto an SDS-PAGE gel. The 
autoradiograph of the SDS-PAGE gel lane loaded with the phosphate labelled protein
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from fraction 42.5 is shown in Fig. 4.2 panel B (an attempt was made to analyse the 
labelled protein from fraction 42, but the transfer of the agarose from the IEF gel to the 
SDS-PAGE gel was poor). The 60 kDa size observed for the phosphate labelled bands 
strongly suggests that the activity detected was indeed that of the 60 kDa protein kinase.
4.2.1.2 100 mM NaCl step elution
Having established that the 60 kDa protein kinase would bind to the DEAE column when 
loaded in a starting buffer of pH 7.65 and that it could be eluted by a 500 mM NaCl step 
(at a buffer pH of 5.7), the next aim was to refine the conditions to obtain a higher level 
of purification. It was decided to retain the initial binding conditions and the pH step 
change but then to elute the protein kinase with successive 100 mM NaCl steps. Fig. 4.3 
panel A shows the absorbance trace for the first anion-exchange separation performed 
using 100 mM NaCl steps for elution while panel B shows the buffer conditions used. As 
previously, the sample was loaded in multiple injections and sample loading was followed 
a large absorbance peak. However, in this separation, the pH step (at 28 minutes) was 
followed by a small absorbance peak. At 40 minutes the first NaCl step (to 100 mM 
NaCl) was introduced, and this was followed by further 100 mM increases in the buffer 
NaCl concentration at 50, 60, and 70 minutes. Each NaCl step was followed by a 
significant absorbance peak.
In this experiment it was not possible to predict at what point in the run the 60 
kDa protein kinase was likely to elute. Therefore, the number of fractions that required 
assay for the 60 kDa protein kinase was larger than could be easily assayed using the IEF 
protein kinase assay and, to deal with this problem, a new protein kinase assay (referred 
to as the slot blot assay) was developed. In this assay system (similar to that of Glover 
and Allis, 1991), a slot blot apparatus is used to blot aliquots from individual column 
fractions to a PVDF membrane. The liquid is drawn through the membrane under 
vacuum leaving proteins adsorbed to its surface. The blot is then incubated in a protein 
kinase assay buffer containing [y-32P]ATP and is then washed and dried. Phosphate 
labelling is detected by autoradiography of the blot but, as non-denaturing conditions are 
used in washing the blot, labelling of protein could be due to ATP-binding activity as 
well as protein kinase activity. The autoradiographs of the blots used to assay the column 
fractions are shown in Fig. 4.4. The first few fractions to show elevated absorbance after
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sample application contained significant activity but elution of this activity was complete 
by 6 minutes. No further activity was detected in fractions collected while the column 
was being washed with the starting buffer or in the fractions showing elevated 
absorbance following the pH step (fractions 31-40). A set of fractions (fractions 50-53.5) 
collected following the 100 mM NaCl step introduced at 40 minutes contained activity 
and a further set of fractions containing activity (fractions 58.5-65) was collected 
following the 200 mM NaCl step. Small numbers of fractions containing weak activity 
were also collected following the 300 mM (fractions 69-70.5) and 400 mM salt steps 
(fractions 78.5-79.5). The slot blot assay could not be used to positively identify the 60 
kDa protein kinase and so the IEF assay was used to test for the presence of the 60 kDa 
protein kinase in some of the fractions identified as containing activity in the slot blot 
assay. The fractions chosen for assay using the IEF system were fractions 1-2.5 and 60-
61.5. Fractions 1-2.5 (collected shortly after sample loading) would obviously not 
contain the 60 kDa protein kinase isoenzymes that eluted after the 500 mM NaCl step in 
the first anion-exchange separation but were analysed because they showed a high level 
o f activity in the slot blot assay. Fractions 60-61.5 were the only other fractions that 
showed a high level of activity in the slot blot assay and might contain the 60 kDa 
protein kinase isoenzymes that were eluted by the 500 mM NaCl step in the first anion- 
exchange separation. Fig. 4.5 panel A shows the autoradiograph of the IEF gel used in 
the assay. The autoradiograph shows no phosphate labelling in the lanes loaded with 
fractions 1-2.5 and so the activity detected in the slot blot assay of these fractions is 
entirely distinct from that of the 60 kDa protein kinase. However, labelled proteins were 
detected in the gel lanes loaded with fractions 60-61.5 which are at a similar position in 
the gel to the labelled bands detected in IEF assay of fractions from the first anion- 
exchange separation (Fig. 4.2) and, as previously, a higher isoelectric point activity was 
only detected in the earliest-eluting fraction. The labelled bands from fractions 60 and
60.5 were analysed by SDS-PAGE and autoradiography (Fig. 4.5 panel B). The 60 kDa 
size of the single labelled protein detected from each fraction confirms that the activity 
identified in the IEF assay of the column fractions was that of the 60 kDa 
autophosphorylating protein kinase.
The result of the first anion-exchange separation using 100 mM NaCl steps was 
confirmed in a further chromatography run in which with longer periods were allowed
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between successive 100 mM NaCl steps. Fig. 4.6 panel A shows part of the absorbance 
trace with the fractions that were analysed by the IEF assay indicated, panel B shows the 
buffer conditions while panel C shows the autoradiograph of the IEF gel used in the 
assay of fractions 67.5-71. It can be seen from panel C that the 60 kDa protein kinase 
was detected in fractions 69.5-71 but not in fractions 67.5-69, showing that the 60 kDa 
protein kinase elutes slightly after the main absorbance peak following the 200 mM NaCl 
step.
4.2.1.3 150 mM and 200 mM NaCl steps
The results of the two chromatography runs using 100 mM NaCl steps for protein kinase 
elution at a buffer pH of 5.7 showed that isoenzymes of the 60 kDa protein kinase with 
significant activity in the IEF protein kinase assay could be eluted by a 200 mM NaCl 
step and that these isoenzymes were not eluted at 100 mM NaCl. In order to refine the 
elution conditions further, an anion-exchange run was performed in which 100 mM, 150 
mM, and 200 mM NaCl steps were used for elution. A new protein kinase assay was 
developed to assay the column fractions from this run. In this assay column fractions are 
mixed with a protein kinase assay buffer and the protein kinase labelling reaction is 
started by addition of [y-32P]ATP. Following the labelling incubation, the reaction is 
stopped by addition of SDS-PAGE sample buffer and boiling. The samples are then 
loaded onto SDS-PAGE gels and phosphate labelled proteins are detected by 
autoradiography of the dried gels. This assay is referred to as the liquid kinase assay.
Fig. 4.7 panel A shows the absorbance trace for the latter part of the run while 
panel B shows the buffer conditions used. The sample was loaded in 20 mM Tris-HCl 
pH 7 .65 as in the earlier separations but the pH step to pH 5.7 was introduced earlier. 
The 100 mM, 150 mM, and 200 mM NaCl steps each produced absorbance peaks. Fig. 
4.8 shows the autoradiographs of SDS-PAGE gels used to analyse the liquid kinase 
assays of fractions 54.5-76.5. The autoradiograph of a gel loaded with assays of fractions 
50-54 is not included in the figure but showed no phosphate labelling at any position. 
The autoradiographs of two sets of fractions showed a labelled band of 60 kDa (and no 
labelled bands of any other size). The first set (fractions 57-60.5) correspond to the latter 
part of the absorbance peak following the 150 mM NaCl step while the second set 
(fractions 73.5-76.5) correspond to the main peak following the 200 mM NaCl step.
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The 60 kDa size for the phosphate labelled bands indicated that the liquid kinase 
assay had identified the 60 kDa protein kinase and the lack of labelling of other proteins 
showed that the assay was specific in spite of the availability to the protein kinase of all 
the proteins in the fractions assayed. This specificity is probably due to the activity of the 
60 kDa protein kinase being specifically autophosphorylating. The detection of two 
peaks of activity eluting after 150 mM and 200 mM NaCl steps was not predicted from 
the previous results but was not particularly surprising considering that multiple 
isoenzymes were detected in the IEF assay. To simplify discussion of the result from this 
run the two protein kinase activities have been named PKI (eluted by 150 mM NaCl) and 
PKH (eluted by 200 mM NaCl).
4.2.1.4 100 mM-200 mM NaCl gradient elution
In order to confirm the result of the 150 mM/200 mM NaCl step run that showed that 
the 60 kDa protein kinase eluted as two peaks (PKI and PKH), and to determine more 
precisely the NaCl concentrations required for elution, a further anion-exchange 
separation was performed in which a linear NaCl gradient (100 mM-200 mM NaCl) was 
used to elute the protein kinase. Fig. 4.9 panel A shows the absorbance trace and panel B 
shows the buffer conditions. In this run the starting buffer was 20 mM Tris-HCl pH 5.7 
where 20 mM Tris-HCl pH 7.65 had been used previously. This change was introduced 
because the results of the previous separations suggested that the use of a higher pH 
starting buffer was unnecessary. The buffer changes during the run and the fractions that 
were assayed using the liquid kinase assay are indicated in Fig. 4.9. The autoradiographs 
of the SDS-PAGE gels used to analyse the liquid kinase assays showed a phosphate 
labelled band at 60 kDa and there was very little labelling at other molecular weights. 
Following autoradiography, gel slices containing the labelled 60 kDa band were cut from 
the SDS-PAGE gels and counted by scintillation counting. The results of this analysis are 
shown overlaid on the absorbance trace (see Fig. 4.9 legend). The profile of radioactive 
counts clearly confirms the result of the 150 mM/200 mM NaCl step run, although 
unfortunately a few fractions eluting just after the end of the gradient that clearly would 
have contained some PKH activity were not assayed. PKI elutes at 148 mM NaCl while 
PKH elutes at 175 mM NaCl.
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To briefly summarise the results of the DEAE anion-exchange chromatography, 
conditions were identified under which the 60 kDa protein kinase would bind the anion- 
exchange column and, using increases in buffer NaCl concentration to elute the protein 
kinase in a buffer that was otherwise 20 mM Tris-HCl pH 5.7, it was shown that the 60 
kDa protein kinase could be eluted as two peaks (PKI and PKII) at 148 mM and 175 
mM NaCl. During the development of the anion-exchange chromatography new assays 
were also developed for analysis of the 60 kDa protein kinase activity from column 
fractions. The liquid assay was found to be robust and informative. The anion-exchange 
chromatography could be developed further to give optimal purification (see Discussion) 
but the fractions containing the protein kinase eluted by the finer NaCl steps or by a 100- 
200 mM NaCl gradient were suitable as the starting material to use in the development 
of other chromatography methods for purification of the 60 kDa protein kinase.
4.2.2 Hydrophobic interaction chromatography (HIC)
The initial aim in the investigation of hydrophobic interaction chromatography for the 
purification of the 60 kDa protein kinase was to identify a suitable chromatography 
matrix. In order that this could be achieved rapidly a test kit containing disposable 
gravity fed columns of different agaroses substituted with straight chain alkyl groups was 
used. Protein kinase activity under high salt conditions was also investigated since high 
salt conditions can be used to promote protein adsorption to hydrophobic matrices. The 
starting material used was the concentrated anion-exchange chromatography fractions 
containing the PKII activity eluted by a 100-200 mM NaCl gradient (Section 4.2.1.4); 
this material was pre-labelled (see Section 2.1.8) and adjusted to the starting buffer 
conditions. The starting buffers were 10 mM Tris-HCl pH 7.2 with 0.5 M or 2 M NaCl.
In order to test whether the protein kinase activity was stable under high salt 
conditions, the liquid protein kinase assay for the 60 kDa protein kinase was performed 
with different concentrations of NaCl added to the assay buffer. Fig. 4.10 shows the 
autoradiograph of the SDS-PAGE gel used to analyse the assays with the final NaCl 
concentration in the assay buffer indicated above each lane. The positions and sizes of 
molecular weight markers are indicated to the left of the figure. The labelling of the 60 
kDa band in each lane shows that the protein kinase was active at all of the NaCl 
concentrations tested. The labelling intensity in each lane appears to be similar. Thus the
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60 kDa protein kinase is active at high NaCl concentrations and NaCl might be used to 
promote its interaction with hydrophobic matrices.
The most hydrophobic HIC matrix that was tested was the agarose substituted 
with dodecyl carbon chains. The sample containing pre-labelled protein kinase was 
loaded and then the column was washed with 10 column volumes of the starting buffer 
(10 mM Tris-HCl pH 7.2, 0.5 M NaCl). Fig. 4.11 panel A shows a silver-stained SDS- 
PAGE gel loaded with aliquots from consecutive fractions eluting during application of 
the starting buffer. There is very little eluted protein apparent and the labelled kinase was 
not detected by autoradiography (not shown). Radioactive counts were detected at the 
top of the column (using a Geiger counter) after washing with starting buffer and in 
order that this radioactive material could be analysed the column was dismantled and the 
agarose containing the counts was boiled in SDS-PAGE sample buffer. The sample 
buffer and suspended agarose was then loaded onto an SDS-PAGE gel. Fig. 4.11 (panel 
B) shows two silver-stained SDS-PAGE gel lanes (left) loaded with different portions of 
boiled agarose and autoradiographs of these gel lanes (right). The silver stains show a 
dark smear through which protein bands can just be seen, while the autoradiographs 
show the phosphate labelling in a low molecular weight band and in a smear near the top 
of the gel. It was noticed in dismantling the gel assembly after electrophoresis that the 
agarose left in the wells was still significantly radioactive. Therefore, it seems likely that 
most of the 60 kDa protein kinase was bound irreversibly to the agarose.
The binding of the pre-labelled kinase to an agarose substituted with hexyl carbon 
chains was examined next. Fig. 4.12 panel A shows silver-stained gels containing 
aliquots from consecutive fractions eluting in the starting buffer (which in this experiment 
contained 2 M NaCl) with the fraction numbers labelled above the gel lanes. The leftmost 
lane contains an aliquot of the sample material applied to the column. The 
autoradiographs of these gels are shown in panel B and show a prominent phosphate 
labelled band at 60 kDa. After washing of the column with 10 column volumes under the 
starting conditions the buffer was changed to 10 mM Tris-HCl pH 7.2. Autoradiography 
of SDS-PAGE gels loaded with these fractions showed no phosphate labelling. These 
results show that the 60 kDa protein kinase failed to bind to the hexyl agarose under the 
conditions used.
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The binding of the pre-labelled 60 kDa protein kinase to octyl agarose was also 
tested. Fig. 4.13 panel A shows a silver-stained SDS-PAGE gel containing consecutive 
fractions eluting in the starting buffer (10 mM Tris-HCl pH 7.2, 0.5 M NaCl). No 
phosphate labelled protein was detected by autoradiography of this gel. After washing of 
the column with several column volumes of the starting buffer, the buffer was changed to 
10 mM Tris-HCl pH 7.2. Lanes 1-8 in the gel shown in panel B were loaded with 
aliquots from consecutive fractions eluting after the buffer change. Autoradiography of 
this gel again detected no radioactive protein. In order to elute the 60 kDa protein 
kinase, the agarose was removed from the top of the column and boiled in sample buffer 
before being loaded onto a gel. Fig. 4.13 panel C shows the silver stained SDS-PAGE 
gel separation of the boiled agarose (left) and the autoradiograph of the gel (right). The 
autoradiograph shows a prominent phosphate labelled band of 60 kDa although, due to 
over-concentration of the anion-exchange fraction before labelling, other proteins have 
also become significantly labelled.
The results from these experiments and possible future experiments to develop 
HIC for the purification of the 60 kDa protein kinase are discussed in section 4.3. It was 
found that the 60 kDa protein kinase bound irreversibly to the dodecyl agarose but failed 
to bind the hexyl agarose when applied in a 2 M NaCl buffer. However, the protein 
kinase did bind to the octyl agarose but was only eluted under denaturing conditions; 
elution under non-denaturing conditions was not tested.
4.2.3 ATP affinity chromatography
The use of ATP affinity chromatography for the purification of protein kinases is 
discussed in Section 4.1.2.6. The ATP affinity matrix that was tested was of the type 
with the ATP linked to the support through the N-6 amino group of the adenine ring. 
The sample material used to evaluate whether the ATP agarose could be used in the 
purification of the 60 kDa protein kinase was the anion-exchange fractions containing 
PKII that had been pooled, concentrated and shown to contain the 60 kDa protein kinase 
activity. Three separate binding reactions were performed in 20 mM Tris-HCl pH 7.0 
with either no NaCl, 10 mM NaCl or 50 mM NaCl. A salt such as NaCl is often included 
in chromatography buffers to reduce non-specific protein-matrix interactions. However, 
low salt buffers have been found to be necessary in some cases for protein kinase
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purifications using ATP matrices (see Haystead et al., 1993). The same buffer containing 
800 mM NaCl was used to elute the protein kinase (the protein kinase activity was 
known to be stable to high NaCl concentration). The binding incubations were carried 
out for 20 minutes at 4 °C after which time the agarose was spun down and the 
supernatant removed before addition of the elution buffer. After incubation in the elution 
buffer the suspension was again centrifuged and the supernatant removed. Liquid kinase 
assays were then performed on the supernatants from the binding and elution steps and 
then analysed by SDS-PAGE.
Fig. 4.14 panel A shows the silver-stained SDS-PAGE gel loaded with the 
products of the kinase assays while panel B shows the autoradiograph of the gel. Lanes 1 
and 2 contain molecular weight markers, lanes 3, 4, 5 were loaded with kinase reactions 
performed on supernatants from the binding reactions performed in 0, 10, and 50 mM 
NaCl buffers respectively, while lanes 8, 9, and 10 were loaded with the corresponding 
reactions from the elution step. There is a phosphate labelled protein of 60 kDa in all 
three lanes loaded with protein kinase reactions from the supernatants of the binding 
reactions (panel B) but no labelling of any protein in those containing supernatants from 
the elution step. Therefore, under the conditions used, the protein kinase did not bind the 
ATP matrix but was readily detectable in the supernatants of the binding reactions.
4.2.4 H-9 affinity chromatography
The protein kinase inhibitor N-(2-Aminoethyl)-5-isoquinolinesulphonamide (H-9) was 
found to be inhibitory towards the autophosphorylating activity of the 60 kDa protein 
kinase in preliminary tests of the effect of various protein kinase inhibitors on this 
activity. In order to test H-9 as an affinity ligand for the purification of the 60 kDa 
protein kinase, H-9 was coupled to cyanogen-bromide activated Sepharose following the 
method of Inagaki et al. (1985) as described in Chapter 2. A batch of control Sepharose 
was prepared identically except that it was reacted only with the blocking agent 
(ethanolamine) and not with H-9.
4.2.4.1 Initial tests of protein kinase binding to H-9 Sepharose
A preliminary test of the binding of the 60 kDa protein kinase to H-9 Sepharose was 
performed with material eluted from the DEAE anion-exchange column by a 500 mM
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NaCl step that had been pre-labelled and then concentrated. The sample was incubated 
with a small volume of H-9 Sepharose in 25 mM Tris-HCl pH 7.0 and the Sepharose was 
then washed 6 times with more buffer. Significant radioactive counts could be detected 
associated with the H-9 Sepharose (using a Geiger counter) following the washes. The 
Sepharose was then boiled in SDS-PAGE sample buffer and loaded onto an SDS-PAGE 
gel. Fig. 4.15 panel A shows the silver-stained gel lane containing the agarose and an 
autoradiograph of the gel. It can be seen that the predominant phosphate labelled protein 
(which is a doublet) is 60 kDa in size. Therefore, it appeared from this experiment that at 
least some of the 60 kDa protein kinase had bound to the H-9 Sepharose, but the results 
did not prove that this binding was specific and the silver-stained gel shows many protein 
bands of other sizes.
In order to test whether the binding of the 60 kDa protein kinase to the H-9 
Sepharose was specific, the binding of pre-labelled protein kinase to H-9 Sepharose was 
compared with its binding to control Sepharose. In this experiment the sample used was 
pooled anion-exchange fractions (eluted by a 100 mM-200 mM NaCl gradient) 
containing both PKI and PKII activities that were concentrated and then pre-labelled. 
Fig. 4.15 panel B shows a silver stained SDS-PAGE gel lane loaded with an aliquot of 
the pre-labelled sample and the corresponding autoradiograph. The predominant labelled 
band at 60 kDa is very broad but appears to be a doublet. Aliquots of this material were 
incubated with equal portions of H-9 Sepharose and control Sepharose. The final buffer 
conditions in the binding reactions were 30 mM Tris-HCl pH 7.0, 25 mM NaCl. 
Following the binding incubations, the two Sepharoses were washed four times with 25 
mM Tris-HCl pH 7.0. Fig. 4.15 panel C shows silver stained SDS-PAGE gel lanes and 
autoradiographs used in the analysis of the supernatants from the binding incubations and 
first washes. It can be seen from the autoradiographs that unbound 60 kDa protein 
kinase was readily detectable in both supernatants from the binding incubations. 
However, comparison of the autoradiographs of the supernatants from the first washes 
suggested that more of the 60 kDa protein kinase was eluted from the control Sepharose 
than from the H-9 Sepharose. In addition, after four washes, radioactive counts could be 
detected bound to the H-9 Sepharose (using a Geiger counter) while almost no counts 
were detected bound to the control Sepharose. Thus it appeared that there was specific 
binding of the 60 kDa protein kinase to the H-9 Sepharose. To investigate different
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elution conditions, the H-9 Sepharose with the bound 60 kDa protein kinase was divided 
into two portions. One portion was incubated in buffer containing 1% Triton-XlOO while 
the other was incubated in buffer containing 100 mM NaCl. The 100 mM NaCl removed 
most of the counts (as judged with a Geiger counter) while the detergent removed very 
few. The supernatants from the two elution conditions were analysed by SDS-PAGE and 
autoradiography. The silver stained gel lanes and autoradiographs used in the analysis of 
the Triton X-100 and 100 mM NaCl eluates are shown to the left of panels D and E 
respectively (Fig. 4.15). The labelled 60 kDa protein kinase is barely detectable in the 
Triton X-100 eluate (the silver stained gel also shows that very little other protein was 
eluted) but was the only phosphate labelled protein detected, while the autoradiograph of 
the gel lane loaded with the 100 mM NaCl eluate shows a prominent doublet at 60 kDa 
and one much weaker band at <45 kDa. Since there were still detectable counts 
associated with the Sepharose that had been incubated in 1% Triton X-100, this 
Sepharose was then incubated in buffer containing 2 mM ATP as a further test of elution 
conditions. The silver stained SDS-PAGE gel lane and autoradiograph used to analyse 
the supernatant from this incubation are shown in panel D alongside those used to 
analyse the supernatant from the incubation in 1% Triton X-100. It can be seen that 2 
mM ATP was a much more effective eluant of the 60 kDa protein kinase than the 
detergent. The silver-stained gel lanes containing the 100 mM NaCl and 2 mM ATP 
supernatants showed a relatively small number of protein bands and so 5x the volume of 
these supernatants were used on a larger format SDS-PAGE gel to determine whether a 
polypeptide corresponding to the 60 kDa protein kinase could be detected. The silver 
stained gel lanes and autoradiographs are shown to the right of panels D and E. There is 
a faint silver-stained band at the position of the upper band of the 60 kDa protein kinase 
doublet detected by autoradiography from both NaCl and ATP supernatants (which 
could be due to a single protein species) while the lower band of the doublet corresponds 
in position to a broader silver-stained band which presumably consists of more than one 
species. This analysis was extended by running further portions of the two supernatants 
in 2-dimensional gel electrophoresis. The volume of supernatant loaded onto the 1st- 
dimension gels was the same as was loaded onto the smaller format SDS-PAGE gels 
shown in Fig. 4.15 panels D and E. Fig. 4.16 panel A shows the silver-stained 2nd 
dimension (SDS-PAGE) gel used in the analysis of the 100 mM NaCl supernatant while
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panel B shows the corresponding autoradiograph. The 60 kDa protein kinase doublet 
was the only phosphate labelled protein detected by autoradiography of the gel. The two 
spots in the autoradiograph correspond almost exactly in position with two spots in the 
silver-stained gel (arrowed) in the vertical (SDS-PAGE) dimension, and are close to, but 
do not correspond exactly in position, to these spots in the horizontal (IEF) dimension. 
The upper of the spots in the autoradiograph is further away from the arrowed silver- 
stained spot at the same vertical position than is the lower (which suggests that the 
discrepancy in position cannot be due to shrinkage of the gel). The autoradiograph of the 
2nd dimension gel from analysis of the ATP eluate showed the same two spots as seen in 
the Fig. 4.16 panel B but no protein spots were visible at any position in the silver 
stained gel. Thus the conclusion from the 2-dimensional gel electrophoresis is that an 
amount of the 60 kDa protein kinase that was detectable by autoradiography was not 
detectable by silver-staining although it is conceivable that the two silver-stained spots 
are forms of the 60 kDa protein kinase that do not autophosphorylate in the liquid kinase 
assay.
4.2.4.2 ATP gradient elution of the 60 kDa protein kinase from an H-9 Sepharose 
column
An HPLC minicolumn packed with H-9 Sepharose was prepared so that ATP gradient 
elution could be tested for the purification of the 60 kDa protein kinase. The starting 
material used in this experiment was a portion of the pre-labelled protein kinase analysed 
by SDS-PAGE (shown in Fig. 4.15 panel B) except that an additional buffer exchange 
step was used to reduce the NaCl concentration to approximately 2 mM. Fig. 4.17 panel 
B shows the run conditions used. Following sample application the column was washed 
with approximately 12.5 column volumes of the starting buffer at a flow rate of 0.5 
ml/minute. The flow rate was then reduced to 0.2 ml/minute and a 0-10 mM ATP linear 
gradient was applied between 25 and 45 minutes. Washing of the column with buffer 
containing 10 mM ATP was continued between 45 and 55 minutes and this was followed 
by a change to buffer containing 1 M NaCl at 55 minutes. Fig. 4.17 panel A shows the 
profile of radioactive counts (taken on whole fractions) eluted from the column between 
25 and 65 minutes with counts per minute on the vertical axis and time on the horizontal. 
No absorbance measurements were taken due to an equipment failure. Although the
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radioactive counts eluted are only shown for the latter part of the run all fractions were 
counted. The first few fractions collected after sample application contained a high level 
of radioactivity but subsequent analysis by SDS-PAGE and autoradiography showed that 
this was not due to elution of the 60 kDa protein kinase (see below). It can be seen from 
panel A that the peak of radioactivity detected in the latter part of the run began to elute 
towards the end of the ATP gradient and was mostly eluted when the ATP concentration 
in the eluate had already reached 10 mM. The 1 M NaCl step failed to produce a second 
peak, suggesting that the ATP had eluted all of the bound 60 kDa protein kinase. The 
fractions that contained >1000 cpm were analysed by SDS-PAGE and autoradiography. 
Fig. 4.18 shows silver-stained SDS-PAGE gels (panels A and C) and autoradiographs 
(panels B and D) used in this analysis with the fraction number loaded indicated above 
each lane and the positions and sizes of protein molecular weight markers shown to the 
left. Fractions 3, 4, and 5 contained significant counts but the autoradiograph shows no 
phosphate labelling. It is likely that the counts detected in these fractions were due to 
radioactive ATP or phosphate. The elution profile of the doublet at 60 kDa in the 
autoradiographs of the gel lanes loaded with fractions 45-57 corresponds well with the 
profile of radioactive counts shown in Fig. 4.17 panel A. Although no absorbance trace 
was obtained for this experiment, it can be seen by comparing the silver-stained gel lanes 
loaded with fractions 3, 4 and 5 with those loaded with fractions that were found to 
contain the 60 kDa protein kinase, that a major contaminating protein at 66 kDa (and 
some proteins of other sizes) were excluded from the protein kinase containing fractions. 
Therefore, the H-9 affinity chromatography gave a degree of purification of the 60 kDa 
protein kinase, although this has still to be quantified. The result o f this experiment also 
confirmed the earlier result showing that ATP could be used to elute the 60 kDa protein 
kinase from H-9 Sepharose (H-9 is known to inhibit a number of protein kinases 
competitively with ATP) but it has not been shown that elution of the 60 kDa protein 
kinase is due to ATP binding at the protein kinase ATP-binding site.
In summary, these experiments demonstrate that the pre-labelled 60 kDa protein 
kinase binds specifically to H-9 Sepharose. The protein kinase was partially eluted from 
H-9 Sepharose by incubation in 2 mM ATP but using column chromatography it was 
shown that the bulk of the protein kinase eluted as a single peak at a higher ATP 
concentration. The protein kinase was also effectively eluted from H-9 Sepharose by 100
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mM NaCl. An experiment in which an NaCl gradient was used to elute pre-labelled 60 
kDa protein kinase from the H-9 Sepharose column was unsatisfactory due to 
unexplained weak labelling of the 60 kDa protein kinase (data not shown) but the results 
appeared to suggest that the protein kinase begins to elute at approximately 25 mM 
NaCl. While this experiment would have to be repeated in future work, the preliminary 
result is consistent with the finding that 100 mM NaCl is an effective eluant. It would 
also provide a possible explanation of why a large amount of protein kinase M ed  to bind 
to the H-9 Sepharose in the experiment in which protein kinase binding to H-9 and 
control Sepharoses was compared (Fig. 4.15, panel C), since the NaCl concentration in 
the binding reactions was approximately 25 mM (in later experiments NaCl remaining 
after elution of the protein kinase from the anion-exchange column was more thoroughly 
removed).
4.2.5 Size-exclusion chromatography
Size-exclusion chromatography is generally most useful in the later stages of a protein 
purification since sample capacity is relatively low, but since a size-exclusion column 
suitable for protein work (separation range 10 kDa-300 kDa, 30 cm long, 8 mm internal 
diameter) was available it was decided to perform a test run at an early stage on the high 
speed supernatant of the total T. brucei bloodstream extract. The run was performed 
under isocratic conditions using a 20 mM Tris-HCl pH 5.7, 200 mM NaCl buffer. The 
flow rate was 0.8 ml/minute and fractions were collected every 30 seconds.
Fig. 4.19 panel A shows the absorbance trace (280 nm) for the size-exclusion 
run. A single sample injection of the high speed supernatant of the crude extract (-3%  of 
column volume) was made at time 0. Note that there were two changes to the scaling of 
the spectrophotometer output at about 6.5 minutes (AUFS from 1.0 to 2.0) and at about
14.5 minutes (AUFS from 2.0 to 1.0). The liquid kinase assay was used to analyse 
fractions from 1-30 minutes. Fig. 4.19 panel B shows the autoradiograph of the SDS- 
PAGE gel loaded with the liquid kinase assays of the fractions that were found to contain 
activity. The fraction number analysed is indicated above each gel lane while the 
positions and sizes of molecular weight markers are indicated to the left of the figure. 
The fractions containing protein kinase activity eluted at a position corresponding to the 
latter part of the first absorbance peak following sample loading, suggesting that the
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elution profile may be consistent with an apparent molecular weight for the protein 
kinase in size-exclusion chromatography similar to its apparent molecular weight in SDS- 
PAGE, rather than with a higher molecular weight. However, the size-exclusion 
chromatography would have to be repeated after column calibration to give a real 
molecular weight estimate for the 60 kDa protein kinase. The autoradiograph also shows 
labelling of proteins at molecular weights other than 60 kDa although the 60 kDa protein 
kinase (which is clearly a doublet in the original autoradiograph) is still by far the most 
prominent.
4.3 Discussion
The aim of the work described in this chapter was to purify the 60 kDa 
autophosphorylating protein kinase first identified using the IEF gel in situ protein kinase 
assay (Chapter 3) so that the purified protein could be microsequenced or injected into 
animals to provide an antiserum Anion-exchange chromatography was used as the first 
purification step and an affinity chromatography step was also developed using a 
Sepharose to which a protein kinase inhibitor (H-9) had been immobilised. Preliminary 
investigations were also made into the suitability of a number of other chromatography 
matrices (discussed below). Sequential anion-exchange chromatography, H-9 affinity 
chromatography and SDS-PAGE were not sufficient to purify the 60 kDa protein kinase 
so that it could be resolved as a single band of protein that could be separated from other 
proteins for micro sequencing and neither the amount of protein kinase per T. brucei cell 
nor the purification factor achieved were quantified. The results obtained and the future 
work that would be required to complete the purification of the 60 kDa protein kinase 
are discussed below.
The reasons for the decision to use the 100 000 g supernatant of the extract of 
bloodstream form T. brucei as the starting material for the purification of the 60 kDa 
protein kinase and for the choice of anion-exchange chromatography as the first 
purification step are discussed in Section 4.2.1. The early development of the DEAE 
anion-exchange chromatography was complicated by the fact that at the start only the 
IEF assay (Chapter 3) was available to use to identify the 60 kDa protein kinase in the 
column fractions. This assay is unsuitable for analysis of large numbers of samples, and 
until more appropriate assays were developed, step changes in buffer conditions rather
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than gradients were used so that only column fractions eluted after each step change had 
to be assayed to give a reasonable chance that the fractions containing the 60 kDa 
protein kinase would be identified. In the initial run (Section 4.2.1.1) it was found that 
the 60 kDa protein kinase would bind to the DEAE column in a pH 7.65 buffer, was not 
eluted by a pH shift to pH 5.7, but could be detected using the IEF assay in fractions 
eluted after a 500 mM NaCl step. Elution conditions were then refined using 100 mM 
NaCl steps (Section 4.2.1.2) and at the same time a new assay (the slot blot assay) was 
developed. This assay was rapid and was successftilly used to eliminate large numbers of 
fractions that showed no activity. However, in addition to those fractions which showed 
activity in the slot blot assay and which were later shown to contain the 60 kDa protein 
kinase using the IEF assay, other fractions showed activity in the slot blot assay but did 
not contain the 60 kDa protein kinase activity. Using the combination of the slot blot and 
IEF assays it was found that the 60 kDa protein kinase activity eluted after a 200 mM 
NaCl step (Section 4.2.1.2). Therefore, in spite of the limitations imposed by the lack of 
more appropriate assays, buffer conditions for protein kinase binding and elution were 
rapidly identified and partly refined.
At the next stage in the development of the anion-exchange chromatography 150 
mM and 200 mM NaCl steps were used to elute the protein kinase (Section 4.2.1.3), and 
a further assay (the liquid kinase assay) was tested. It was found that the 60 kDa protein 
kinase eluted as two peaks (PKI and PKII) after the 150 mM and 200 mM NaCl steps 
respectively and that the 60 kDa protein kinase was the only phosphate labelled protein 
detected. Finally, in a chromatography run using a 100 mM-200 mM NaCl linear 
gradient, it was shown that the two forms of the 60 kDa protein kinase elute at 148 mM 
(PKI) and 175 mM NaCl (PKII). The fractions containing the 60 kDa protein kinase 
eluted from the anion-exchange column were suitable for use as the starting material for 
the development of new chromatography methods and, since a complete purification of 
the 60 kDa protein kinase would inevitably involve a number of purification steps, it was 
decided to focus on the identification of new chromatography matrices for purification. 
However, in retrospect, at this stage it would have been better to have performed at least 
some further development of the anion-exchange chromatography. Three aspects in 
particular were unsatisfactory: 1) It was not decided whether to purify both PKI and 
PKII activities (Sections 4.2.1.3 and 4.2.1.4) or just one and some simple experiments to
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determine whether it might be possible to distinguish between the autophosphorylated 
forms of PKI and PKn by SDS-PAGE and autoradiography were not carried out. 2) The 
buffer conditions used in the chromatography could probably have been developed to 
give a higher level of protein kinase purification from runs of shorter duration. 3) The 
chromatography conditions could have been standardised and the liquid kinase assay 
developed further to allow an estimate of the purification factor obtained in the anion- 
exchange chromatography to be determined and to provide a standardised partially 
purified preparation of the 60 kDa protein kinase to use in the development of further 
chromatography steps. These aspects are discussed in turn below, although in practice 
they are interrelated and some flexibility would be required in the approach taken to 
further development of the anion-exchange chromatography.
To behave differently in anion-exchange the 60 kDa polypeptides PKI and PKH 
(Section 4.1.2.3 and 4.1.2.4) must differ in some way from each other (unless one or 
both are non-covalently associated with other molecules) and it might be expected that 
differences in mobility between PKI and PKII labelled by autophosphorylation would be 
observed in autoradiographs of SDS-PAGE gels (unless the differences in behaviour of 
PKI and PKII were due to phosphorylation state and the labelling reaction of the liquid 
kinase assay lead to autophosphorylated PKI and PKII becoming identical). 
Unfortunately, liquid kinase assays on fractions containing PKI and PKII activities were 
never analysed in adjacent SDS-PAGE gel lanes and so small mobility differences could 
have been missed. An obvious experiment would be to label PKI and PKII separately and 
run three adjacent SDS-PAGE gel lanes containing PKI only, PKII only, and a mixture 
of the two (mixed after denaturation in sample buffer) and then expose the gel to film. 
The autoradiograph of such a gel would show whether autophosphorylated PKI and 
PKII have different mobilities in SDS-PAGE and if so which form had higher mobility 
and which form had lower. In most of the work to identify new chromatography matrices 
for protein kinase purification, using protein kinase partially purified by anion-exchange, 
only fractions containing PKII were used and the 60 kDa phosphate labelled band 
appeared as a singlet in these experiments. However, in an experiment in which the 100 
000 g supernatant of bloodstream T. brucei extract was used as the sample in size- 
exclusion chromatography (Section 4.2.5), the 60 kDa protein kinase appeared as a 
doublet in the autoradiographs of SDS-PAGE gels used to analyse liquid kinase assays
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performed on the column fractions (Fig. 4.19). In addition, in the experiments to test 
binding of the 60 kDa protein kinase to H-9 Sepharose the samples used were pooled 
anion-exchange fractions containing both PKI and PKH activities that were pre-labelled 
before binding to H-9 Sepharose (see Section 4.2.4 for more details) and 
autoradiography of aliquots of the samples (Fig. 4.15 panels A and B) and of the eluates 
from the H-9 Sepharose (Figs. 4.15, 4.16, and 4.18) showed the labelled 60 kDa protein 
kinase as a doublet. Therefore, although it has not been shown whether the doublets 
observed in the autoradiographs from these experiments do represent the 
autophosphorylated forms of PKI and PKH, at least two forms of the 60 kDa protein 
kinase with different mobility in SDS-PAGE have been detected.
It is possible that PKI and PKH only differ as a result of secondary modifications, 
and if, for instance, their different behaviour in anion-exchange is due to one form being 
more heavily phosphorylated than the other, then it might be possible to convert the 
more phosphorylated form to the less phosphorylated form by phosphatase treatment. It 
would also be interesting to examine the behaviour of the labelled (i.e. 
autophosphorylated) forms of PKI and PKH in anion-exchange chromatography (and 
also to perform phosphoamino acid analysis). If  the autophosphorylated forms behaved 
significantly differently from PKI and PKH it might be possible to achieve a useful level 
of purification by a second anion-exchange step. In summary, a small number of simple 
experiments would show whether autophosphorylated PKI and PKH have the same 
mobility or different mobility in SDS-PAGE and it would also be relatively simple to test 
the behaviour of PKI and PKH in size-exclusion and H-9 affinity chromatography. This 
would aid interpretation of earlier results and would allow a more informed decision to 
be made about whether to purify both PKI and PKH or just one activity.
As stated above, the buffer conditions used in the anion-exchange 
chromatography might be refined further. In particular, the starting buffer conditions 
might be changed. Throughout most of the development of the anion-exchange 
chromatography the starting buffer was 20 mM Tris-HCl pH 7.5 and a pH shift to pH 
5.7 used in the first separation was retained. In the gradient separation (Section 4.2.1.4) 
this was altered so that the binding buffer had a pH of 5.7. However, even with this 
alteration the starting buffer conditions are probably still rather conservative. PKI and 
PKH remained bound to the DEAE column at 100 mM NaCl after loading in a buffer
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lacking NaCl, and 20 mM Tris-HCl pH 5.7, 100 mM NaCl might be tested as a starting 
buffer. If liquid kinase assays of fractions eluted shortly after sample loading showed 
significant amounts of unbound protein kinase then starting buffers containing lower 
NaCl concentrations could be tested. The use of more stringent starting buffer conditions 
would leave more contaminating protein unbound which could lead to improvements in 
the level of purification attained, would reduce the duration of the chromatography runs 
required and would also allow more sample to be applied to the column without 
overloading.
The IEF and slot blot assays were not suitable for providing a quantitative 
estimate of the activity of the 60 kDa protein kinase in column fractions. However, the 
liquid kinase assay with scintillation counting of the SDS-PAGE gel bands containing the 
60 kDa protein provides a more suitable assay for a quantitative measurement of protein 
kinase activity. Using the liquid kinase assay in this manner with some standardisation of 
the chromatography procedure it would have been possible to perform a more detailed 
characterisation of the anion-exchange chromatography. With a standard amount of the 
100 000 g supernatant loaded in each chromatography run and protein concentration 
measurements (e.g. by Bradford assays) taken on the fractions found to contain PKI and 
PKH and the starting material, a purification factor (i.e. amount of protein in the 
fractions containing the protein kinase activity divided by the total amount of protein 
loaded) could be calculated for a particular set of run conditions. The availability of this 
information would make it possible to compare the suitability of anion-exchange runs 
performed using different sets of run conditions. Once the conditions for a standardised 
anion-exchange run had been decided on it would be possible to use the liquid kinase 
assay to assess quantitatively factors such as the effect of freezing on protein kinase 
activity (which so far has only been assessed qualitatively). It would also be interesting to 
concentrate samples of the standardised protein kinase preparation and to then assay 
serial dilutions to determine at what protein concentration proteins other than the 60 kDa 
protein become labelled. As discussed below the liquid kinase assay might also be used 
to provide an estimate of the amount of the 60 kDa protein.
The second chromatography step developed for the purification of the 60 kDa 
protein kinase that would be likely to form part of a complete purification procedure was 
H-9 affinity chromatography. H-9 Sepharose was tested as an affinity matrix for
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purification of the 60 kDa protein kinase because H-9 was found to be inhibitory to the 
kinase and because H-9 Sepharose is well characterised as an affinity matrix for the 
purification of PKC, PKA, and PKG (Inagaki et al., 1985). The 60 kDa protein kinase 
was found to bind to H-9 Sepharose and could be effectively eluted by 100 mM NaCl or 
by 10 mM ATP (2 mM ATP caused some elution). The results of another experiment 
(data not shown) using a NaCl gradient suggested that the 60 kDa protein kinase elutes 
from H-9 Sepharose at about 25 mM NaCl. This result would provide a possible 
explanation of why much of the kinase failed to bind H-9 Sepharose in an earlier 
experiment (see Section 4.2.4.2) in which the NaCl concentration was above 25 mM.
The elution of the 60 kDa protein kinase from H-9 Sepharose by a low 
concentration of NaCl limits the stringency of the conditions that can be used for binding 
of the protein kinase to H-9 Sepharose and subsequent washes. Therefore it is necessary 
to try to maximise the efficiency of the elution step by using a specific eluant. ATP was 
used as a specific eluant and in fixture work GTP might also be tested as well as the 
effect of the inclusion of Mg2+ ions in the elution buffer. While it was clearly 
demonstrated that the binding of the 60 kDa protein kinase to H-9 Sepharose was 
dependent on H-9 in a comparison of the binding of the protein kinase to H-9 Sepharose 
and control Sepharose, it would be necessary in future work to estimate a purification 
factor for the H-9 chromatography step, and this would be best performed individually 
for standardised preparations of PKI and PKII.
A preliminary investigation was carried out to evaluate the feasibility of using 
HIC for purification of the 60 kDa protein kinase. The autophosphorylating activity of 
the 60 kDa protein kinase was shown to be stable to 2 M NaCl suggesting that it might 
be possible to use salt-promoted adsorption in HIC of the 60 kDa protein kinase. The 
pre-labelled protein kinase failed to bind to the hexyl agarose tested while its binding to 
the dodecyl agarose was apparently irreversible, even after boiling of the agarose in 
SDS-PAGE sample buffer. The protein kinase bound to the octyl agarose in a 0.5 M 
NaCl starting buffer but failed to elute when a similar buffer lacking NaCl was applied to 
the column. In contrast to the situation with the dodecyl agarose, the protein kinase was 
completely removed from the agarose by boiling in SDS-PAGE sample buffer. While the 
stability of the protein kinase activity to high salt conditions suggests that HIC might be a 
suitable purification method for the 60 kDa protein kinase the development of HIC for
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the purification of the 60 kDa protein kinase would require substantial further 
experimentation. As well as further work with matrices substituted with 6-8 carbon 
straight chain alkyl groups, matrices substituted with phenyl groups and branched-chain 
alkyl groups might be tested (no source was identified for a heptyl agarose). In 
performing further screens for suitable HIC matrices the buffer conditions used should 
probably also be changed. NaCl was included in the starting buffers to promote protein 
adsorption but NaCl is a relatively weak salting-out agent and might only be effective at 
higher concentrations. Ammonium sulphate at 1 M concentration would probably have 
been a better choice. While salt-promoted adsorption of the protein kinase to an HIC 
column followed by elution in a decreasing salt gradient represents the ideal, it is quite 
common in HIC purifications to have to use additives such as ethylene glycol to promote 
protein desorption and no such agents were tested. In summary, under the conditions 
tested the 60 kDa protein kinase bound an agarose substituted with octyl carbon groups 
while failing to bind a hexyl agarose. It is not known whether the protein kinase can be 
eluted from the octyl agarose without denaturation. Although much more work would be 
required to develop HIC as a purification step, the protein kinase activity was stable in a 
buffer containing 2 M NaCl suggesting that the protein is sufficiently robust for HIC to 
be used for its purification.
As described in Section 4.2.3 the 60 kDa protein kinase failed to bind to an ATP 
affinity matrix tested. This could have been due to the use of a buffer that was unsuitable 
for binding but the conditions used were mild and the 60 kDa protein kinase activity was 
readily detected in assay of the supernatants from the binding incubations (Fig. 4.14). 
The ATP agarose tested was of the type with the ATP immobilised through the adenine 
N-6 group. This may not be a suitable linkage to produce an affinity matrix for protein 
kinase purification as has also been suggested for the linkages involving the adenine C-8 
group and the ribose hydroxyls (see discussion in Section 4.1.2.6). However, a y- 
phosphate-linked ATP-Sepharose of the type developed by Haystead et a l  (1993) has 
become commercially available since the work directed towards the purification of the 60 
kDa protein kinase was discontinued. This matrix has been used in the purification of a 
MAP kinase kinase (Haystead et al., 1993), an AMP-activated protein kinase (Davies et 
al., 1994) and an IL-1 activated protein kinase (Kracht et al., 1994). It thus appears that 
the y-phosphate-linked ATP-Sepharose has promise as a general affinity matrix for
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protein kinase purifications, and should certainly be tested for its suitability for the 
purification of the 60 kDa protein kinase in any future work to complete its purification. 
Although binding of the 60 kDa protein kinase to H-9 Sepharose is likely to he through 
the ATP-binding site, the affinity of the protein kinase for the y-phosphate-linked ATP- 
Sepharose would probably be higher than for H-9 Sepharose allowing more stringent 
washing conditions, however, fewer contaminating proteins are likely to bind specifically 
to the H-9 Sepharose. Therefore, it seems likely that chromatography with both types of 
matrix would be useful in a full purification procedure.
A single size-exclusion chromatography separation was performed as a 
preliminary investigation to find out whether protein kinase activity could be recovered 
after chromatography of the high speed supernatant of the extract of bloodstream forms. 
Using the liquid kinase assay the 60 kDa protein kinase activity was detected in fractions 
eluted towards the latter part of the first absorbance peak following sample application 
(Section 4.2.5, Fig. 4.19). Size-exclusion chromatography represents the mildest 
purification step used prior to assay of any that were investigated and, in this respect, it 
is interesting that the protein kinase was detected as a doublet. As discussed above, the 
two bands of the doublet could represent PKI and PKH (Section 4.1.2.4) but this has not 
been established. It would be useful to calibrate the size-exclusion column and then to 
determine molecular weights under non-denaturing conditions for the 60 kDa protein 
kinase purified by size-exclusion chromatography alone and for PKI and PKII from 
anion-exchange fractions. It might also be possible to perform experiments to determine 
whether PKI and PKH interact. Size-exclusion chromatography might be used in the 
future for purification of the 60 kDa protein kinase but would be best used at a late stage 
in the purification procedure since it is a low capacity technique. The applicability of 
size-exclusion chromatography as a purification method for the 60 kDa protein kinase 
would also depend on its apparent molecular size in size-exclusion chromatography after 
earlier purification steps. If the 60 kDa polypeptide(s) form multimers or are associated 
with other polypeptides, then size-exclusion chromatography might be a good 
purification step, however, if the apparent molecular size of the protein kinase in size- 
exclusion chromatography is close to 60 kDa this method would probably not be useful 
for purification since SDS-PAGE would be likely to be the last step of a full purification 
procedure.
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It was decided to discontinue work on the purification of the 60 kDa protein 
kinase and to investigate the PCR amplification of T. brucei protein kinase cDNAs as an 
alternative strategy for the study of protein kinases in T. brucei (Chapter 5). This 
decision was taken because of time constraints, particularly as only anion-exchange 
chromatography and H-9 Sepharose affinity chromatography had been developed. It also 
remains undetermined whether or not the amount of the 60 kDa protein kinase per 
bloodstream T. brucei cell might he so small as to make protein purification in quantities 
sufficient for micro sequencing unrealistic. An estimate of the amount of the 60 kDa 
protein kinase in an SDS-PAGE gel band could be calculated from a measurement of 
radioactivity incorporated in the liquid kinase assay (by scintillation counting). However, 
such a calculation would require assumptions to be made, one of which would be that a 
certain number of radiolabelled phosphate groups are added to each 60 kDa polypeptide 
in the liquid kinase assay. Unfortunately, this important factor cannot be determined with 
any certainty. Another way in which it might be possible to radiolabel the 60 kDa protein 
kinase for the purpose of estimating the amount of protein would be to use an affinity 
label (e.g. [14C]FSC>2PhCOAdo, see Zoller et al., 1981) that incorporated a radioactive 
group and that would irreversibly inactivate the protein kinase. This would potentially be 
quite an accurate way in which to quantify the protein since only one label should be 
incorporated per available active site but this would require more development.
An alternative to estimating the amount of protein kinase purified from given 
mass of cells following anion-exchange and H-9 affinity chromatography would be to 
first develop at least one further chromatography step using SDS-PAGE and 2- 
dimensional gel electrophoresis to analyse fractions containing the 60 kDa protein kinase 
activity in the hope that it would become possible to visualise the 60 kDa protein kinase 
as a distinct band or spot by silver staining. Once this became possible, the purification 
procedure could be scaled up using protein stains with progressively higher detection 
limits to estimate the amount of protein kinase recovered. If this latter approach were 
undertaken, the y-phosphate-linked ATP-Sepharose would be the obvious 
chromatography matrix to test first since the affinity of the 60 kDa protein kinase for this 
matrix is likely to be high and the development of the chromatography would probably 
be uncomplicated (an ATP gradient could be used to elute the protein kinase and if 
necessary the protein kinase could be pre-labelled). If the protein kinase proved not to
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bind to this matrix, HIC or cation-exchange chromatography (which was not tested) 
would probably be the best choices.
In summary, the priorities in fixture work would be to fully develop and 
standardise the procedures for the anion-exchange and H-9 affinity chromatography and 
to obtain estimates of the purification achieved in each step (with PKI and PKH probably 
being purified separately) and then to perform experiments to estimate the amount of 
protein recovered to assess the feasibility of purifying sufficient quantities of the 60 kDa 
protein kinase for microsequencing or the raising of antibodies. Depending on the 
approach chosen the latter aim might be simplified by the development of at least one 
fiirther purification step.
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Fig. 4.2 Assay of fractions from the initial anion-exchange separation using the IEF gel 
in situ protein kinase assay. Panel A shows the autoradiograph of the IEF gel used in the 
assay of column fractions from the initial anion-exchange separation (Fig. 4.1). The 
fractions loaded are indicated above the gel lanes and the origin of electrophoresis (O) 
and the position of the anode (+) and cathode (-) are also indicated. In order to obtain 
molecular weight estimates for the phosphate labelled proteins detected in the IEF 
protein kinase assay, gel bands were cut out from the dried IEF gel and loaded onto an 
SDS-PAGE gel which was then dried and autoradiographed. Panel B (left panel) shows 
the autoradiographs of a gel lane containing radiolabelled protein molecular weight 
markers with the molecular weights (in kDa) indicated to the left. The right panel shows 
the autoradiograph of a gel lane loaded with the phosphate labelled protein from fraction
42.5. The labelled protein from fraction 42.5 (indicated by the arrow) is 60 kDa in size.
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Fig. 4.4 Assay of fractions from the 100 mM NaCl step separation (Fig. 
4.3) using the slot blot assay. The figure shows the autoradiographs of 
the blots used in the assay. The fractions loaded in each slot are indicated 
alongside the autoradiographs. Fractions 1-2.5 and 60-61.5 were 
analysed using the IEF gel protein kinase assay (Fig. 4.5).
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Fig. 4.5 Assay of fractions from the 100 mM NaCl step elution (Fig. 4.3) using the IEF 
gel in situ protein kinase assay. Panel A shows the autoradiograph of an IEF gel used in 
the assay of column fractions from the second anion-exchange run (100 mM NaCl step 
elution). Two sets of fractions that showed high activity in the slot blot system were 
chosen for assay. The gel lanes are labelled above with the numbers of the fraction 
loaded and the origin of electrophoresis (O) and the position of the anode (+) and 
cathode (-) are also indicated. To obtain molecular weight estimates for the labelled 
proteins detected in the IEF assay, the gel bands containing the phosphate labelled 
protein were cut from the dried IEF gel and loaded onto an SDS-PAGE gel. Panel B 
shows the autoradiograph of part of the SDS-PAGE gel. The leftmost gel lane was 
loaded with radiolabelled protein molecular weight markers, the sizes of which (in kDa) 
are indicated to the left of the figure. The other two lanes shown were loaded with the 
phosphate labelled bands from fractions 60 and 60.5 (Fig. 4.3). The labelled protein in 
each lane is 60 kDa in size.
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Fig. 4.6 Results of a confirmatory anion-exchange separation using 100 mM NaCl steps 
for protein kinase elution. Panel A shows the absorbance trace from part of the run that 
includes the fractions eluting after the 200 mM NaCl step that were assayed for protein 
kinase activity. The buffer conditions used are shown in panel B. Panel C shows the 
autoradiograph of the blot of the IEF gel used to assay fractions 67.5-71 for the 60 kDa 
protein kinase. The leftmost lane was loaded with a total extract as a positive control.
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Fig. 4.8 Assay of column fractions from the 150 mM/200 mM NaCl step separation 
(Fig. 4.7) using the liquid kinase assay. The figure shows autoradiographs of SDS- 
PAGE gels used to analyse the liquid kinase assays of fractions 54.5-76.5. Fractions 50- 
54 were also assayed but the autoradiograph of the SDS-PAGE gel (which showed no 
phosphate labelling at any position in the gel) is not included in the figure. Radioactive 
protein molecular weight markers were run alongside the assay samples and the sizes (in 
kDa) are shown to the left of each row.
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Fig. 4.10 Activity of the 60 kDa protein kinase in buffers of different NaCl 
concentration. The figure shows the autoradiograph of an SDS-PAGE gel used in the 
analysis of liquid kinase assays for the 60 kDa protein kinase in which NaCl was added 
to the labelling reactions at different concentrations. The sample material was 
concentrated anion-exchange chromatography fractions containing the PKII activity 
eluted by a 100-200 mM NaCl gradient (Section 4.2.1.4). The final NaCl concentrations 
in the different labelling reactions are indicated above the SDS-PAGE gel lanes and the 
positions and sizes (in kDa) of protein molecular weight markers run alongside the 
samples are indicated to the left of the figure.
Fig. 4.11 Binding of pre-labelled 60 kDa protein kinase to the dodecyl agarose column. 
Panel A shows a silver-stained SDS-PAGE gel loaded with aliquots of consecutive 
fractions eluting in the starting buffer. The autoradiograph of the gel showed no 
phosphate labelling of any protein. Panel B shows two gel lanes from a silver-stained 
SDS-PAGE gel loaded with portions of agarose from the top of the dodecyl agarose 
column (left), and the corresponding autoradiographs (right). The positions and sizes (in 
kDa) of protein molecular weight markers run are indicated to the left of panels A and 
B.
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Fig. 4.12 Binding of pre-labelled 60 kDa protein kinase to the hexyl agarose column. 
Panel A shows silver-stained SDS-PAGE gels loaded with aliquots from consecutive 
fractions eluting from the hexyl HIC column in starting buffer. The leftmost lane 
contains an aliquot of the sample that was applied to the column. Panel B shows the 
autoradiographs of the gels. The positions and sizes (in kDa) of protein molecular 
weight markers run alongside the samples are indicated to the left of the figure.
Fig. 4.13 Binding of pre-labelled 60 kDa protein kinase to the octyl agarose column. 
Panel A shows a silver-stained SDS-PAGE gel loaded with consecutive fractions eluting 
from the octyl HIC column in starting buffer (10 mM Tris-HCl pH 7.2, 0.5 M NaCl). 
No labelled protein bands were detected by autoradiography of this gel. Panel B shows 
an SDS-PAGE loaded with consecutive fractions eluting after the buffer was changed to 
10 mM Tris-HCl (pH 7.2). Autoradiography of the gel again showed no labelled bands. 
The left block of Panel C shows a silver stain of an SDS-PAGE gel lane loaded with 
agarose removed from the top of the octyl HIC column. The autoradiograph of the gel 
lane is shown to the right. The positions and sizes (in kDa) of protein molecular weight 
markers are indicated on the figure.
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Fig. 4.14 Binding of the 60 kDa protein kinase to ATP agarose. Panel A shows a silver- 
stained SDS-PAGE gel used to analyse liquid kinase assays performed on supernatants 
from the binding and elution steps. Lanes 3, 4, and 5 contain the reactions performed on 
supernatants from binding incubations performed in buffers containing no NaCl, 10 mM 
NaCl, and 50 mM NaCl respectively while lanes 6, 7, and 8 contain the corresponding 
kinase reactions performed on the supernatants from the elution step. Panel B shows the 
autoradiograph of the gel. Lanes 1 and 2 contain protein molecular weight markers, the 
positions and sizes of which are indicated in panels A and B.
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Fig. 4.15 Binding of pre-labelled 60 kDa protein kinase to H-9 Sepharose. In each block 
the left section shows a silver-stained SDS-PAGE gel lane and the right section shows 
the corresponding autoradiograph. Protein molecular weight markers are shown to the 
left in each panel. While it is not apparent in all of the photographs of the 
autoradiographs, examination of the originals shows clearly that in each case the strong 
band at 60 kDa is a doublet.
Panel A shows the SDS-PAGE analysis of material eluted from H-9 Sepharose 
by boiling in SDS-PAGE sample buffer after the Sepharose had been incubated with 
partially purified pre-labelled protein kinase in buffer and then washed five times in the 
same buffer. It can be seen that the 60 kDa protein kinase was readily detectable in the 
supernatant of the boiled Sepharose.
Panel B shows the SDS-PAGE analysis of an aliquot from a separate batch of 
pre-labelled protein kinase used in an experiment to compare kinase binding to H-9 
Sepharose and control Sepharose (panels C, D and E). Panel C shows the SDS-PAGE 
analysis of supernatants from incubations of the pre-labelled protein kinase with H-9 
Sepharose and control Sepharose in which the buffer was 30 mM Tris-HCl pH 7.0, 25 
mM NaCl (first two blocks) while the latter two blocks show the analysis of the first 
washes (for which the buffer was 25 mM Tris-HCl pH 7.0). Following further washes 
the H-9 Sepharose was divided into two equal portions. One portion was incubated in 
buffer + 1%  Triton-XlOO and then in buffer + 2 mM ATP. The left block of panel D 
shows the SDS-PAGE analysis of the two supernatants. The 60 kDa protein kinase is 
clearly detectable in the ATP eluate but is barely visible in the Triton-XlOO eluate. A 
larger volume of the ATP eluate (5x the volume) was also analysed in a large format 
SDS-PAGE gel (right block of panel D). Panel E shows the silver-stained gel lanes and 
autoradiographs for an equivalent analysis of the other portion of H-9 Sepharose in 
which incubation in 100 mM NaCl was used to elute the 60 kDa protein kinase.
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Fig. 4.16 Two-dimensional gel electrophoresis of protein eluted from H-9 Sepharose. 
Portions of the 2 mM ATP and 100 mM NaCl eluates shown in Fig. 4.15 panels C, E 
and D, F respectively were analysed by two-dimensional electrophoresis. Panel A shows 
the silver-stained second dimension gel used in the analysis of the NaCl eluate (first 
wash) while panel B shows its autoradiograph. The autoradiograph (not shown) of the 
gel used to analyse the ATP eluate showed the same two spots as seen in panel B (these 
were weaker in intensity compared to those from the NaCl eluate as seen in Fig. 4.15) 
but no protein was detected by silver-staining at any position in the gel. The two spots 
in panel B correspond exactly in position with the two silver-stained spots (arrowed) in 
panel A in the vertical dimension (SDS-PAGE), but do not quite match in position in 
the horizontal dimension (IEF). The lower molecular weight labelled spot (panel B) is 
closer in the horizontal dimension to the silver-stained spot at the same vertical position 
than the higher molecular weight labelled spot is to the higher molecular weight silver- 
stained spot.
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Fig. 4.17 Elution of pre-labelled 60 kDa protein kinase from the H-9 affinity column by 
a 0-10 mM ATP gradient. Panel A shows scintillation counts taken on whole fractions 
prior to analysis by SDS-PAGE (Fig. 4.18). Radioactive counts are shown on the 
vertical axis while time is shown on the horizontal. Panel B shows the run conditions 
used. Fractions were collected every minute throughout the experiment.
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Fig. 4.18 SDS-PAGE analysis of fractions collected from the H-9 affinity column 
during application of a 0-10 mM ATP gradient (Fig. 4.17). Panels A and C show silver- 
stained SDS-PAGE gels while panels B and D show the corresponding autoradiographs. 
The sizes of protein molecular weight markers are indicated to the left. Fractions 
containing >1000 cpm were analysed and the fraction numbers are indicated above each 
gel lane. Fractions 3, 4, and 5 (top left) were collected shortly after sample application 
under the starting buffer conditions, while fractions 45-57 were collected while the 
column was being developed with the ATP gradient (Fig. 4.17).
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Fig. 4.19 Size-exclusion chromatography of the 100 000 g supernatant of the extract of 
T. brucei bloodstream forms assayed for the 60 kDa protein kinase. Panel A shows the 
absorbance trace from the size-exclusion chromatography experiment with absorbance 
(280 nm) shown on the vertical axis and time on the horizontal axis. The sample was 
loaded at time 0 and the mobile phase throughout the run was 20 mM Tris-HCl pH 5.7, 
200 mM NaCl. The flow rate was 0.8 ml/minute and fractions were collected every half 
minute. Panel B shows the autoradiograph of an SDS-PAGE gel used to analyse liquid 
kinase assays of column fractions 10.5-14 (fraction numbers are indicated above the gel 
lanes). The positions and sizes of molecular weight markers are indicated the left of the 
figure.
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Chapter Five
Cloning of a Trypanosoma brucei cDNA 
encoding a protein kinase
134
5.1 Introduction
As an alternative strategy to the biochemical study of the 60 kDa autophosphorylating 
protein kinase for characterising protein kinases in T. brucei, PCR amplification of 
protein kinase cDNAs could be carried out using degenerate oligonucleotide primer 
pools designed from highly conserved peptide sequences from the catalytic domain. A 
number of potentially interesting partial sequences had been previously described from a 
study of this type (Hua and Wang, 1994). These sequences were examined to see if any 
of them were likely to be derived from genes for members of the protein kinase C family 
since the cloning of T. brucei genes for members of this protein kinase family would 
complement previous biochemical investigations of protein kinase C like activities (Keith 
et al., 1990). The predicted peptide sequences from two of the amplified cDNA 
fragments (TbPK-A2 and TbPK-Bl) were found to be similar to catalytic domain 
sequences of members of the protein kinase C family in database searches performed by 
Hua and Wang (1994). The predicted peptide sequence from TbPK-Bl showed 47% and 
42% identity to catalytic domain sequences from a Drosophila protein kinase C 
(Schaeffer et al., 1989) and the Aspergillus protein kinase NimA, respectively (Osmani 
et al., 1988), while that from TbPK-A2 showed 56% and 58% identity to catalytic 
domain sequences from a rat protein kinase C (Qno et al., 1988a+b) and the Drosophila 
polo kinase (Llamazares et al., 1991). Based on these data TbPK-A2 (a product of 
primers based on catalytic subdomains VTb and DC) was chosen for further investigation. 
The similar level of sequence identity of this fragment to two protein kinases, only one of 
which is from the protein kinase C family, did not allow a firm prediction as to whether 
or not the short TbPK-A2 sequence was from a gene encoding a member of the PKC 
family. Two approaches were used to extend the TbPK-A2 sequence. The first of these 
was RACE (rapid amplification of cDNA ends) which is explained briefly in the next 
paragraph, while the second was to screen a X cDNA library with a cloned PCR product 
similar to TbPK-A2. This was performed using standard procedures which are described 
in Chapter 2.
The basic strategy for 3' RACE is shown in Fig. 5.1. First-strand cDNA synthesis 
is carried out using an oligo(dT) primer that anneals to the poly(A) tail of mature 
mRNAs. The oligo(dT) portion of the primer is tagged at its 5' end by a sequence that is 
more suitable as a PCR primer. Such cDNA synthesis primers are sometimes called
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adapter primers. Following cDNA synthesis PCR amplification is carried out using a 
sense gene-specific primer and a primer (the anchor primer) corresponding to the 5' 
extension of the adapter primer. The specificity for the target cDNA in this method 
comes only from the gene-specific primer so it is often necessary to use a “nested” gene- 
specific primer in a second amplification using a small amount of the products of the 
initial reaction as the PCR template. To amplify 5' cDNA ends from most organisms, 5' 
RACE is carried out by engineering the addition of homopolymer tails to the pool of 
cDNAs using a terminal deoxynucleotide transferase. PCR of these tailed cDNAs is 
performed between antisense gene-specific primers and 5 ' adapter primer complementary 
at its 3 ' end to the homopolymer tail but with a 5' anchor sequence. However, T. brucei 
mature mRNAs have a spliced leader sequence at their 5' ends and, as an alternative to 
tailing of cDNAs, a primer based on the spliced leader can be used in combination with a 
gene-specific primer. As well as being technically easier than conventional 5" RACE, the 
use of the spliced leader primer introduces a selection for amplification only of full length 
cDNAs derived from T. brucei mRNAs. However, the sequence of the T. brucei spliced 
leader has a considerably lower G+C content than is ideal for PCR. Fig. 5.2 shows the 
strategy for 5' RACE using the spliced leader.
5.2 Results
5.2.1 Amplification of a cDNA fragment homologous to TbPK-A2
Non-degenerate gene specific primers were synthesised using sequence information from 
TbPK-A2. In order to simplify explanation of the PCR reactions carried out, the primerp 
used have been given numbers. Fig. 5.3 shows the primer positions and their sequences. 
The 5' ends of the two outermost primers 2 and 5 overlap the original degenerate 
primers by 7 and 5 bases respectively.
A PCR reaction, using primers 2 and 5 with a first strand cDNA template from 
bloodstream T. brucei, was performed to confirm the presence of TbPK-A2 in stock 869 
and to generate a probe for library screens. Fig. 5.4 panel A shows an agarose gel 
containing the products of 30 cycles of PCR (annealing temperature 48 °C, extension 
time 1 minute) with primers 2 and 5 (lane 2) and DNA size markers (lane 1). The 
product band in lane 2 is of the size expected (171 bp) for an amplified cDNA fragment 
similar to TbPK-A2. To confirm the similarity between this fragment and that reported
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by Hua and Wang (1994), DNA from the gel band was used as the template for PCR 
reactions with the different possible combinations of gene-specific primers. Fig. 5.4 panel 
B shows a gel containing aliquots of these reactions. All reactions gave single products 
of the expected sizes. The product of primers 2 and 5 was then cloned and sequenced 
completely in both strands. It was found to be identical in sequence to TbPK-A2 across 
the region of overlap except for a single base pair difference which led to a difference in 
the predicted peptide sequence.
5.2.2 Amplification of the 5' cDNA sequence
To extend the sequence in the 5' direction, T. brucei first-strand cDNA was amplified 
using primer 1 (spliced leader) and primer 5 (gene-specific). Fig. 5.5 panel A shows an 
agarose gel lane containing the products of 30 cycles of amplification (annealing 
temperature 47 °C, extension time 2 minutes) with these primers. The sizes of DNA 
markers are described to the left. Identical products were obtained with annealing 
temperatures of 38 °C and 50 °C. Individual DNA bands from the initial 5' reaction were 
then re-amplified from gel slices. Since the desired 5 ' products would overlap with the 
entire length of the cloned PCR product of primers 2 and 5 this fragment was used to 
probe a Southern blot of the second round 5' RACE reactions. Fig. 5.5 panel B shows 
the gel used to separate the reaction products while Fig. 5.5 panel C shows the 
autoradiograph of the hybridised blot. The strongly hybridising band (lane 3) is from the 
DNA that was used to make the probe, included as a positive control. The high level of 
hybridisation suggests that the probe was labelled efficiently and was specific as a probe, 
although a rather large area of the blot was labelled due to overloading of the gel. Lanes 
6, 8, and 10 contain products of PCR reactions using the spliced leader primer and gene- 
specific primer 5. Several of the bands hybridised to the probe but the signal was weak 
compared to that from the positive control. The intensity of the ethidium bromide 
staining of the test gel bands compared to that of the positive control band shows that 
the lower degree of hybridisation cannot be accounted for by lower quantities of DNA in 
the test samples if the hybridisation is to the visible gel bands. The most likely 
explanation of the hybridisation is that it is either entirely non-specific or is due only to 
hybridisation to the primers rather than to internal sequences. Therefore, no products 
likely to contain the 5' end of the gene were obtained by 5' RACE.
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5.2.3 Amplification of the 3' cDNA sequence
PCR amplification was carried out on T. brucei first-strand cDNA using primer 2 (gene- 
specific) and an ofigo(dT) primer. Fig. 5.6 (panel A) shows an agarose gel used to 
analyse the products obtained. Lane 1 contains DNA size markers, lane 2 contains the 
products of a positive control reaction while lane 3 contains the products of the 3' 
RACE reaction. It can be seen in lane 3 that no specific bands were obtained in the 
RACE reaction while the positive control template was successfully amplified (lane 2). A 
possible reason for the failure of the 3' reaction to amplify products was that the lower 
annealing temperature used with an oligo(dT) primer was reducing the specificity of the 
reaction. To address this problem a new batch of cDNA was synthesised using an 
adapter primer so that the corresponding anchor primer could be used for PCR Fig. 5.6 
panel B depicts a gel containing products of the 3' reaction using gene-specific primer 3 
and an anchor primer (primer 6) in 33 cycles of PCR with annealing temperatures of 56 
°C, 58 °C, and 60 °C (indicated on figure) and a 3 minute extension time. Two product 
bands were cloned from the 56 °C reaction (marked on the figure). Fig. 5.6 panel C 
shows duplicate lanes (2, 3, and 4, 5) containing products of reactions between the 
anchor primer and the gene specific primers 2 and 3 respectively. Lane 1 contains DNA 
size markers. The annealing temperatures were 50 °C for the primer 2 reaction and 46 °C 
for the primer 3 reaction. The extension time was 3 minutes in both cases. The ends of 
the two products cloned from the reaction between primers 3 and 6 were sequenced. The 
larger product had the anchor sequence at both ends. Furthermore, the failure of a 
sequencing reaction using the gene specific primer as the sequencing primer suggested 
that this primer was not present internally. The other clone had the gene-specific primer 
at one end and the anchor primer at the other but the sequence internal to the gene- 
specific primer was not similar to that of TbPK-A2. Thus the 3 ' RACE also failed to 
extend the known sequence.
5.2.4 Isolation of a Xgtll cDNA clone containing the TbPK-A2 sequence
As an alternative strategy to isolating a cDNA containing the TbPK-A2 sequence, the 
cloned PCR product similar to TbPK-A2 (Section 5.2.1) was used as a probe to screen a 
T. brucei cDNA library constructed in A,gtll. In the primary screen only a single plaque 
from a confluent plate appeared to show hybridisation to the probe and this was picked
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for further screening. Fig. 5.7 shows autoradiographs of plaque lifts from secondary and 
tertiary screens enriched from the primary pick. The plaque chosen from the secondary 
screen (panel A) is marked with an arrow. In the tertiary screen (panel B) 22 plaques 
hybridised to the probe from a total of 78. One of these plaques (also marked) that was 
well separated from its neighbours was picked to provide a master stock for preparation 
of DNA. Purified phage DNA was restriction digested with Eco RI and the products run 
out in an agarose gel. The ethidium bromide stained gel was then examined by UV 
transillumination and, as well as the bands representing the X vector, a single insert band 
of 2.8 kbp was seen. This DNA band was extracted from the gel and subcloned into the 
Eco RI site of pGEM7Zf(+) to give plasmid pTbplkl.
5.2.4.1 Subcloning and sequencing of pTbplkl
Plasmid pTbplkl was digested with a variety of restriction enzymes and a physical map 
of the insert constructed (Fig. 5.8). Subclones were made of fragments A, B, C, D, and E 
as indicated in the figure. A deletion set was also made across subclone A from the 5' 
end. The deletion set and subclones B and C were sequenced using standard procedures. 
The ends of subclone D were also sequenced and the overlap of the ends of subclone C 
with subclones B and D was checked by sequencing of pTbplkl using gene-specific 
sequencing primers. Therefore, a continuous stretch (1554 bp) has been sequenced from 
the 5' Eco RI site (nucleotide 1) to just past the Hinc II site in subclone D. Short 
sections have also been sequenced from the 3 ' end of subclone D and from the 3' end of 
the whole insert in pTbplkl. Fig. 5.9 panels A, B, and C shows the sequences of these 
three sections, arranged so that the start of each sequence corresponds to the end nearest 
the 5' of the insert in pTbplkl.
The contiguous sequence from the 5' end of pTbplkl was translated using the 
Pepdata program of the Wisconsin GCG package which produces a single file with all 
possible translations linked together. A preliminary database search was then performed 
on the Pepdata output using the Fasta program of the GCG package. Predicted 
polypeptide sequences from two different sections of pTbplkl (the open reading frames 
are also in opposite orientations) were significantly homologous to peptide sequences in 
the databases. As expected, one of these is similar to a range of protein kinase peptide 
sequences and includes the TbPK-A2 peptide sequence while the other is approximately
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50% identical to a part of the ribosomal protein S4 (RPS4) komologues from mammals 
and yeast. Examination of the peptide sequence with homology to protein kinases shows 
a complete protein kinase catalytic domain according to the homology based definition of 
Hanks and Quinn (1991). They defined the amino terminal boundary at a position seven 
residues upstream from the first glycine in the glycine-rich loop of catalytic subdomain I 
(consensus G-x-G-x-x-G where x is any amino acid, see Section 1.2.2) and the carboxyl 
terminus at a hydrophobic residue 12-18 amino acids (for protein serine/threonine 
kinases) downstream of the conserved arginine of subdomain XI, with the last four 
amino acids commonly according with the consensus H-P-(aromatic amino acid)- 
(hydrophobic amino acid). The protein kinase catalytic domain predicted from pTbplkl is 
labelled as block C in Fig. 5.9 (nucleotides 503-1267, sense strand in bold). The residues 
that define the boundaries of the catalytic domain are individually boxed, although the 
third glycine of the subdomain I consensus sequence is substituted by an alanine (see 
Section 5.2.4.3). The sequence that overlaps with TbPK-A2 is indicated by underlining 
(see Fig. 5.4 for more detailed information).
The section of sequence with homology to eukaryotic ribosomal protein S4 is 
labelled as block A in Fig. 5.9 (nucleotides 356-1, sense strand in bold). Alignments of 
the predicted peptide sequence with that of other RPS4 komologues strongly suggests 
that only a partial coding sequence is contained in pTbplkl (Section 5.2.4.4). The coding 
sequence for the C-terminus of the partial protein sequence ends at the 5' end (Eco RI 
site) of the insert in pTbplkl while the boundary of the most N-terminal coding sequence 
has been set at nucleotide position 356 because extension of the open reading predicts 
peptide sequence unlike that of any known RPS4 homologue, although it is not at the 
end of the open reading frame.
The protein kinase catalytic domain from pTbplkl was found to be most 
homologous to those of members of a distinct protein kinase family (polo-like kinases, 
see next section) and a 30 amino acid sequence encoded by nucleotides 127-216 of 
Block E (Fig. 5.9 panel B) shows a high level of homology to a C-terminal domain (PH2 
domain) conserved among polo-like kinases (see Section 5.2.4.3). Thus the putative 
protein kinase from pTbplkl appears to be a polo-like kinase. The predicted domain 
structure of the putative T. brucei protein kinase is compared with the domain structure 
of known polo-like kinases in Fig. 5.10. It has been assumed that both of the
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unsequenced sections of pTbplkl contain coding sequence for the protein kinase as both 
fall between sections of nucleotide sequence for which the predicted peptide sequences 
show significant homology to polo-like kinases (see Fig. 5.13). The different domains are 
described briefly in the legends to figures 5.9 and 5.10 and discussed further in Sections
5.2.4.2 and 5.2.4.3.
The finding that a region of pTbplkl predicts a polypeptide with a high level of 
homology to a part of the sequence of RPS4 homologues was unexpected since the X 
clone was obtained using a probe from the protein kinase coding sequence and a cDNA 
clone would be expected to contain coding sequence for only a single protein. The most 
likely explanation seemed to be that partial cDNAs for the protein kinase and RPS4 
homologues had become artifactually ligated during library construction in which case 
there would be no expectation that the two genes need be close to each other in the 
genome. In order to check whether the protein kinase and RPS4 coding sequences were 
co-linear in the genome, a Southern blot of T. brucei genomic DNA was hybridised 
sequentially to probes from the protein kinase and RPS4 coding regions. Fig. 5.11 panel 
A shows the autoradiograph of the blot hybridised to the protein kinase probe (insert of 
subclone B) while panel B shows the autoradiograph of the same blot after it was 
stripped and hybridised to the RPS4 probe (insert of subclone E). The T. brucei genomic 
DNA was digested with Hind III or Eco RI (indicated on figure), neither of which cuts 
anywhere internally to pTbplkl. The hybridisations were performed under high 
stringency conditions. As seen in panel A the protein kinase probe hybridises to a single 
band in each lane (similar to the results of Hua and Wang, 1994) while the ribosomal 
probe hybridised to two bands in the Hind HI lane but only one in the Eco RI lane. The 
single band hybridising to the protein kinase probe is not similar in size to any of the 
bands hybridising to the RPS4 probe. Therefore, while both the probe sequences used 
appear to be from T. brucei, they are not co-linear in the genome although are co-linear 
in the cDNA clone. This supports the simplest conclusion that the protein kinase and 
RPS4 coding sequences are artifactually ligated. Hybrid cDNAs that include ribosomal 
protein cDNAs are common contaminants of cDNA libraries, presumably because the 
messages are abundant. This has been shown to be the case in T. brucei by the high 
representation of ribosomal protein cDNAs in the randomly chosen T. brucei cDNAs 
sequenced by El-Sayed et al. (1995).
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5.2.4.2 The putative protein kinase from pTbplkl is a member of the polo-like 
kinase family
In order to identify protein kinases similar to the protein kinase predicted from pTbplkl, 
database comparisons with the catalytic domain peptide sequence (i.e. the peptide 
sequence of Block C in Fig 5.9) were performed using the BLAST network service at 
the NCBI to search the PDB, SwissProt, PIR, and GenPept databases and also the 
SwissProt and GenPept updates. Then, in order to determine percentage identities across 
the full catalytic domain for the closest matches (rather than the segments aligned by the 
BLAST program), the Fasta program of the Wisconsin GCG package was used. Table
5.1 lists the closest matches identified in the database searches. The highest level of 
identity is with Cdc5 of Saccharomyces cerevisiae to which the T. brucei catalytic 
domain peptide sequence is 53% identical over 257 amino acids. The T. brucei sequence 
also shows a very similar level of homology to plol of Schizosaccharomyces pombe. The 
next best match is with the human protein kinase Plkl closely followed by the murine 
protein kinase STPK13 and a protein kinase from rat (rat plk). Three further sequences 
similar to Plkl and two similar to STPK13 have been published but have not been 
included in this analysis because the degree of similarity between the reported sequences 
in both cases is so high that it seems likely that the differences represent polymorphisms 
in the same gene. The Plkl, STPK13 and rat plk proteins are very closely related to each 
other (> 94% identity over the entire proteins) and are probably functional homologues. 
The next two most related sequences are from two further murine protein kinases, Fnk 
and Snk, which are, respectively, 46.7% and 46.5% identical to the T. brucei sequence, 
but are both only about 52% identical to murine STPK13, while being 68.8% identical to 
each other. The last three entries in the table are a C. elegans protein kinase predicted 
from genomic DNA, a protein kinase from Drosophila named polo, and a fourth murine 
protein kinase Sak, for which there are two isoforms which have identical catalytic 
domains. The level of identity of the T. brucei sequence to the sequences listed in Table
5.1 compares with 25%-35% identity to many members of the cyclic nucleotide 
dependent and protein kinase C families. This lower level of identity suggests that the 
cloned sequence is not a member of the protein kinase C family.
Examination of the literature showed that Cdc5, plol, Plkl, STPK13, rat plk, 
Fnk, Snk, and polo are all recognised members of a family of protein kinases (polo-like
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kinases) for which the Drosophila protein kinase polo is the prototype. The common 
features which define members of this protein kinase family are closely related N-terminal 
catalytic domains and C-terminal extensions of about 300 amino acids that share a well- 
conserved 30 amino acid domain (termed the PH2 domain by Hamanaka et al., 1994). 
Sak a and Sak b (Fode et al., 1994) have N-terminal catalytic domains and significant C- 
terminal extensions but in neither case is the sequence C-terminal to the catalytic domain 
similar to that of polo-like kinases. The C. elegans protein kinase predicted from 
genomic sequence is not a recognised polo-like kinase but examination of the sequence 
suggests that it belongs to this protein kinase family (see Section 5.2.4.3). The high level 
of homology of the catalytic domain of the putative protein kinase from T. brucei to 
those of polo-like kinases suggested that it might be a family member. This hypothesis 
was strongly supported by the finding that an open reading frame, extending through the 
3 ' most sequenced section of subclone D (i.e. Block E in Figs. 5.9 and 5.10), predicts a 
peptide sequence that includes a domain homologous to the PH2 domain. Therefore, 
although the frill coding sequence is not yet available, the putative protein kinase from T. 
brucei has been named TbPLK (T. brucei polo-like kinase).
5.2.4.3 The probable primary structure of TbPLK and alignments of the catalytic 
domain and C-terminal sequences with those of other polo-like kinases 
It is expected that complete sequencing of pTbplkl will show that the open reading 
frame for TbPLK extends at least from the 5' end of Block C (nucleotide 503) to the 3' 
end of the whole insert in pTbplkl. The open reading frame of Blocks C and D can be 
extended 5' through Block B and this block of sequence probably encodes at least part 
of the N-terminus of TbPLK No significant homology was found between the predicted 
peptide sequence from Block B and the peptide sequences N-terminal of the catalytic 
domain of other polo-like kinases, but the N-termini of polo-like kinases are poorly 
conserved except between the closely related Plkl, STPK13 and rat plk. Therefore the 
lack of homology between the T. brucei sequence and the other sequences is not 
evidence against Block B encoding the N-terminus of TbPLK If Block B is part of the 
protein kinase cDNA it is unclear whether the N-terminal coding sequence is complete or 
not. There is a possible start codon (nucleotides 377-379) which, if used, would give an 
N-terminal domain of 42 amino acids but, if the open reading frame is extended slightly
143
5' the predicted peptide sequence is KKKKRM similar to short strings of basic amino 
acids found in the N-termini of Cdc5 and Snk. These amino acid sequences could 
represent nuclear localisation signals (Dingwall and Laskey, 1986; Goldfarb et al., 1986). 
However, not all the polo-like kinases have such sequences in their N-termini and similar 
sequences internal to the catalytic domain of polo-like kinases might fulfil a nuclear 
targeting function (Holtrich et al., 1994). Whatever the true sequence for the N-terminus 
of TbPLK, it will clearly have to be confirmed from new library clones or PCR products.
It also appears that pTbplkl does not contain the complete coding sequence for 
the C-terminal end of TbPLK since an open reading extending throughout Block F 
(which is from the very 3' end of the insert in pTbplkl) predicts a peptide sequence that 
shows significant homology to the C-termini of polo-like kinases. However, there may be 
very little 3' coding sequence for TbPLK not contained within pTbplkl (see below). To 
summarise, pTbplkl probably contains almost all of the coding sequence for the putative 
protein TbPLK but some 3' coding sequence for TbPLK is not contained in pTbplkl 
and, while the 5' coding sequence may be complete, this sequence will also have to be 
confirmed from independent clones. The TbPLK message would also appear to have a 
considerable amount of untranslated sequence that is not contained in pTbplkl since the 
size of the region within pTbplkl that is likely to be protein kinase coding sequence is 
about 2 kb smaller than the size of the poly(A)+ RNA that hybridised to TbPK-A2 in a 
Northern analysis performed by Hua and Wang (1994). The catalytic domain, junction 
domain, PH2 domain and C-terminal sequences are considered in more detail below.
Fig. 5.12 shows an alignment of the putative T. brucei protein kinase catalytic 
domain with the sequences from its closest homologues as fisted in Table 5.1. For Plkl 
and STPK13, for which further very closely related sequences have been published, a 
consensus of the available sequences was used. The C. elegans protein kinase (Wilson et 
al., 1994) is a putative protein kinase predicted from genomic DNA by the program 
Genefinder, and the predicted peptide sequence in the databases ends at a stop codon 
shortly after the invariant arginine of subdomain XI. However, another predicted open 
reading frame that begins shortly downstream encodes polypeptide sequence 
homologous to the C-terminal extensions of polo-like kinases, including the PH2 
domain. It therefore seems likely that the current prediction of two proteins from this 
region of genomic DNA is incorrect, and that the true message encodes a protein kinase
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similar to the recognised polo-like kinases. Introduction of a small additional intron 
(position 21871 in cosmid K06H7 to 1040 in cosmid C14B9) gives a putative mRNA 
encoding a polo-like kinase. The last few amino acids of the catalytic domain predicted 
from this “corrected” putative mRNA are a closer match both to the corresponding 
positions in polo-like kinases and to the protein kinase consensus than the current 
prediction in the databases. The peptide sequences in the alignments are from the 
“corrected” putative mRNA.
Fig. 5.13 is a similar alignment of the polypeptide sequences of polo-like kinases 
from the junction domain to the C-termini. In both figures the Pileup program of the 
Wisconsin GCG package was used to make the alignments but in Fig. 5.13, because the 
full predicted peptide for the C-terminus of TbPLK is not yet available, the three partial 
sequences (from Blocks D, E and F; see Figs 5.9 and 5.10) were added to the alignment 
of the other complete sequences. Residues that are identical between two or more 
sequences are indicated by shading, while dots represent gaps introduced to align the 
sequences. In Fig. 5.12 the protein kinase catalytic subdomains are indicated by Roman 
numerals, and the PH2 domain is indicated in Fig. 5.13 by dashed underlining. The 
STPK13 and rat plk C-terminal sequences, both of which are very similar to that of Plkl 
(H.s.), have been omitted in Fig. 5.13 for reasons of space.
Considering first the catalytic domain alignment in Fig. 5.12, subdomain I of 
protein kinases is a glycine-rich loop between P-strands that anchors the P-phosphate of 
the nucleotide substrate (reviewed by Bossemeyer, 1994). The consensus sequence for 
both protein serine/threonine and protein tyrosine kinases is GxGxxGxV, where x is any 
amino acid. The residue preceding the first glycine is hydrophobic in all the 117 protein 
kinases included in the alignment of Hanks and Quinn (1991) while the residue preceding 
the third glycine is very frequently tyrosine or phenylalanine. The sequence of TbPLK 
(GRGGFAKC) differs at two positions from this consensus; the valine replaced by 
cysteine being more heavily conserved than the third glycine replaced by alanine. 
Examination of Fig. 5.12 shows that these differences are conserved among polo-like 
kinases, with all known members of this family having subdomain I sequences 
corresponding to a consensus GxGGFAxC. The functional significance of the differences 
between the subdomain I consensus for polo-like kinase compared to the general protein 
kinase consensus is not known but it is thought that for some protein kinases the residues
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between the glycines make important contacts with peptide substrates and 
pseudosubstrate inhibitors. Human CDK2 is negatively regulated by phosphorylation at 
two threonine residues between the second and third glycines: phosphorylation of T14 
disrupts ATP binding while phosphorylation of either or both residues might also affect 
peptide substrate binding (De Bondt et al., 1993). Therefore, while the glycine rich loop 
of protein kinases is a conserved motif necessary for nucleotide binding, the peptide 
sequence in this part of the catalytic domain can clearly have functional significance 
specific to particular protein kinases, and the conservation of an unusual subdomain I 
sequence among polo-like kinases suggests that this may be true for this protein kinase 
family.
Subdomain II has an invariant lysine and subdomain m  an invariant glutamate 
(the subdomain labels have been placed directly below these residues) that are present in 
all the polo-like kinases including TbPLK. In PKA, the protein kinase which is best 
understood in structural terms, the lysine interacts with the ATP a- and (3-phosphates 
and forms an ion-pair with the glutamate of subdomain HI. Subdomain IV corresponds 
to the junction of the major and minor lobes and has no invariant residues. Subdomains 
V and VIb also lack invariant residues but there is still significant homology in small 
blocks between the polo-like kinases shown in the figure. Subdomain VIb is the catalytic 
loop in which the glutamate and asparagine are invariant among all protein kinases and 
the lysine is highly conserved among protein serine/threonine kinases. There is a high 
degree of sequence homology between the different polo-like kinases in this subdomain. 
Subdomains VH, with the highly conserved DFG moti£ and VIII with a highly conserved 
PE doublet, also represent regions where there is a very high level of sequence 
conservation between the different polo-like kinases including TbPLK All of the polo­
like kinases correspond exactly to the protein kinase consensus DxWxxG in subdomain 
IX, while in subdomain X there is more divergence before the invariant arginine of 
subdomain XI present in all the sequences. To summarise, outside subdomain I, TbPLK 
has all o f the most highly conserved residues of protein serine/threonine kinases while its 
subdomain I sequence corresponds to the consensus for polo-like kinases. Therefore, as 
far as can be judged from the catalytic domain peptide sequence alone, the putative 
protein TbPLK could be active as a polo-like protein kinase.
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A feature common to many protein kinases is a phosphorylation site between 
subdomains VII and VQI. In PKA this site (T197) is phosphorylated shortly after protein 
synthesis, is phosphatase resistant and contributes to protein stability through 
electrostatic interactions with several other residues (Shoji et al., 1979; Knighton et al., 
1991b). In ERK2 and CDK2 phosphorylation at equivalent positions has a regulatory 
role (reviewed by Taylor and Radzio-Andzelm., 1994). TbPLK and all other known 
polo-like kinases have a threonine at an equivalent position to T197 of PKA (indicated 
by an asterisk in Fig. 5.12) and it is possible that phosphorylation of this site is required 
for activity. Autophosphorylation has been demonstrated for Plkl and STPK13 (see 
Section 5.3.3) and a labelled gel hand that probably represents autophosphorylated polo 
kinase was detected in the products of protein kinase assays performed by Fenton and 
Glover (1993) but the phosphorylation sites have not been determined.
Golsteyn et a l  (1994) noted that three glutamate residues in PKA that are 
implicated in binding to positively charged peptide substrates are replaced in human Plkl 
by uncharged residues but at a further three positions, implicated in substrate binding in 
PKA, both protein kinases have hydrophobic residues. The positions where PKA has 
glutamates are indicated in Fig. 5.12 by filled boxes while the hydrophobic residues are 
indicated by open boxes. It can be seen that TbPLK and all the other polo-like kinases 
have uncharged residues at the former positions and hydrophobic residues at the latter as 
for Plkl. The preferential use of casein over histone HI by polo, Cdc5 and Plkl/STPK13 
(Fenton and Glover, 1993; Kitada et al., 1993; Golsteyn et al., 1995; Lee et al., 1995) is 
consistent with the idea that the marked residues are involved in determining substrate 
specificity in polo-like kinases.
As mentioned above the complete sequence for the C-terminal extension of 
TbPLK is not yet available but there are three partial sequences likely to be from this 
region (peptide sequences of Block D, E and F) that have been added to the alignment of 
the other polo-like kinase sequences in Fig. 5.13. The peptide sequence of TbPLK 
immediately C-terminal to the catalytic domain (from Block D) could not be aligned 
convincingly with the other sequences and the TbPLK sequence in this region has 
therefore simply been presented in Fig. 5.13 without gaps. The next partial sequence 
(from Block E) includes the highly conserved PH2 domain that confirms the relatedness 
of TbPLK to polo-like kinases from other organisms. The PH2 domain was used to align
147
this section with the other sequences. It also proved possible to align the most C-terminal 
partial sequence (from Block F) with the alignment of the other polo-like kinase 
sequences. Examination of Fig. 5.13 shows that immediately C-terminal to the end of the 
catalytic domain there is a region of about 20 amino acids across which there is 
significant homology between all of the polo-like kinases from multicellular organisms, to 
which the Cdc5 and plol sequences show some homology while the TbPLK sequence is 
quite divergent. This is followed by a large region in which the Pileup program has 
introduced extensive gaps to align the sequences and there are only short sections of 
sequence identity. Assuming that the TbPLK open reading frame extends through 
subclone D, the putative protein kinase will have an insert of about 60 amino acids in the 
junction domain compared to Cdc5. In view of the divergence between the other polo­
like kinases in this region in terms of both sequence and length of polypeptide chain, this 
does not seem particularly improbable. Following the large divergent junction domain is 
the highly conserved PH2 domain (dashed underlining). TbPLK has substitutions at five 
positions where all the other sequences in the alignment have the same amino acid, but 
three of these could be considered conservative. The TbPLK sequence is most similar to 
that of plol across the PH2 domain (53% amino acid identity). The alignment shows 
that, as well as a high degree of sequence conservation between polo-like kinases in the 
PH2 domain, the sequences C-terminal to this domain are more highly conserved than 
the junction domain and, consistent with this, the partial T. brucei sequences C-terminal 
to the PH2 domain show a degree of homology to the sequences of the other polo-like 
kinases.
5.2.4.4 Similarity of the partial T. brucei ribosomal protein S4 sequence to 
sequences of ribosomal protein S4 (RPS4) homologues from other eukaryotes 
The nucleotide sequence from pTbplkl that predicts a peptide sequence similar to that of 
RPS4 homologues extends from nucleotides 1-356, translated in the reverse orientation 
(see Fig. 5.9). Fig. 5.14 depicts an alignment of the predicted peptide sequence from T. 
brucei with those of RPS4 homologues from S. cerevisiae, Tetrahymena, human (X 
isoform), Drosophila and potato. Residues common to two or more sequences at a 
particular position are indicated by shading. RPS4 sequences derived from two T. brucei 
expressed sequence tags (ESTs) are also included in the figure (El-Sayed et al., 1995). In
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both of these sequences there are ambiguities and only blocks of peptide sequence with a 
high degree of similarity to the other RPS4 homologues are shown. One of these EST 
sequences predicts peptide sequence similar to the N-termini of RPS4 homologues but 
does not overlap with the partial sequence from pTbplkl. The sequence of the other EST 
predicts a peptide sequence similar to the C-termini of other RPS4 homologues and 
overlaps with the sequence from pTbplkl. This EST sequence has an Eco RI site at a 
position corresponding exactly to the 5' end of the insert from the X clone, indicating 
that the 5' end of the insert was ligated into the X vector at a naturally occurring Eco RI 
site within the RPS4 coding region.
It can be seen from the alignment that there is very significant homology between 
the putative T. brucei RPS4 and the other RPS4 sequences. The T. brucei sequence from 
pTbplkl is 51.3% identical to the S. cerevisiae RPS4 homologue over 115 amino acids 
and 50, 47.5, 47.5, and 44.1% identical to the human, Drosophila, potato, and 
Tetrahymena RPS4 homologues respectively over 118 amino acids. Unfortunately, little 
functional data is available for RPS4 proteins so it is not possible to comment on the 
significance of similarities and difference between the sequences but, because of the high 
degree of similarity of the T. brucei sequence to that of RPS4s from other organisms, the 
putative protein has been named TbS41p (T. brucei S4-like protein).
5.3 Discussion
To complement earlier biochemical studies of protein kinase C from T. brucei it was 
decided to isolate a full length cDNA corresponding to a PCR fragment (TbPK-A2) for 
which the predicted peptide sequence showed homology to some members of the protein 
kinase C family. Various approaches were used in attempts to isolate a frill length cDNA 
including 5' and 3' RACE and library screening. A A,gtl 1 clone was obtained by 
screening a library with a PCR fragment similar to TbPK-A2. Sequencing the insert from 
this clone showed that it encodes a complete protein kinase catalytic domain that, as 
expected, includes the TbPK-A2 sequence. However, analysis of the predicted protein 
sequence showed that the kinase belongs to a distinct family of protein kinases implicated 
in cell cycle control in a number of organisms (polo-like kinases) rather than to protein 
kinase C. In the next section the results of the 5' and 3 ' RACE are discussed. The T. 
brucei RPS4 homologue is discussed briefly in Section 5.3.2. The available information
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about polo-like kinases in higher eukaryotes is reviewed in Section 5.3.3 while possible 
future work into the cellular function of TbPLK is discussed in Section 5.3.4 in relation 
to what is known about cell cycle control in trypanosomes.
5.3.1 5 ' and 3 'RACE
The 5' and 3' RACE proved unsuccessful as approaches for obtaining the complete 
protein kinase gene sequence. This lack of success might have been overcome by using a 
number of improvements to the procedure. In the 5' RACE, a gene-specific primer could 
have been used in cDNA synthesis. This would bias cDNA synthesis towards producing 
only the desired products, and reduce the length of mRNA that has to be reverse- 
transcribed thereby reducing the chances of premature termination. Instead, oligo(dT) 
primers (with and without anchor sequences) were used in all cDNA syntheses. The 
specific product of primers 2 and 5 could, however, be readily amplified from both 
batches of cDNA that were made. Another possible problem in the 5' RACE was the 
relatively low annealing temperatures that were used with the 22 bp primer based on the 
T. brucei spliced leader (primer 1). The sequence of the 39 bp spliced leader has a low 
G+C content and to compensate for this a longer primer could have been synthesised 
which would have allowed higher annealing temperatures in the PCR reactions with 
possible improvements in reaction specificity.
The 3 ' RACE reactions had not been well characterised at the time the decision 
was made to abandon PCR in favour of library screening. The preliminary reactions 
appeared more promising than those from the 5' RACE as products of a significant size 
were amplified in reactions with annealing temperatures much higher than could be used 
in the 5' RACE. The major products were cloned and the ends sequenced but these 
proved not to be the specific products desired. It is possible that one or more further 
rounds of PCR with nested primers might have given the desired product as a single band 
but the results obtained show that an improvement to the procedure that was clearly 
needed was the use of single primer controls. One of the two products that was cloned 
had the anchor primer at both ends while a number of the product bands from the 3' 
RACE with the two different gene-specific primers 2 and 3 and the 3' anchor primer 
appeared to be similar (Fig. 5.6 panel C), suggesting that these too could be products of 
only one primer.
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The results of Hua and Wang (1994) showed that the messenger RNA 
hybridising to TbPK-A2 was large (5.4 kb), while the closest matches to the peptide 
sequence predicted by TbPK-A2 were protein kinases with the catalytic domain in very 
different positions within the polypeptide chain. Therefore, it was not possible to judge 
the likely sizes of specific products for products of either the 5 ' or 3 ' RACE reactions. 
The largest likely sizes for the 5' and 3 ' product were also towards the limit of what 
might be considered reasonable for RACE, at least using standard PCR reagents and 
conditions. Therefore, RACE was not an ideal approach compared to screening of a 
cDNA library but only a small amount of a cDNA library was available. The clone 
obtained from the library screen is not full length and 5' and 3 ' RACE with the 
improvements suggested above and with new primers from sequence nearer the 5' and 3' 
ends respectively would be one way to isolate amplified cDNAs from which to complete 
the sequence. Another approach would be to re-screen the library with subclones from 
the 5' and 3' ends of pTbplkl.
5.3.2 A ribosomal protein S4 homologue from T. brucei
Part of pTbplkl appears to be a truncated coding sequence for a T. brucei RPS4 
homologue. Ribosomal proteins in general are highly conserved among eukaryotes and 
the degree of homology of the putative T. brucei protein and other RPS4 homologues is 
high. Its T. brucei origin was confirmed by high stringency genomic Southern 
hybridisation (Section 5.2.4.1). The putative protein has been named T. brucei S4-like 
protein (TbS41p).
Ribosomes, as large molecular assemblies of many components, are difficult to 
study and only very limited data is available on the functional role of RPS4 homologues. 
One way of probing the proximity of different ribosomal components to each other in the 
assembled ribosomes is through the use of cross-linking agents. In studies of this type 
RPS4 has been found to contact eIF-3 in the 40S subunit near to the interface with the 
60S subunit and to be situated close to the 28S rRNA (Nygard and Westermann; 1982 
Nygard and Nika, 1982). Cross links identified between RPS4 and ribosomal protein L5 
also place RPS4 at the subunit interface and ribosomal protein L5, in association with the 
5S RNA, may be important in placing the AUG start codon into the correct position for 
initiation (Uchiumi et al., 1986).
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Although obtained as an artifact, the T. brucei RPS4 sequence might be useful 
for phylogenetic studies if a full length sequence was obtained. T. brucei ribosomes do 
not appear to have been studied in any detail, but it is interesting that in Tetrahymena the 
RPS4 homologue is phosphorylated and its phosphorylation state correlates with the 
nutritional state of the cell, the thermal stability of its ribosomes and the sensitivity of the 
ribosomes to cycloheximide (Hallberg et al., 1981; Palm et al., 1995).
5.3.3 Polo-like kinases in higher eukaryotes
The polo-like kinases are a recently discovered protein kinase family (the sequence of the 
Drosophila gene polo was published in 1991 although the phenotypes of mutants in both 
polo and CDC5 were examined before the genes were sequenced) but work on the 
cellular function of these kinases has progressed rapidly. The mitotic defects of polo 
mutants in Drosophila, CDC5 mutants in S. cerevisiae andp lo l+ disruptants in S. pombe 
implicate the encoded protein kinases in regulation of the cell cycle and, while no genetic 
or reverse genetic experiments have been reported for Plkl and STPK13, there is 
considerable evidence to suggest that polo, Cdc5, plol, Plkl, STPK13 are functional 
homologues. However, Snk and Fnk are expressed as early growth response genes and 
thus differ in expression pattern to the other polo-like kinases (Simmons et al., 1992; 
Donohue et al., 1995). Therefore there are likely to be different roles for different polo­
like kinases, at least in mammals.
The phenotypes of mutants in polo have been studied in some detail (Sunkel and 
Glover, 1988; Llamazares et al., 1991). The polo1 allele was originally discovered by its 
female sterile phenotype (the stronger polo2 allele is lethal at the larval stage in 
homozygotes). A proportion of female polo1 homozygotes of heterozygote mothers 
survive to adulthood hut the embryos of these homozygotes (which lack maternally 
provided wild-type protein) accumulate defects during the syncytial stage in which 
multiple nuclear divisions occur in a single cytoplasm and fail before the fourteenth 
syncytial cell cycle when the embryo would normally become cellular. The nuclei of these 
embryos become polyploid and the chromatin is disorganised despite undergoing 
synchronous rounds of condensation and decondensation. Spindle structures were 
observed that did not appear to be nucleated by a centrosome. The mitoses of other 
developmental stages were also examined in these studies. Spindle morphologies of
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larval neuroblasts of polo1 homozygotes included condensed chromosomes that had 
failed to align on a metaphase plate, overcondensed chromosomes and monopolar 
spindles nucleated from a single centro some, consistent with the defects found in the 
syncytial stage. The meiotic defects of polo mutants also point to a role for the polo 
kinase in regulating centrosome and spindle structure (Sunkel and Glover, 1988). 
Chromosomal non-disjunction occurs in spermatids of polo1 males and mitochondrial 
segregation, which is also mediated by the meiotic spindle, was abnormal suggesting that 
the defect is with the spindle rather than the chromosomal kinetochores. The second 
meiotic division (similar to mitosis) is also more severely affected than the first division 
in which the centromeres do not split apart.
CDC5 was shown to be an essential gene in S. cerevisiae in an experiment in 
which one copy of the CDC5 gene was replaced in diploid cells by the LEU2 gene and 
the disruptant cells then sporulated. In 24 tetrads analysed only 2 spores were viable in 
each and these were all Leu' and therefore contained the wild type CDC5 gene. Spores 
possessing the disrupted gene could be rescued by a multicopy plasmid carrying the 
CDC5 gene (Kitada et al., 1993). However, a plasmid carrying the gene for a mutant 
Cdc5 with a single substitution at an essential protein kinase catalytic residue was unable 
to rescue disruptant spores, strongly suggesting that protein kinase activity is required 
for Cdc5 function. Wild-type cells transfected with a plasmid expressing CDC5 grew but 
with increased doubling times, suggesting that overexpression of CDC5 is harmful. 
“Switch-off” experiments were also performed in CDC5 disruptants carrying a plasmid 
expressing CDC5 under control of the GAL1 promoter. When glucose was added to the 
growth medium to repress expression of the CDC5 gene from the plasmid, cell number 
stopped increasing by about 2 hours after the addition of glucose but cell mass continued 
to increase for up to 6 hours before stopping. At 4 hours after the addition of glucose 
82% of the cell population consisted of enlarged cells which each had a large bud while 
15% of the population consisted of two enlarged connected cells with large buds in 
which the nuclei had almost completed division but were connected by a thin chromatin 
bridge. The DNA content of the cells was analysed by flow cytometry. Before the 
addition of glucose, 25% of cells had a 1C DNA content (Gi phase cells) and 61% of 
cells had a 2C DNA content (G2/M phase cells) while at the 6 hour time point (after 
addition of glucose) only 3% of cells had a 1C DNA content, 71% of cells had a 2C
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DNA content and 23% of cells had a 4C DNA content (presumably due to the enlarged 
connected cells each with a large bud observed by microscopy). The cellular effects of 
disruption and overexpression ofp lo l+ in S. pombe have also been examined (Ohkura et 
al., 1995). In tetrad analysis experiments in which one copy of the p lo l+ gene was 
replaced in diploids by the ura4+ gene and the cells then sporulated and grown in 
medium containing uracil to allow only ura4+ spores to grow, the disruptant haploids 
were inviable, showing that p lo l+ is an essential gene. These spores showed three types 
of defect. Some cells had one cluster of overcondensed chromosomes, others had two 
interphase nuclei and were unseptated, while a third set had two clusters of 
overcondensed chromosomes and were also unseptated. Analysis over a time course 
suggested that the first two types of defect resulted from arrest in the anaphase of the 
first mitosis and that the third type resulted from a blockage in the second mitosis after 
failure to produce a septum in the first mitosis. Loss ofp lo l+ function was also examined 
in experiments in which haploid p lo l+ disruptants were maintained by episomal 
expression of p lo l+ under the control of a thiamine repressible promoter. In the absence 
of thiamine, the cells grew apparently normally but, following the addition of thiamine to 
the growth medium, the cells accumulated both mitotic and septation defects as seen in 
the spore germination experiments. In the spore germination experiments, it appeared 
that most spores were blocked in their first mitosis with the remainder blocked in the 
second mitosis. However, in the switch-off experiments, cells were observed which had 
multiple nuclei but no septum, suggesting that one or two nuclear divisions had occurred 
after the failure of septum formation before mitosis also became blocked. Since the loss 
of p lo l+ function would be more gradual in the switch-off experiments, it was suggested 
that a lower level of plol activity might be required for mitosis than for septum 
formation. Immunochemical experiments showed that, in both spore germination and 
switch-off experiments, over-condensed chromosomes could be observed that were 
associated with monopolar spindles (similar to defects seen in polo mutants in 
Drosophila) and that actin ring formation and the deposition of septal material were 
abnormal. Episomal expression of p lo l+ was also used to overexpress the protein in wild 
type cells leading to cells with over-condensed chromosomes and cells with one or more 
septa and an interphase nucleus. It was also shown, in a temperature-sensitive mutant of 
cdc25 that arrests in late G2, that overexpression of p lo l+ could drive septum formation
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at the restrictive temperature and a similar result was also obtained with a cdc2 mutant, 
suggesting that p lo l+ can drive septum formation without p34cJc2 activation being 
required. Furthermore, p lo l+ overexpression could also drive septum formation in 
temperature-sensitive mutants of cdclO that arrest prior to Start in Gi. Therefore it 
appears that in S. pombe, plol is the key inducer of septum formation while also being a 
regulator of spindle formation. Based on the similarity of the mitotic defects in p lo l+ 
disruptants to those in cut7+ mutants (Hagan and Yanagida, 1990; Hagan and Yanagida, 
1992; cut7 is a member of the kinesin superfamily) it was suggested that cut7 might be a 
substrate of plol.
No gene disruption experiments have been performed for any of the mammalian 
polo-like kinases but Hamanaka et al. (1994) found that microinjection of in vitro 
transcribed STPK13 mRNA into NIH 3T3 cells maintained in low serum medium 
induced thymidine incorporation while microinjection of antisense RNA into growing 
NIH 3T3 cells blocked thymidine incorporation.
The biochemical properties of polo, Cdc5, Plkl and STPK13 have also been 
examined. Kitada et al. (1993) were able to use an antiserum against Cdc5 to 
immunoprecipitate a casein kinase activity from S. cerevisiae overexpressing CDC5 but 
not from cells overexpressing the mutant of CDC5 (encoding a protein substituted at a 
single catalytic domain residue) that had been shown to be unable to complement CDC5 
disruptants. However, they were unable to assay Cdc5 activity from wild-type cells. 
Fenton and Glover (1993) measured the activity of polo with respect to progress through 
the Drosophila syncytial embryo cell cycle again using casein as a model substrate. Polo 
kinase activity was maximal at a time corresponding to late anaphase-telophase when 
histone HI kinase activity, immunoprecipitated by a cyclin B antibody, was at a low 
level. A phosphorylated band was detected in the assays that probably represents 
autophosphorylated polo, but it was not determined whether autophosphorylation affects 
casein kinase activity. The most detailed biochemical studies of polo-like kinases have 
been performed for Plkl and STPK13 (Golsteyn et al., 1994; Golsteyn et al., 1995; 
Hamanaka et al., 1995; Lee et al., 1995). Golsteyn et al. (1994) examined Plkl protein 
levels in populations of HeLa cells sorted by centrifugal elutriation. Plkl protein was at a 
very low level in cell populations enriched for Gi cells, was at a higher level in 
populations enriched for S phase cells and was at maximal levels in populations with the
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highest proportion of cells in G2/M. As expected p34cdc2 levels did not vary significantly 
between the populations at different cell cycle stages. A more precise examination of 
Plkl levels during mitosis was performed using HeLa cells arrested in prometaphase by a 
nocodazole block and then sampled at various time points following release. Consistent 
with the results from the cells sorted by elutriation Plkl levels were high in the cells 
blocked in M phase and remained high 30 minutes after release. Plkl levels were 
detectably lower 1 hour after release and by 4 hours, when the great majority of the cells 
had re-entered Gi (as assessed by re-attachment to the culture dish), Plkl was almost 
undetectable. Thus it appears that Plkl protein levels fall during late mitosis/early Gi. 
This analysis was extended in the later study (Golsteyn et a l,  1995) to include assay of 
Plkl protein kinase activity. HeLa cells were synchronised at Gi/S by a 
thymidine/aphidicolin double block and then collected at regular intervals after release 
from the block. Plkl activity (assayed with casein) and p34c^ c2 activity (assayed with 
histone H I) were low between 0 and 8 hours after release from the block but increased 
dramatically as the cells passed through mitosis between 12 and 16 hours after release. 
By 18 hours when most cells had completed mitosis and re-entered Gi both Plkl and 
p34cdc2 activities had decreased again. Similar experiments, either performed using cells 
released from a nocodazole-induced prometaphase block or cells from an asynchronous 
culture fractionated by centrifugal elutriation, confirmed that Plkl activity was maximal 
during mitosis. Plkl protein levels were shown to fluctuate during the cell cycle as found 
in the previous study but it was reported that Plkl from mitotically arrested cells was 4-6 
times more active in phosphorylating casein than the equivalent amount of Plkl from 
interphase cells. Similar results showing maximal levels of Plkl at G2/M with a 4-6 fold 
increase in specific activity in Plkl/STPK13 isolated from mitotic cells compared to that 
isolated from S phase cells were obtained by Hamanaka et al. (1995) and Lee et al. 
(1995). Hamanaka et al. (1995) also found that Plkl isolated from mitotic cells migrates 
slower in SDS-PAGE than Plkl/STPK13 from S phase cells and immunoprecipitation of 
STPK13 from NIH 3T3 cells cultured in medium containing [32P]orthophosphate 
showed that STPK13 from mitotic (non-adherent) cells was phosphorylated while that 
from adherent cells was not. As expected, the phosphorylated form had reduced mobility 
in SDS-PAGE and also showed increased protein kinase activity against casein. 
Phosphoamino acid analysis showed that STPK13 isolated from mitotic NIH 3T3 cells
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labelled with orthophosphate in vivo was phosphorylated only on serine, while in vitro 
autophosphorylation (also activated in mitotic Plkl/STPK13) with [y-32P]ATP was on 
both serine and threonine, but did not cause the mobility shift associated with 
Plkl/STPK13 isolated from mitotic cells (autophosphorylation ofPlkl/STPK13 in kinase 
assays was also detected by Golsteyn et al., 1995 and Lee et al., 1995). Treatment of 
STPK13 immunoprecipitated from mitotic cells with protein phosphatase 2A converted 
most of the slower migrating protein to the faster migrating form and reduced the protein 
kinase activity 5-10 fold. It seems likely that the lower mobility form of Plkl/STPK13, 
phosphorylated on at least one serine residue, is an activated form. However, it is also 
possible that Plkl/STPK13 is phosphorylated at multiple sites and that an intermediately 
phosphorylated form is the activated form. Since in vitro autophosphorylation of 
Plkl/STPK13 did not activate the enzyme one or more other protein kinases are 
probably responsible for the activating phosphorylation(s). The possibility that p34c^ 2 
was the activating enzyme was investigated by Hamanaka et al. (1995). Examination of 
the Plkl/STPK13 peptide sequence showed no consensus p34cJc2 phosphorylation sites 
containing serine and, although p34c</c2/cyclin B was found to phosphorylate Plkl in 
vitro, this did not lead to a mobility shift and caused only a small activation of Plkl (<2- 
fold). Phosphorylation of Plkl by p34cJc2 followed by autophosphorylation of Plkl also 
failed to lead to the mobility shift associated with Plkl/STPK13 isolated from mitotic 
cells. In contrast, Lee et al. (1995) were unable to show any phosphorylation of Plkl by 
p3 4 ^ C2/cyciin g  and aiso found that the MAP kinase ERK1 was unable to phosphorylate 
Plkl.
Having found that Plkl/STPK13 from mitotic cells was phosphorylated and that 
this phosphorylation caused a mobility shift in SDS-PAGE, Hamanaka et al. (1995) re­
examined the kinetics of phosphorylation and activation of Plkl in cells progressing from 
Gi/S to G2/M as a comparison with those of p34cdc2 dephosphorylation and activation at 
the G2/M transition. Cells were sampled at various time points from a culture 
synchronised at the Gi/S transition by a double aphidicolin block and then released into 
nocodazole (to trap the cells at prometaphase). At 7.5 hours after nocodazole release 
when the slower migrating form of Plkl was first detected 90% of the cells were in G2/M 
and 40% had entered M phase. The amount of the slower migrating (phosphorylated) 
form of Plkl increased at later time points as more cells entered mitosis. The higher
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mobility (dephosphorylated) form of p34c<fe2 appeared at approximately the same time as 
the lower mobility form of Plkl and, as expected, these changes coincided with 
activation of both enzymes. In order to test whether Plkl phosphorylation and activation 
are under the control of a G2 checkpoint response to DNA damage, a similar experiment 
was performed except that after release from the aphidicolin block and before addition of 
nocodazole the cells were treated with nitrogen mustard for 30 minutes to cause DNA 
damage and delay at the G2 checkpoint. In this experiment 17.5 hours after release, 90% 
of cells were in G2/M, but less than 15% were in mitosis and no mobility shifts were 
observed in either Plkl or p34c(/c2. There was gradual increase in Plkl casein kinase 
activity over the time course which paralleled the increase in Plkl protein; no abrupt 
increase in Plkl casein kinase activity (which is presumably due to the activating 
phosphorylation) was observed. Thus Plkl activation appears to be associated with the 
G2/M transition and is blocked by activation of the G2 checkpoint response to DNA 
damage. The sharp reduction in Plkl/STPK13 activity in cells exiting mitosis could be 
due to post-translational modification of the protein (perhaps by removal of the 
activating phosphate(s)) but Lee et al. (1995) found that Plkl/STPK13 activity 
correlated closely with the protein level in cells exiting mitosis and re-entering Gi and 
suggested that post-translational modifications were probably not responsible for the 
decline in Plkl/STPK13 activity at this stage. A possible mechanism for the loss of 
Plkl/STPK13 protein would be through its localisation to the spindle microtubule 
overlap zone during anaphase and then to the midbody of the postmitotic bridge between 
the dividing cells (see below), a region that may be discarded as the dividing cells split 
apart.
The expression of the transcripts encoding polo-like kinases has also been 
examined. The abundance of the mRNA for Cdc5 was found to vary at least 20-fold in a 
cell cycle dependent manner in synchronised populations of S. cerevisiae (Kitada et al.,
1993). The mRNA was at a very low level in Gi phase cells and increased during cell 
cycle progression to peak at G2/M coincidentally with the peak in abundance of the 
mRNA for the Clbl mitotic cyclin. The expression of STPK13 mRNA during the cell 
cycle was examined in NIH 3T3 cells by Lake and Jelinek (1993). In cell populations 
trapped in Go by serum starvation and then sampled at various time points after serum 
replenishment, STPK13 was first detected from cells at approximately the middle of S
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phase and reached maximal levels at the end of S phase. The variation in STPK13 levels 
between Go and late S phase cells was at least 15-fold. Since the levels of STPK13 
mRNA in the first cell cycle following serum replenishment might not be typical of those 
in subsequent cell cycles, STPK13 mRNA levels were also measured in cells sampled 
from a population synchronised by serum starvation followed by serum replenishment 
and subsequent addition of nocodazole to block the cells in prometaphase of the first 
mitosis. Non-adherent (mitotic) cells were then placed in fresh medium lacking 
nocodazole and Northern analysis was performed on samples of the blocked cells and 
cells collected at late Gi and at S phase. STPK13 mRNA was detected in mitotic cells, 
was undetectable in Gi phase cells, but could be detected in S phase cells confirming the 
results of the earlier experiment. A further experiment was also performed to test 
whether completion of S phase might be required for accumulation of STPK13 mRNA 
using the DNA polymerase inhibitor aphidicolin to block DNA synthesis. It was found 
that although cells blocked in S phase showed reduced STPK13 mRNA accumulation 
compared to untreated controls, STPK13 mRNA was nevertheless readily detectable. 
Therefore, accumulation of STPK13 mRNA does not appear to be obligatorily linked to 
completion of DNA synthesis. Cell cycle fluctuations in STPK13 mRNA abundance 
could be due to cell cycle regulation of transcription or to post-transcriptional processes. 
In order to investigate this, Lake and Jelinek (1993) isolated nuclei from serum starved 
(Go) cells and from cells collected 6 and 24 hours after serum replenishment 
(corresponding to Gi and G2/M respectively) and analysed the production of STPK13 
transcripts. The three sets of nuclei produced STPK13 RNA at similar rates indicating 
that the differences in abundance of the mRNA at different stages of the cell cycle must 
he due to post-transcriptional processes. Lee et al. (1995) also found that STPK13 
mRNA was undetectable during GI and early S phase but became detectable at late S 
phase. Consistent with the fact that STPK13 mRNA could not be detected in Go phase 
cells, mRNAs for STPK13/Plkl have been found to be most abundant in tissues with a 
high proliferative index (including tissues from embryonic and newborn mice and from 
human cancers) but at a low or undetectable level in other tissues (Clay et al., 1993; 
Lake and Jelinek, 1993; Golsteyn et al., 1994; Hamanaka et al., 1994; Holtrich et al.,
1994). In Drosophila, polo transcripts were also found to be abundant in tissues and in 
developmental stages in which there is a high level of mitotic activity. Particularly high
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levels were detected in early embryos and in adult females presumably reflecting the 
requirements for cell cycle proteins in the growth of early embryos and for oogenesis. 
The expression of mRNA for mammalian polo-like kinases has also been examined in cell 
lines induced to differentiate. Lake and Jelinek (1993) examined STPK13 expression in 
murine erythroleukaemia cells (MELC) induced to differentiate and in a mutant MELC 
line that fails to differentiate. STPK13 poly(A)+ mRNA levels decreased 6-fold in normal 
MELC induced for 12 hours, but were only slightly reduced in the mutant MELC. This 
decrease in poly(A)+ mRNA levels was not mirrored by the total STPK13 RNA level 
which was at similar levels in cells induced for 12, 24 and 48 hours (total STPK13 RNA 
was measured in the cell cycle experiments described above). The explanation favoured 
by Lake and Jelinek (1993) for the loss of oligo(dT) binding was that it was due to 
shortening of the poly(A) tail. These authors were not able to measure STPK13 protein 
levels but shortening of the poly(A) tail is known to reduce the efficiency of translation 
of a number of mRNAs. After 12 hours of induction MELC cells are not committed to 
terminal differentiation so the decline in STPK13 poly(A)+ mRNA abundance is a 
precommitment event. Hamanaka et al. (1994) found that when rat PC 12 overexpressing 
the NGF receptor were induced to differentiate by treatment with NGF, rat plk mRNA 
expression was greatly reduced. Holtrich et al. (1994) found that in human T 
lymphocytes stimulated for 1 day with phytohaemagglutinin, Plkl mRNA was induced 
between days 2 and 3 and that this induction could be blocked by cycloheximide. On this 
basis the Plkl gene is not a early growth response gene (see below).
The cellular localisation of polo and of Plkl/STPK13 has been examined by 
immunochemistry. The staining observed with antibodies to the polo protein kinase in 
Drosophila syncytial embryos was found to undergo cyclical changes (Llamazares et al., 
1991). Staining of interphase cells was mainly cytoplasmic but this became weaker in 
prophase and the antigen began to be associated with condensing chromatin. The 
association of polo with chromatin was strongest in metaphase and anaphase with 
cytoplasmic staining beginning to return in telophase. The subcellular localisation of Plkl 
and STPK13 has been examined in HeLa cells and NIH 3T3 cells (Golsteyn et al., 1994; 
Golsteyn et al., 1995; Lee et al., 1995). Golsteyn et al. (1995) performed a detailed 
analysis of the localisation of Plkl at different stages o f the cell cycle. Plkl was diflusely 
distributed throughout interphase cells although the centrosomes were most strongly
160
stained. The spindle poles remained strongly stained throughout prophase and 
metaphase, however, during anaphase, the staining of the spindle poles disappeared but 
Plkl could be detected at the equatorial plane in the spindle microtubule overlap zone. 
Plkl staining was detected in the region of the cleavage plane during telophase and then 
near to the midbody of the postmitotic bridge. In contrast to the results of Llamazares et 
al. (1991) in Drosophila, no association of Plkl with chromatin was observed. Lee et al. 
(1995) first examined the localisation of STPK13 in NIH 3T3 cells and obtained similar 
results to those of Golsteyn et al. (1995). They also noted that the localisation of 
STPK13 during M phase was similar to that of MKLP-1 (mitotic kinesin-like protein), a 
member of the kinesin superfamily (Nislow et al., 1992). Microinjection of the CHOI 
antibody which recognises MKLP-1 into PtKi fibroblast cells was shown to cause mitotic 
arrest in metaphase, the mitotic defects including failure of one or more chromosomes to 
migrate fully to the spindle equator and failure of some spindle microtubules to focus at 
the spindle poles (Nislow et al., 1992). Immunoprecipitations were performed on S150 
fractions from HeLa cells arrested in mitosis by nocodazole in order to investigate 
whether co-localisation of Plkl and MKLP-1 might reflect interaction between the two 
proteins. MKLP-1 was found to co-precipitate with Plkl and Plkl could phosphorylate 
MKLP-1 in kinase reactions performed in vitro on the immunoprecipitates. It was also 
found that, after denaturation of the immunocomplexes and subsequent 
immunoprecipitations, the Plkl antibody only precipitated Plkl and did not co­
precipitate MKLP-1 while the CHOI antibody only precipitated MKLP-1. Therefore, co­
precipitation of the two proteins is not due to cross-reactivity of the Plkl antibody. Thus 
it appears that MKLP-1 associates with Plkl and may well be an endogenous substrate 
for this protein kinase.
The murine polo-like kinases Snk and Fnk (Simmons et al., 1992; Donohue et 
al., 1995) have not been as well studied as STPK13 and, in particular, no work has been 
performed with the proteins. The gene for Snk was identified via cloning of a partial Snk 
cDNA artifactually ligated to another cDNA under investigation. The section of the 
chimaera which was later used to isolate full length Snk clones was examined further 
because it was found to be responsible for the hybridisation of the chimaeric cDNA to an 
RNA strongly induced in mitogen-stimulated murine F-2 cells. Fnk was identified in a 
search for genes induced by FGF in fibroblasts using targeted differential display with
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one PCR primer based on protein kinase catalytic domain VIb and the other based on 
zinc-finger domains (Fnk does not in fact contain a zinc finger domain). Snk mRNA was 
found to be strongly induced (10 to 20-fold) within 1 hour after stimulation of serum- 
starved NIH 3T3 cells with serum or with phorbol myristate acetate. This induction was 
transient, the Snk mRNA returned to basal levels within 6 hours following mitogen 
stimulation and the level of induction was increased when the translational inhibitor, 
cycloheximide, was added to the cell culture at the same time as the serum or phorbol 
ester. Nuclear run-on analysis showed that serum induction of Snk mRNA occurred at 
the transcriptional level. The synthetic glucocorticoid dexamethasone prevented 
induction of Snk mRNA in living cells and in run-on analysis but did not affect basal 
expression. The mRNA for Fnk was found to be rapidly induced following exposure of 
serum-starved NIH 3T3 cells to FGF-1 with maximum levels at 1 hour after stimulation. 
Expression had returned to basal levels by 8 hours. FGF-2 which is related to FGF-1 had 
similar effects on Fnk expression as did PDGF-BB, serum and phorbol myristate acetate, 
while TGF-(31, EGF and IGF-1 had little effect. The RNA synthesis inhibitor actinomycin 
D prevented induction of Fnk by FGF-1 showing that induction of Fnk mRNA 
expression by FGF-1 is at least partly due to transcriptional activation of the fn k  gene. As 
for Snk, addition of a protein synthesis inhibitor (cycloheximide) with the mitogen 
increased the level of induction of Fnk mRNA expression. On the basis of these results 
both Snk and Fnk can be characterised as early-growth-response genes (also known as 
immediate-early genes) based on the fact that their transcription is rapidly and transiently 
upregulated following mitogen stimulation. The lack of dependence of this increase in 
transcription on protein synthesis is a common feature of many of these genes. Snk 
mRNA could be detected at fairly low levels in lung, heart and brain tissues from an adult 
male mouse but not in thymus, spleen, liver, kidney and intestine while Fnk mRNA was 
found to be expressed at a low level in the heart of newborn animals but at significant 
levels in intestine, kidney, liver, lung and skin. In adult tissues only skin showed a high 
level of expression.
To summarise, genes encoding protein kinases related to polo have recently been 
isolated from organisms ranging from mammals to yeasts and, in this work, from the 
evolutionarily distinct kinetoplastid T. brucei. There is significant evidence to suggest 
that polo, Cdc5, plol, Plkl, STPK13 and rat plk are functional homologues but a
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number of differences should also be noted. Casein kinase associated with polo 
immunoprecipitated from Drosophila syncytial embryos was maximal at late anaphase 
and telophase at which point cdc2 kinase activity was low (Fenton and Glover, 1993), 
while Plkl/STPK13 was found to be activated at the G2/M transition (Golsteyn et al., 
1995; Hamanaka et al., 1995; Lee et al., 1995). The polo kinase was also reported to be 
associated with condensed chromosomes at certain points in the cell cycle (in both 
syncytial and cellular embryos) while no association with chromosomes has been 
reported for Plkl. At present not sufficient is known about polo and Plkl/STPK13 for 
these data to be reconciled but it would not be surprising for cell cycle events to be 
regulated differently in syncytial embryos compared to mammalian cells grown in culture. 
Another difference is found between the cellular phenotypes observed in the S. cerevisiae 
and S. pombe switch-off experiments. The gradual removal of Cdc5 in these experiments 
led to failure in late nuclear division with the arrested cells having an intact spindle. 
Similar experiments in S. pombe showed that bipolar spindle formation was defective 
and, as described above, polo and Plkl/STPK13 are also implicated in spindle regulation. 
Ohkura et al. (1995) suggested that the different phenotypes observed could reflect the 
fact that in S. cerevisiae bipolar spindle formation begins during S phase while in S. 
pombe S phase is completed before spindle assembly. Another difference between the 
cell cycles of the two yeasts is that actin ring formation in S. cerevisiae occurs after 
spindle elongation while in S. pombe the two events are approximately simultaneous (see 
references in Ohkura et al., 1995) although actin ring formation was not specifically 
examined in the CDC5 switch off experiments. It seems likely that polo-like kinases will 
have multiple substrates and while some are probably shared between divergent 
eukaryotes, others are probably not; this is likely to relate to differences in the 
organisation of the cell cycle in different organisms.
Future work with polo-like kinases is likely to involve the identification of 
substrates and more detailed studies into the regulation of protein kinase activity. The 
only known substrate for a polo-like kinase is the human kinesin-related protein (KRP) 
MKLP-1. However, another KRP, cut7, has been suggested as a likely substrate for plol 
in S. pombe and given that a number of KRPs are known to be involved in spindle 
function (see reviews by Moore and Endow, 1996 and Barton and Goldstein, 1996) it 
would not be surprising if KRPs are among the substrates of other members of the polo-
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like kinase family. Plkl/STPK13 appear to be substrates for a separate protein kinase, 
and identification of proteins other than substrates with which polo-like kinases interact 
will also be an important area of work. It seems possible that the highly conserved PH2 
domain may be involved in an interaction between polo-like kinases and another 
conserved protein. Another question which awaits investigation is the cellular role of the 
Snk and Fnk polo-like kinases which have not yet been examined at the protein level.
5.3.4 Future studies into the cellular function of TbPLK
The available data on polo-like kinases in higher eukaryotes (Section 5.3.3) suggests that 
TbPLK will be an interesting protein to study in T. brucei. Of the known polo-like 
kinases there is evidence implicating polo, plol, Plkl, STPK13 (and by implication rat 
plk) in regulation of the centrosome and mitotic spindle during mitosis. Cdc5 is also 
implicated in control of mitotic progression (CDC5 disruptants failed in late nuclear 
division in switch off experiments) but may not act on the mitotic spindle. Therefore it 
seems likely that TbPLK will be involved in mitotic regulation in T. brucei. As described 
briefly in Section 1.1.4, T. brucei is one of the best-studied examples of a lower 
eukaryote in which cell division is asymmetrical and occurs without extensive 
disassembly of the cytoskeleton. The mitotic spindle has only been visualised in electron 
micrographs (Sherwin and Gull, 1989a, Robinson et al., 1995) but it was shown in these 
studies that the T. brucei spindle is unusual in that it persists after the daughter nuclei 
have separated, perhaps acting to place the daughter nucleus into the gap left between 
the basal bodies after they have moved apart (see Fig. 1.3 panel A and Robinson et al.,
1995). The study of the T. brucei spindle would also be interesting with respect to the 
question of how the numerous minichromosomes are segregated. It seems unlikely that 
each minichromosome could have its own microtubule and so minichromosomes may not 
be segregated by the mitotic spindle. While it seems probable that TbPLK will be 
involved in regulating spindle function, there is evidence for the involvement of polo-like 
kinases in regulating other processes involved in cell division; in particular, plol in S. 
pombe appears to be the key regulator of septum formation (both formation of the actin 
ring and deposition of septal material). At present there is no evidence for an actin ring in 
T. brucei although actin genes are transcribed (BenAmar et al., 1988). The microtubular 
structures of T. brucei are quite different to those of higher eukaryotes and are potential
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drug targets; differences in sensitivity between T. brucei and mammalian cells to drugs 
that disrupt microtubules have been reported (Seebeck and Gehr, 1983). The further 
study of proteins that may be involved in regulating microtubule structures such as the 
mitotic spindle is therefore interesting in this respect. In summary, although no data have 
been obtained regarding the cellular function of TbPLK, most of its homologues from 
higher eukaryotes appear to be involved in control of mitosis and its further 
characterisation could complement earlier morphological studies of the T. brucei cell 
cycle.
One of the most immediate aims in any future work would be confirm the coding 
sequence for TbPLK as the 3' coding sequence is incomplete and, although the 5' coding 
sequence could be complete (with the open reading frame starting at position 377 in 
Block B (see Fig. 5.9)), it is equally likely that there is further 5' coding sequence not 
contained within pTbplkl (see Section 5.2.4.3). Ideally, a full length cDNA would be 
obtained by library screening or alternatively 3 ' and 5' RACE might be used with the 
improvements suggested in Section 5.3.1. PCR amplification could be used with a library 
as template with gene-specific and vector primers. The isolation of genomic clones for 
TbPLK would be another possibility. Many of the experiments that might be performed 
to investigate the cellular function of TbPLK would depend on the availability of 
antibodies to the protein and the raising and characterisation of antisera to TbPLK would 
be another priority.
Methods have recently been developed for the transfection of T. brucei that 
would allow reverse genetics to be used in investigating the cellular function of TbPLK 
One type of experiment would be to examine the cellular effects of loss of function of 
tbplk and of overexpression of tbplk. It seems likely that tbplk will be an essential gene in 
T. brucei and so it would probably be necessary to knockout one copy of tbplk, then 
express the gene under the control of an inducible promoter from an expression 
construct either integrated into the genome or as an episome followed by knocking out 
the second genomic copy before removing the inducer and examining cellular phenotype. 
Wirtz and Clayton (1995) have described a system that would appear to be suitable. A 
procyclic cell line expressing the E. coli tetracycline repressor from a construct 
introduced into the tubulin locus is used as the genetic background. The gene of interest 
is ligated into an expression construct that includes an upstream PARP promoter
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(mutated to include the TetR operator sequences) and downstream selectable marker 
(phleomycin resistance) with the ends of the construct coming from an rDNA 
nontranscribed spacer region to target the construct to this (transcriptionally inactive) 
region of the genome (stable transformation of T. brucei occurs by homologous 
recombination). Using a luciferase reporter gene Wirtz and Clayton (1995) found that 
the level of expression could be controlled over a range of four orders of magnitude in 
response to tetracycline concentration but there is a possible problem with the present 
system for genes that express toxic products. As the gene of interest and the selectable 
marker gene are under control of the same promoter, selection of transfectants has to be 
carried out in the presence of tetracycline leading to the expression of the gene under 
study. In view of the work performed with polo-like kinases in other systems, it seems 
likely that loss of function of tbplk would lead to defects in the mitotic spindle and the 
results of an experiment performed by Robinson et al. (1995) using the antimicrotubule 
agent rhizoxin (which had been shown to affect mitosis and subpellicular microtubule 
events more severely than flagellum growth) suggest a possible phenotype for disruptants 
in tbplk. In this experiment, exponentially growing procyclic cells were treated with a 
low concentration of the drug and the phenotypes of cells examined at various time 
points. It was found that, in such cultures, about 30% of the cells had a kinetoplast but 
were anucleate (IKON, these cytoplasts were termed zoids) while the proportion of cells 
with one kinetoplast and one nucleus (1K1N) was greatly reduced compared to control 
cultures; in addition, a second unusual cell type with one kinetoplast and two nuclei 
(1K2N) was also observed. The 1K2N and IKON cells were assumed to be siblings but, 
after approximately one cell cycle period, the number of IKON zoids was about twice the 
number of 1K2N cells suggesting that more than one type of cell division was leading to 
zoid production. Closer examination of the 1K1N cells from the drug treated culture 
showed that the nuclei of these cells had a higher DNA content than those of 1K1N cells 
from the control culture. The interpretation of these results was that in the divisions 
producing one 1K2N cell and one IKON zoid, mitosis occurred producing two nuclei but 
that nuclear segregation was defective. The second type of division producing IKON 
zoids was assumed to involve the IK IN cells with elevated nuclear DNA content as the 
sibling to the zoid. This type of division presumably results from failure of mitosis at an 
earlier stage (i.e. before two nuclei can be observed by staining) but nevertheless after
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nuclear DNA replication. Thus the two types of division postulated are essentially similar 
and could be explained by defects of differing severity in the mitotic spindle. It seems 
possible that tbplk disruptants would show similar morphologies although this would 
depend on whether TbPLK mainly or exclusively acts on the mitotic spindle or whether it 
has a wider role. If  the latter was the case, then cytokinesis might also be blocked in 
TbPLK disruptants and there might be other morphological defects. Given the large 
range over which Wirtz and Clayton (1995) were able to control the level of expression 
of a reporter gene it should be possible to examine the cellular effect of different degrees 
of underexpression and overexpression of TbPLK. ‘Dominant negative” strategies in 
which a mutant protein that may interfere with the function of the wild-type protein is 
expressed in a wild-type background might also be useful in examining TbPLK function.
Using antibodies, it would be possible to determine the subcellular localisation of 
TbPLK As described in Section 5.3.3, the localisation of polo and of Plkl/STPK13 has 
been shown to change during the cell cycle and, since the procyclic cell cycle has been 
well characterised by microscopy, a similar analysis could be performed for TbPLK An 
association of TbPLK with the mitotic spindle seems likely but TbPLK might also be 
associated with other microtubule structures and, in particular, an association of TbPLK 
with the basal bodies or associated microtubules seems possible. Once the subcellular 
localisation of the wild-type protein during the cell cycle had been determined, it would 
be interesting to compare this with the localisation of mutant forms of TbPLK. For 
instance, if the conserved PH2 domain is involved in an interaction between TbPLK and 
another protein then mutation or deletion of this domain might lead to the mutant protein 
having a different subcellular localisation to the wild-type protein. Since it would be 
desirable to be able to distinguish directly between mutant and wild-type proteins in 
experiments of this type it would be useful to have developed a system for expression of 
an epitope-tagged form of TbPLK and to shown similar localisation of the tagged and 
wild-type proteins so that two different antibodies could be used to detect wild-type and 
mutant proteins independently.
Antibodies could also be used together with nucleic acid probes, in an analysis of 
the level of expression of TbPLK protein and mRNA respectively. It would clearly be of 
interest to examine the expression of TbPLK and its mRNA both between life cycle 
stages and between cells from the same life cycle stage at different points in the cell
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cycle. The expression of TbPLK protein and message could be examined in slender 
bloodstream, stumpy bloodstream, procyclic and metacyclic forms by Western and 
Northern analysis respectively. Since TbPLK is likely to be cell cycle regulated both 
proliferating and stationary phase cultured procyclic forms should be included in this 
analysis. It would be expected that TbPLK protein would be detectable in slender 
bloodstream and proliferating procyclic forms but at a low or undetectable level in the 
non-proliferating stumpy, metacyclic and stationary phase procyclic forms. In general T. 
brucei mRNA levels correlate with the level of expression of the protein and it would 
seem likely that the level of TbPLK message would be lower in non-proliferating forms 
than in proliferating forms. A 5.4 kb poly(A)+ RNA hybridising to TbPK-A2 was found 
to be at similar levels in slender bloodstream and procyclic forms in a Northern analysis 
performed by Hua and Wang (1994) but the level of expression of the RNA has not yet 
been examined in any non-proliferating cell type. Ideally the levels of both hybridising 
poly(A)+ and total hybridising RNA would be measured in future analyses.
Analysis of the expression of TbPLK mRNA and protein during the cell cycle 
would be more technically demanding than a comparison between life cycle stages 
because of the need to obtain populations of cells at similar stages of the cell cycle using 
either cell synchronisation or cell sorting methods. Gale et al. (1994a) found that 
stationary phase cultured procyclic forms, stimulated to proliferate by addition of fresh 
medium, underwent the first cell cycle in a semi-synchronous manner as assessed by flow 
cytometric analysis of cellular DNA content. This synchronisation method could be used 
to assess the cell cycle expression of TbPLK protein and mRNA at different cell cycle 
stages, however, as noted by Gale et al. (1994a), it is possible that the first cell cycle in 
previously quiescent cells may not be typical of later cell cycles. Nutrient deprivation has 
also been used to synchronise culture-adapted bloodstream forms but the yield obtained 
was low (Morgan et al., 1993). Affranchino et al. (1993) used hydroxyurea treatment to 
synchronise procyclic cells at the Gi/S transition and this would be another possible 
approach to obtaining synchronous cultures. The alternative to the production of 
synchronous cultures of T. brucei is the sorting of asynchronous populations by flow 
cytometry (density centrifugation methods are not applicable due to the high motility of 
T. brucei). Although this method allows the use of a broader range of cell types, at 
present the only satisfactory method for sorting cell populations on the basis of cell cycle
168
stage is by analysis of DNA content using propidium iodide staining. The method for 
propidium iodide staining requires methanol fixation of the cells and RNase treatment. 
The latter treatment precludes Northern analysis and although Western analysis could be 
performed on cells sorted using this method, other analyses that might be desired, such 
as assay of protein kinase activity would probably not be possible due to protein 
denaturation (although Gale and Parsons, 1994a were able to assay the activity of 
renaturable protein kinases from cells stained in this way). It would be interesting to 
compare the expression of TbPLK with that of other putative cell cycle proteins such as 
the T. brucei cdc2-related protein kinases (Mottram and Smith, 1995) and the mitotic- 
like cyclin homologue CYC1 (Affranchino et al., 1993) although none of these are well 
characterised with respect to cellular function. The expression of TbPLK protein and 
mRNA could also be examined during the stumpy to procyclic transition performed in 
vitro a process that occurs coincidentally and synchronously with re-entry into a dividing 
cell cycle (Matthews and Gull, 1994b). It might be expected that TbPLK would be at a 
low or undetectable level in stumpy forms but that levels would increase at some point in 
the first cell cycle.
The biochemical properties of TbPLK could be investigated using 
immunoprecipitated protein from T. brucei cells, some experiments might also be 
performed with TbPLK overexpressed in another system All of the polo-like kinases 
studied to date use casein as substrate and, given that TbPLK has similar residues to 
those of other polo-like kinases at positions likely to be important for substrate binding 
(Section 5.2.4.3), it seems likely that TbPLK will be active as a casein kinase. The results 
of Hamanaka et al. (1995) suggest that a protein kinase phosphorylates and activates 
Plkl/STPK13 at the G2/M transition and it would be of interest to determine whether 
TbPLK is also phosphorylated in vivo and at what stages of the cell cycle by 
immunoprecipitating TbPLK from cultures grown in medium containing 
[32P]orthophosphate. At least some of the polo-like kinases also autophosphorylate. It 
would be desirable to determine the sites of any such phosphorylations. If  large amounts 
of active TbPLK could be obtained from an expression system such as Sf9 insect cells (as 
used for Plkl by Golsteyn et al., 1995 and Lee et al., 1995) it should be possible to 
determine the site(s) of any in vitro autophosphorylation by phosphopeptide mapping, 
however the determination of sites phosphorylated in vivo would probably be difficult
169
due to smaller amounts of protein. An alternative approach would be transfection of T. 
brucei with constructs expressing mutant forms of TbPLK with substitutions at the 
putative phosphorylated residues and an epitope tag to allow isolation separately from 
wild type TbPLK It is likely that phosphorylated sites in polo-like kinases from higher 
eukaryotes will be identified in the future and this knowledge should aid the investigation 
of the positions of any phosphorylated sites in TbPLK.
While reverse genetic and immunolocalisation experiments may well give an 
indication of the cellular role of TbPLK, in the longer term it will be important to identify 
proteins (particularly substrates) that TbPLK interacts with. One way of achieving this 
would be through co-immunoprecipitation of TbPLK and interacting proteins followed 
by identification of co-immunoprecipitated proteins by partial protein sequencing. 
However, preparation of sufficient amounts of protein(s) interacting with TbPLK for 
protein sequencing is likely to be very difficult. An alternative approach to the 
identification of proteins interacting with TbPLK would be to use the yeast two-hybrid 
system but this is also technically difficult. However, as described in Section 5.3.3, Lee et 
al. (1995) have reported strong evidence that a member of the kinesin superfamily of 
motor proteins, MKLP-1, is an endogenous substrate for Plkl while Ohkura et al. 
(1995) found that disruptants of p lo l+ showed similar phenotypes to those of mutants in 
cut7+ which encodes a kinesin-related protein (KRP) as well as reporting a genetic 
interaction betweenp lo l+ and cut7+. Therefore, it would not be unreasonable to perform 
experiments to test whether TbPLK showed any interaction with KRPs. One way in 
which this might be performed would be to immunoprecipitate TbPLK and then perform 
Western blot analysis with antibodies against KRPs to test for co-immunoprecipitation. 
No genes encoding T. brucei KRPs have been isolated although a gene for a KRP has 
been cloned fromLeishmania chagasi (Bums et al., 1993b). The motor domain of KRPs 
(about 340 amino acids) includes some highly conserved subdomains and antibodies 
against peptides corresponding to two motor subdomains (which are reasonably well 
conserved in die Leishmania KRP) have been used to identify proteins that showed 
biochemical properties similar to those of KRPs from organisms as divergent as Xenopus 
(Sawin et al., 1992) and Chlamydomonas (Fox et al., 1994) as well as being used to 
isolate a Xenopus cDNA encoding a KRP from an expression library (Walczak et al.,
1996). It should be possible to use such antibodies to probe Western blots of protein
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immunoprecipitated by antibodies to TbPLK. If the results of such analysis suggested 
that TbPLK did bind to one or more KRPs, it is less clear how such a protein would be 
identified more specifically. The only identified polo-like kinase substrate, human MKLP- 
1, cannot be grouped with any of the known KRP subfamilies (see review by Moore and 
Endow, 1996) and the only other known member of the outgroup is from another 
mammal (hamster). On this basis, it cannot at present be predicted whether lower 
eukaryotes are likely to have KRPs related to MKLP-1, although the other KRP 
currently suggested as a polo-like kinase substrate, cut7 (S. pombe), is from a defined 
subfamily of KRPs (the BimC subfamily) that has members from both multicellular and 
unicellular organisms. If evidence was obtained for an interaction of TbPLK with one or 
more KRPs, it would be possible to clone the genes for T. brucei members of this 
superfamily. This could be performed by PCR or library screening with degenerate 
oligonucleotides based on the peptide sequences of conserved motor subdomains or by 
expression library screening with antibodies to these subdomains.
In summary, on the basis of homology to polo-like kinases in higher eukaryotes 
TbPLK is likely to be involved in regulating the mitotic spindle in T. brucei and perhaps 
in other aspects of cell cycle control. Cell division in this organism is very different to 
that in both multicellular eukaryotes and in the yeasts S. cerevisiae and S. pombe but has 
been relatively well studied with respect to changes in the subpellicular cytoskeleton. 
Examination of the cellular function of Tbplk should complement both these studies and 
recent studies into cdc2-related kinases in T. brucei (see Section 1.3.2.2). T. brucei is at 
present the most evolutionary divergent organism from which a polo-like kinase 
homologue has been identified and the further study of TbPLK would also be interesting 
in terms of determining the extent of conservation of function among the polo-like 
kinases.
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Fig. 5.1 Schematic diagram showing the main features of the 3’ RACE method. (A) 
cDNA synthesis; (B) PCR.
Fig. 5.2 Strategy for 5’ RACE using a 5’ primer based on the T. brucei spliced leader 
(A) cDNA synthesis; (B) PCR.
Fig. 5.3 Primers used in PCR reactions. The figure shows schematically the placement of 
the primers on a cDNA that includes TbPK-A2. The boxed section of the line indicates 
TbPK-A2 (not to scale), the two arrows in bolder type represent the original degenerate 
primers at the ends of TbPK-A2.
BmRNA 5 '---------------------------------------------------------------- AAAAAAAAAAAAAAAAAAAAAAAAAA
cDNA < --------------------------------------------------------------------------------  TTTTTTTTTTTTTTT
Anchor sequence
7cDNASense  gene-specific __ /  \  “Nested" gene-specific primer
primer (used in later round of PCR) \  Antisense
anchor primer
Fig. 5.1
mRNA 5'
Spliced leader /
“AAAAAAAAAAAAAAAAAAAA
\
cDNA synthesis can be performed using an 
oligo(dT) primer or a gene-specific primer
aDNA > -  ^----------
B \  S ense spliced Antisense gene-
leader primer specific primer
Fig. 5.2
5'
Primer 1: sense primer based on the spliced leader 
Primer 2: sense gene-specific primer 
Primer 3: “nested” sense gene-specific primer 
Primer 4: “nested” antisense gene-specific primer 
Primer 5: antisense gene-specific primer 
Primer 6: anchor antisense primer
5’ TTAGAACAGTTTCTGTACTATA 3’
5’ TGACAACATAATGATGGATGCA 3’
5’ AAGATTAGGGACTTCGGTTTGG 3’
5’ GCGAACCTTCAATGATCTCCGG 3’
5’ ACGTCCACTTCGTAACTATGTC 3’
5’ CGAGAATTCGGTGGCAGCAGCCAACT 3’
Fig. 5.3
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Fig. 5.4 Amplification of a cDNA fragment homologous to TbPK-A2. Panel A shows a 
2% agarose gel stained with ethidium bromide containing products of 30 cycles of PCR 
using primers 2+5 with a cDNA template. The strongly stained band in Lane 2 is of the 
size expected (171 bp) for a fragment similar to TbPK-A2. Panel B shows an agarose gel 
containing products of PCR reactions with aliquots of the primer 2+5 product as 
template. The primer combinations used are indicated above each lane. The major 
products are of the sizes predicted (171, 143, 109 and 137 bp for the products generated 
using primers 2+5, 2+4, 3+4 and 3+5 respectively). The major product generated using 
primers 2+5 was cloned and sequenced. Panel C shows the nucleotide and predicted 
peptide sequences of this PCR product and the original clone TbPK-A2 compared with a 
similar sequence (labelled Tbplkl) from a A,gtl 1 cDNA clone (Section 5.2.4.1). Dashes 
indicate identity with the sequence from the X gtll clone while PCR primers are 
underlined. Note that the 3’ primers (bottom left) are shown as their complements (sense 
strand) but are actually antisense primers. The primer 2+5 product and TbPK-A2 differ 
at a single nucleotide position internal to the primer regions at which the sequence of the 
A-gtll clone agrees with that of the primer 2+5 product. As might be expected there are 
further differences between the sequence of the Xgt i l  clone and TbPK-A2 within the 
region of the degenerate primers used to amplify TbPK-A2.
Fig. 5.5 Amplification of the 5’ cDNA sequence. Panel A shows a gel loaded with the 
products of 30 cycles of PCR using the modified 5’ RACE procedure shown in Fig. 5.2. 
The primers were 1 (spliced leader primer) and 5 (gene specific) and a cDNA template 
was used. The annealing temperature in the PCR reactions was 47 °C and the extension 
time was 2 minutes. Repeating the reaction with annealing temperatures between 38 °C 
and 50 °C made little difference to the results (not shown). Products of the 5’ RACE 
reaction shown in panel A were re-amplified from agarose gel slices with primers 1 and 
5. In order to test whether any of these reactions contained the specific product desired 
aliquots were run out in an agarose gel (panel B) which was blotted, and the blot was 
probed with the cloned fragment similar to TbPK-A2 (panel C shows the autoradiograph 
of the blot). Lanes 1, 2, 4, 5, 7, 9, and 11 are empty, lane 3 contains a portion of the 
DNA that was used to make the probe as a positive control, while lanes 6, 8, and 10 
contain aliquots of the different PCR reactions performed with products of the original 5’ 
RACE reaction as template.
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T b P K -A 2  ---------------------- ---------------- ------------------------------------------------------------------------------
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- - G  T - - G  A C  --------------------------------------------------- ------------
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Fig. 5.6 Amplification of the 3’ cDNA sequence. Panel A shows an agarose gel 
containing products of a 3’ RACE reaction between primer 2 and an oligo(dT) primer. 
Lane 1 contains DNA size markers, lane 2 contains the products of a control reaction, 
while lane 3 contains the products of the 3’ RACE reaction. It can be seen that there are 
no visible product bands of significant size, a possible reason for the failure of the 
reaction being that the lower annealing temperatures that have to be used with an 
oligo(dT) primer were reducing reaction specificity. In order to address this a new batch 
of cDNA was made using an adapter primer so that 3’ RACE could be performed with a 
3’ anchor primer (primer 6) and gene specific primers 2 or 3 at higher annealing 
temperatures. Panel B shows the products of 3’ RACE reactions using primers 3 and 6 at 
annealing temperatures of 56 °C, 58 °C, and 60 °C. The annealing temperatures used are 
indicated above each lane while the positions and sizes of DNA markers are indicated to 
the left. Two of the products from the 56 °C reaction were cloned (marked on figure). 
Panel C shows products of 3’ RACE reactions between primer 2 and primer 6, and 
between primer 3 and primer 6. Lane 1 contains DNA size markers, lanes 2 and 3 are 
duplicate lanes containing products of primers 2+6, while lanes 4 and 5 are duplicate 
lanes containing products of primers 3+6.
1 2 3
517/506
154/134
517/506
Reaction products 
cloned 220/201
154/134
7 5 '517/506
154/134
Fig. 5.6
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Fig. 5.7 Screening of a Xgtl 1 cDNA library with the PCR product homologous to 
TbPK-A2. In the primary screen only a single plaque hybridised to the probe on a 
confluent plate and was picked for further rounds of screening (not shown). Panel A 
shows the autoradiograph of a plate from the secondary screen from which the plaque 
indicated by the arrow was picked for further screening. In the tertiary screen (panel B) 
22 plaques hybridised to the probe from a total of 78. The plaque that was picked for the 
production of larger quantities of the phage, isolation of DNA, and subcloning of the 
insert into a bacterial plasmid is arrowed.
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A
TCGTGACCAGACGCATCCT’TGAGGCGGGCGATGTCGAAGGCGCCAGGGTGACG'rrCAATGGACACAATTTCTCCAATACGACCACGGTTGGCACCACCTG
-------- +--------- +--------- +--------- +-Block A +-------- +---------+---------+--------- +--------
AGCACTGGTCTGCGTAGaAACTCCOCCCGCTACAQCTTCCQCQQTCCCACTOCAAGTTACCTGTGTTAAAGAGGTTATQCTQGTQCCAACCGTOGTQGAC
H G S A D K L R A I D F A G P H R E I S V I E G I R G R N A G G
-------- +--------- +--------- +--------- +-Block A +---------+---------+---------+---------+--------
AGTQGTAGTGTTGQAACGGCAACGGTTAaAACTAATCCAGGTTTTGQAAAAAAAGAAAGTQCAGTATGTQaTTTCACAGAGQTQCCQAGCATGCCCCCAG
T V M V V K G N G I K I L D L V K K E K V D Y V L T D G R S T R P D
GGGATAGCGAATCCGGTGGCCGTCGTGTGTCACAGCAACAGGAATGCGTCCCGTGCCGGTGTATACGTTGACAACCTTCATCATCTTGATGCTCGACTCA
-------- +--------- +--------- +--------- + -Block A +-------- +---------+---------+---------+--------
CCCTATCQCTTAOGCCACCGGCAQCACACAGTQTCOTTQTCCTTACGCAQQGCACOGCCACATATQCAACTGTTQOAAQTAGTAaAACTACaAQCTGAQT
P Y R I R H G D H T V A V P I R G T G T Y V N V V K M M K I S S E
IAAOGCCTCGCTCACGCGGACAAGCGCAAAGCGTCCTITCACGTCATATAGGATGCGG.
-------- +--------- +.... +--------- +-Block A + ------ 3 5 6
CQOAGCaAQTGCGCCTGTTCGCQTTTCQCAGGAAAaTQCAaTATATCCTACaCCT
A E S V R V L A F R G K V D Y L I R E
^GGaQAAAAAAAAAAAAAQAATQCACQCAACCGCTQAGACQTGT 
-- +-Block B +-------- +---------+--------
G K K K K R M H A T A E T C
GAAACQCCQTCQAOTTCGCaGCGCCCTCCAAATaACAQQCCGaACTTTCGTQAQGGTTCAACTCTTAAQGAQTTTQATAAAAGTGQCCGTCTCGTGGaAT
-------- +--------- +--------- +---------+--------- +--------- + -Block B +-------- +--------- +--------
CnTGCGGCAGCTCAAGCGCCGCGGGAGGTrrACTGTCCGGCCTGAAAGCACTCCCAAGTTGAGAAITCCTCAAACTATnTCACCGGCAGAGCACCCTA
E T P S S S R R P P N D R P D F R E G S T L K E F D K S G R L V G Y
A1 TTCCaTTacaaAAaaATGCTCaaacaTaOTaaCTTTaCAAAaTGTTATGAAaTGaAGCAGaaTaGCGATACGTATGCaTTaAAGaTTGTaaACCGCTC
- - 503----+-Block C + ------------------- + --------------------+ --------------------+ --------------------+ --------------------+ --------------------+ --------------------- + ----------------
TA AAGGCAACGCCTTCCTACGAGCCCGCACCACCGAAACGTTTCACAATACTrCACCTCGTCCCACCGCTATGCATACGCAACTTCCAACACCTGGCGAG
[ f ] r c q r m l [g ] r [g ] g f [ T | k c y e v e q q g d t y a l k v v d r s
 + -Block C +--------- +--------- +--------- +---------+---------+---------+---------+--------
TGATGACGTCTTTTGATTCTGTGATGTCTTTGAGGTGAGACTCTATAGGTAAGTGGCGGCGTACTTCGTGTTTGTGTAACAATTGAAGTATGCCTGGAAG
L L Q K T K T L Q K L H S E I S I H R R M K H K H I V N F I R T F
CATaACaACTGaAATOTTTATATTCTaTTQOAaAAOTaCAaCAATCAOACaCTaATOaAAATATTaAAOCQCCQaCAACaTTTCAaTaTGCCAGAOACAC
 + -Block C +--------- +---------+--------- +---------+---------+---------+---------+--------
GTACTGCTGACCTTACAAATATAAGACAACCTCTTCACGTCGTrAGTCTGCGACTACCTTTATAACTTCGCGGCCGTTGCAAAGTCACACGGTCTCTGTG
H D D W N V Y I L L E K C S N Q T L M E I L K R R Q R F S V P E T Q
AATACATTaCATTQCAGTCQCTTTCCGCCATTCAATATATOCATOAaCAATOTQTTATTCATCaTQACCTaAAACTTQQTAACATAATaATQQATaCAAA
---------+-Block C +---------+--------- +---------+--------- +---------+--------- +---------+--------- +
TTATGTAACGTAACGTCAGCGAAAGGCGGTAAGTTATATACGTACTCGTTACACAATAAGTAGCACTGGACTTTGAACCATTGTATTACTACCTACGTT’I  
Y I A L Q S L S A I Q Y M H E Q C V I H  R D L K L G N I M M D A N
TATaAACaTaAAGATTaGaaACTTCGaTTTaaCTaCTaAaTTaCAaTACOACaGQaAGCaGAAACaCACTATTTaTGGCACOCCCAATTATATCGCACCG
 + - Block C +--------- +--------- +---------+--------- +---------+---------+---------+--------
ATACTTGCACTrCTAACCCCTGAAGCCAAACCGACGACTCAACGTCATGCTGCCCCTCGCCTTTGCGTGATAAACACCGTGCGGGTTAATATAGCGTGGC
M N V K I G D F G L A A E L O Y D Q E R K R T I C Q T P N Y I A P
GAGATCATTaAAGGTTCGCaCQAaGaACATAaTTACQAAGTQQATGTGTQGTCGCTCQGTQTQATCCTCTACACGCTGTTGQTTQQAGAQCCQCCGTTTC
 + -Block C + --------------------+ --------------------+ --------------------+ --------------------+ ------------------- + --------------------+ ------------------- + ---------------------+
CTCTAGTAACTTCCAAGCGCGCTCCCTGTATCAATGCTTCACCTACACACCAGCGAGCCACACTAGGAGATGTGCGACAACCAACCTCTCGGCGGCAAAG 
E I I E G S R E G H S Y E V D V W S L G V  I L Y T L L V G E P P F Q
AaACATCAaATGTGAAaaCCACTTACCGTCaTATTAaaCAATGCCaaTATaAATTTCCTTCACATGTAOATaTaCCAGAGAGTGaaAAGGAACTTATTCA
 + -Block C + ------------------- + --------------------+ --------------------+ --------------------+ ------------------- + ------------------- + --------------------+ ------------------
TCTGTAGTCTACACTTCCGGTGAATGGCAGCATAATCCGTTACGGCCATACTTAAAGGAAGTGTACATCTACACGGTCTCTCACCCTTCCTTGAATAAG'I
T S D V K A T Y R R I R Q C R Y E F P S H V D V P E S G K E L I H
CAQTATTCTQCAGAQCCaCCCCGAjCCAACQQCCaACQTTQCTaaAAATTCQTTCACATCCATTTTTi
---------+-Block C +--------- +---------+--------- +--------- +---1267
GTGATAAGACGTCTCGG CGGGG CTGGTTG CCGG CTG CAACGACCTTTAAG CAAGTGTAGGTAAAAA(
s i l q s r p d q [r ] p t l l e i r s [ h ] [ p ] [ f ] [ f ]
CCGCCTCCCGCCaCCACCaACaACAGCACCTACC
-- + -Block D +-------- +--------- +
CGGAGGGCGGCGGTGGCTQCTGTCGTGGATGG
R L P P P P T T A P T
ACACTCTTCTACAGTTCACGCCGCCGTCAGCATTCAGATaACCCCCOAaaACATGCGCAaGGACCACTTCCACTTCGCCQCCAAAAATCAGGGOACATTC
-------- +---------+--------- +---------+--------- +--------- + + - Block D +--------- +-------
TGTGAGAAGATGTCAAGTGCGGCGGCAGTCGTAAGTCTACTGGGGGCTCCTGTACGCGTCCCTGGTGAAGGTGAAGCGGCGGTTTTTAGTCCCCTGTAAG
T L F Y S S R R R Q H S D D P R G H A Q G P L P L R R Q K S G D I Q
AOacaacaTTaCAOAAACAAACACCaCAACaCCaTCAACCaCAQTCaCAGCCCAAATCAaTTaAAaCTaTTCGCTaCATTTCaAGTCCGCGTGTaTCCCG
-------- +---------+--------- +---------+--------- +--------- + + -Block D +-------- +--------- +
TCCGCCGCAACGTCTTTGTTTGTGGCGTTGCGGCAGTTGGCGTCAGCGTCGGGTTTAGTCAACrrCGACAAGCGACGTAAAGCTCAGGCGCACACAGGGC
A A L Q K Q T P Q R R Q P Q S Q P K S V E A V R C I S S P R V S R
CGAAGTQCTTCAACCTATCAOCACAAATCTTCCCAAAACaGACCQATACCACCT
-------- +---------+--------- +--------- +-Block D +----
GCTTCACGAAGTTGGATAGTCGTGTTTAGAAGGGTTTTGCCTGGCTATGGTGGA 
E V L Q P I S T N L P K T D R Y H
B
CAAACCAAACGQTCACCQCAAGTGQCTCCCTTGCCAOTGGCGAACTCACCCACAACATCTACAGTTCCTGCATTAACGCCCAQATGCGAAQACQAOCCGQ
--------- + -Block E +---------+---------+---------+---------+--------- +--------- +--------- +--------- +
GTirGGTTTGCCAGTGGCGTTCACCGAGGGAACGGTCACCGCTTGAGTGGGTGTrGTAGATGTCAAGGACGTAATTGCGGGTCTACGCTTCTGCTCGGCC 
Q T K R S P Q V A P L P V A N S P T T S T V P A L T P R C E D E P A
CGCCATCGTTaCCACTTCCCACTQTTTQQGTGACGAaTTTCGCGGATTTCTCCGAAAAATACGGQTTGTaTTACCGGTTQAaCACCaGCCATACCQGTQT
---------+ -Block E +---------+---------+---------+---------+---------+--------- +--------- +--------
GCGGTAGCAACGGTGAAGGGTGACAAACCCACTGCTCAAAGCGCCTAAAGAGGCTTTTTATGCCCAACACAATGGCCAACTCGTGGCCGGTATGGCCACA
P S L P L P T V W V T S F A D F S E K Y G L C Y R L S T G H T G V
GCACTTCAACGACTCCACTAAAATGQTQTQQQAaCCCATTACAAACCQTQTAGAOTATTATATGCGAGTGAAGGAAQTTGTTGCGCGTQQTAATGCCAACQ
---------+ -Block E +---------+---------+---------+---------+---------+--------- +--------- +--------- +
CGTGAAGTTGCTGAGGTGATTTTACCACACCCTCGGGTAATGTTTGGCACATCTCATAATATACGCTCACTTCCTTCAACAACGCGCACCATTACGGTTGC 
H F  N D S  T K M V W E P I T N R V E Y Y M R V K E V V A R G N A N
TATTCTAAGTTCGGAGTCG CGTGTTGTTACATATACAGAAC CAACTGGCAAC CG CGTGACAATGTCG CTATCGTCTGTTG CG ACACG CTCTAGAGAAATI
-------- +--------- +-Block F +---------+---------+--------- +---------+--------- +--------- +--------
ATAAGATTCAAGCCTCAGCGCACAACAATGTATATGTCTTGGTTGACCGTTGGCGCACTGTTACAGCGATAGCAGACAACGCTGTGCGAGATCTCTTTAA
I L S S E S R V V T Y T E P T G N R V T M S L S S V A T R S R E I
GCTGCACGGCTTCGTTACACCAAAGACATCCTCAGCGAGCTCATACAAAACCGCCATGGTACCCGGATCCTC
-------- + + -Block F +---------+---------+---------+--------- + --
CGACQTGCCGAAGCAATGTGGTTTCTGTAGGAGTCGCTCGAGTATGTnTGGCGGTACCATGGGCCTAGGAG
A A R L R Y T K D I L S E L I Q N R H G T R I L
Fig. 5.9 Nucleotide sequences from pTbplkl and predicted peptide sequences (sense 
strands in bold). Panel A: sequence from the 5’ end of pTbplkl (5’ Eco RI site to 
approximately 100 bp 3’ of the Hinc II site in subclone D); Panel B: sequence from the 3’ 
end of subclone D; Panel C: sequence from the 3’ end of the insert in pTbplkl. The 
sequences have been arranged so that nucleotide 1 in A, B, C corresponds to the end 
nearest the 5’ end of pTbplkl (see Fig. 5.8). The boxed blocks refer to the blocks shown in 
the schematic diagram in Fig. 5.10. The peptide sequence from Block A shows homology 
to eukaryotic ribosomal protein S4 while that from Block C is homologous to protein 
kinase catalytic domains and includes the TbPK-A2 sequence (underlined). The boundaries 
of the protein kinase catalytic domain have been set according to the definition of Hanks 
and Quinn (1991) and the residues that they used in making this definition are boxed (see 
text). Note that the alanine residue in the box with the heavier outline is at a position at 
which most protein kinases have a glycine (see Section 5.2.4.3). The open reading frame of 
Block C extends through all of Blocks B and D while that of Block A is in the opposite 
orientation. However, the ends of Blocks A and B at their junction are not the ends of open 
reading frames (see text). The underlined section of Block E (panel B) is homologous to a 
highly conserved C-terminal domain of polo-like protein kinases (PIE  domain).
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blocks defined 
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double 
slash 
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and 
protein 
kinase 
sequences. The polo-like 
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Chapter 6
Future Perspectives
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Protein kinases have been studied in T. brucei on the basis that they might play 
similar cellular roles to protein kinases studied in higher eukaryotes. Biochemical 
approaches to the study of T. brucei protein kinases have provided little information 
about their functional role. However, the future prospects for a functional analysis of T. 
brucei protein kinases in studies based on gene cloning seem much better particularly as 
transfection technologies for T. brucei, suitable for use in examining protein function, 
have recently been developed. Reverse genetics experiments, such as gene knockouts, 
can give clues to the cellular function of a particular protein kinase. However, as both 
protein kinases and protein phosphatases are often organised into networks, the isolated 
study of an individual protein kinase may be of limited interest and a priority in much 
protein kinase research is the identification of proteins with which the catalytic subunit of 
the protein kinase under investigation interacts. These proteins will include substrates 
and might also include regulatory and targeting subunits and other signalling proteins 
such as other protein kinases. Unfortunately, T. brucei remains a difficult organism to 
study with respect to the identification of proteins interacting with a known protein 
because approaches such as co-immunoprecipitation followed by protein 
microsequencing are hampered by the difficulty of obtaining large quantities of T. brucei 
cells. The identification of proteins interacting with the known proteins based on 
informed guesses about their identity would be limited by the fact that only a small 
proportion of T. brucei protein coding genes have been sequenced and specific 
antibodies are only available for a few proteins. A technique that can be used to 
overcome these problems is known as the yeast two-hybrid system. In this screen for 
protein-protein interactions the gene for a known protein of interest is fused to that for 
the DNA-binding domain of a yeast transcriptional activator that binds to a specific DNA 
sequence but cannot activate transcription except when in the close proximity of an 
activation domain. The construct is expressed in a yeast strain that has a binding site for 
the transcriptional activator upstream of a reporter gene. A library of cDNAs or genomic 
fragments is then created using an expression vector encoding the activation domain and 
the yeast strain expressing the hybrid "bait" protein is transfected with this library. If any 
of the hybrid proteins including the transcriptional activator domain bind to the "bait" 
protein the DNA-binding and transcriptional activator domains of the two hybrids will be 
brought into close proximity and the reporter gene will be expressed. Cells expressing
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the reporter gene are selected and the vector recovered to allow sequencing of the gene 
for the protein that interacts with the known protein (see review by Evangelista et ah, 
1996).
On the other hand research into protein kinases in biological model systems 
including unicellular eukaryotes such as S. cerevisiae is progressing rapidly. In S. 
cerevisiae, for example, the investigation of protein function is greatly simplified by fact 
that classical and reverse genetics are well developed and the entire genome has been 
sequenced (see reviews by Dujon, 1996 and Johnston, 1996). The future results from 
research into protein kinases in these organisms would be certain to simplify the study of 
protein kinases in T. brucei by providing a more complete set of characterised protein 
kinases to which T. brucei protein kinases could be compared first for sequence 
homology and, if chosen for further study, for functional homology. This would be 
particularly true if the complete sequence of the T. brucei genome or a more extensive 
database of T. brucei EST sequences was available. Therefore, while T. brucei protein 
kinases are surely involved in the regulation of processes that are of great interest with 
respect to its biology (such as differentiation between life cycle stages), there does not at 
present seem to be justification for the study of large numbers of T. brucei protein 
kinases in comparison to other research that might be undertaken. Research into a 
particular T. brucei protein kinase is most likely to be justified when homology to protein 
kinases characterised in other organisms suggests that study of such a kinase will 
complement existing work into an aspect of T. brucei biology.
At present the only putative signalling network in T. brucei for which a number 
of potential components have been identified is one utilising cAMP as second messenger. 
Pays et al. (1989) identified an expression site associated gene (named ESAG 4) 
encoding a putative transmembrane protein predicted to have an extracellular N-terminal 
domain and a smaller C-terminal domain with adenylate cyclase activity (based on 
sequence homology to the catalytic domain of S. cerevisiae adenylate cyclase). In further 
studies at least 3 GRESAGs (Genes-Related to ESAGs) related to ESAG 4 were 
identified (GRESAGs 4.1, 4.2 and 4.3). These genes were shown to be transcribed in 
both bloodstream and procyclic forms and ESAG 4 and GRESAG 4.1 were able to 
complement a S. cerevisiae adenylate cyclase mutant. Immunolocalisation experiments 
using antibodies raised against the ESAG 4 protein (which cross-reacted with the
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GRESAG 4.1 protein and possibly also the GRESAG 4.2 and 4.3 proteins) showed that 
in both bloodstream and procyclic forms the proteins are located along the length of the 
flagelhun but could not be detected elsewhere (Alexandre et al., 1990; Paindavoine et 
al., 1992). Rolin et al. (1993) investigated whether adenylate cyclase activity varied 
during the in vitro differentiation of stumpy bloodstream forms to procyclic forms and 
showed a transient peak of activity at about 4 hours after differentiation was induced. As 
dividing cells began to appear, adenylate cyclase activity rose gradually to a second peak 
at about 40 hours (although maximal activity was considerably lower than that for the 
first peak) and then declined so that by 48 hours activity was similar to that in established 
procyclic forms. There is also evidence for a possible role for cAMP signalling in other 
differentiation events in T. brucei. Mancini and Patton (1981) analysed parasite 
intracellular cAMP levels during infections of rats with a pleomorphic T. brucei stock 
and found that levels were low early in infection but rose during the first peak of 
parasitaemia and were highest just before intermediate and stumpy forms began to 
appear but then fell dramatically as intermediate and stumpy forms became predominant. 
The levels of cAMP per parasite cell then rose again as the infection progressed to the 
second wave of parasitaemia; this increase preceding the appearance of the new 
population of slender forms. Van den Abbeele et al. (1995) found that a crude membrane 
fraction prepared from tsetse proventriculus/oesophagus stimulated adenylate cyclase 
activity in procyclic forms while soluble and membrane fractions from other tsetse tissues 
were inactive. This fraction also stimulated activity in bloodstream forms but while a 
number of different treatments of bloodstream form cells have this effect (see references 
in Paindavoine et al., 1992) the proventriculus/oesophagus membrane fraction is the only 
stimulus known for adenylate cyclase in procyclic forms suggesting possible signalling 
from the vector to the parasite through one or more of the GRESAG 4 proteins.
The family of adenylate cyclases related to the ESAG 4 protein are the only 
components of a putative cAMP signal transduction cascade characterised in T. brucei, 
however, three genes encoding putative T. brucei PKA homologues and a gene encoding 
a putative T. brucei cAMP phosphodiesterase have recently been isolated (M. Boshart, 
personal communication) and the proteins seem likely to be involved in cAMP signal 
transduction. The predicted amino acid sequence of ESAG 8 was found to contain 
leucine-rich repeats and similar repeats have been found in a regulatory domain of S.
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cerevisiae adenylate cyclase which mediate interaction with Ras homologues. On this 
basis, it was suggested that the ESAG 4 and ESAG 8 proteins might interact to form an 
adenylate cyclase complex that might be regulated by T. brucei Ras homologues (Ross et 
al., 1991), however, there is currently no experimental evidence to support this. Given 
the good evidence for involvement of cAMP signalling in several differentiation events in 
T. brucei and the fact that several genes encoding proteins known or likely to be 
involved in cAMP signalling have already been cloned, further study of this putative 
signal transduction cascade would be worthwhile. Among the questions that need to be 
addressed are the nature of the ligands that bind to the extracellular domain of the 
adenylate cyclases and the substrates for the T. brucei PKA enzymes.
In addition to the putative cAMP signalling pathway a number of other studies 
have been published dealing with possible pathways through which T. brucei might sense 
and respond to extracellular events. There is also some evidence for signalling from the 
parasite to the host. Among these Hide et al. (1989) showed an effect of EGF on the 
growth of procyclic T. brucei in culture and suggested that T. brucei might have an EGF 
receptor homologue. Sztein and Kierszenbaum (1991) found that a soluble factor from 
T. b. rhodesiense was able to prevent activated human T cells progressing through the 
cell cycle while Keku et al. (1993) found that a soluble factor from T. brucei was able to 
inhibit the growth of HL-60 cells. Kardami et al. (1992) identified molecules from T. 
brucei and from Leishmania that had properties similar to those of basic FGF. A T. 
brucei factor that has been studied in more detail is trypanosome-derived lymphocyte- 
triggering factor (TLTF) which is released by T. b. brucei and stimulates CD8+ T cells to 
divide and to secrete IFN-y, probably through binding directly to CD8. It was also shown 
that IFN-y and a neuronally-produced molecule related to IFN-y stimulate parasite 
growth suggesting that there may be bi-directional signalling between T. b. brucei and its 
mammalian hosts (Olsson et al., 1991; Olsson et al., 1993; Olsson et al., 1994). It has 
also been suggested that the production of stumpy forms in the mammalian bloodstream 
is induced by an exogenous soluble factor(s) that accumulates during infection (Seed and 
Sechelski, 1989; Hesse et al., 1995, M. Boshart, personal communication) and the 
results from the latter two studies suggest that this is parasite produced. The 
identification of T. brucei receptors and their ligands would be particularly interesting 
with respect to understanding the parasite’s biology and cell surface receptors would also
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present possible targets for immune intervention in African trypanosomiasis. However, in 
none of these studies has a T. brucei receptor been identified by gene cloning.
Putative proteins defined by gene cloning that might be involved in the 
intracellular aspects of T. brucei signal transduction cascades include the two T. brucei 
MAP kinases, Nrk, and TbZFK (see Table 1.2) as well as the T. brucei PKA homologues 
(the TbCRKs and TbPLK seem more likely to be involved in regulation of the cell cycle 
than in signal transduction) and small GTP-binding proteins (Field et al., 1995; M. Sowa, 
personal communication). At present no signal transduction cascades linking any of these 
proteins together have been mapped. There is also very little known about downstream 
targets of signal transduction cascades in T. brucei but cellular processes such as 
differentiation require major changes in gene expression. In many other eukaryotes, 
transcription factors are targets of signal transduction cascades but the equivalent targets 
in T. brucei might be proteins involved in controlling RNA maturation and mRNA 
stability as there is limited transcriptional regulation of gene expression. No genes 
encoding proteins likely to be involved in these processes have been isolated.
With respect to future work, the identification of T. brucei cell surface receptors 
by biochemical studies seems unlikely to be a profitable approach in view of the fact that 
cell surface receptors involved in signal transduction tend to be low abundance molecules 
and T. brucei cells are difficult to obtain in large numbers. However, biochemical studies 
might provide evidence for a particular type of receptor for which the gene could then be 
isolated using a homology based approach. Such an approach might also be adopted 
based on information about receptors in other organisms. For instance, it seems possible 
that T. brucei will have members of the superfamily of proteins known as “two- 
component systems” (see Section 1.2.1). In the bloodstream stages the proteins encoded 
by ESAGs (and any related GRESAGs) of currently unknown function might be 
investigated as potential receptors (as is already known to be the case for ESAG 4) since 
a number of these appear to be cell surface associated.
T. brucei may be able to monitor its environment without utilising cell surface 
receptors dedicated exclusively to a sensory function. For example, a stimulus for the 
initiation of the stumpy to procyclic transformation (at least in vitro but quite possibly 
also in vivo) is a temperature shift which would obviously not require a cell surface 
receptor (the mechanism through which this signal acts is unknown). In addition to a
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temperature shift, citrate and cis-aconitate induce stumpy to procyclic transformation in 
vitro. These are intermediates in the TCA cycle and it is possible that a change in the flux 
through a particular metabolic pathway caused by differences in the profile of metabolic 
substrates, available in the tsetse compared to the mammal, signals differentiation in vivo. 
In view of this possibility, some T. brucei signal transduction cascades might only be 
identified through the initial characterisation of intracellular signalling molecules such as 
protein kinases and members of the Ras superfamily (for which genes can be cloned 
using homology-based techniques) followed by searches for interacting proteins. The 
downstream targets of signal transduction cascades in T. brucei are likely, in many cases, 
to be more divergent from downstream targets of signal transduction cascades already 
characterised in higher eukaryotes compared to proteins playing an intermediate role in 
signal transduction cascades. The difficulty of characterising such molecules would be 
another reason to begin mapping a T. brucei signal transduction cascade from initial 
studies of a protein such as a protein kinase. In this respect MAP kinase cascades which 
are known as central mediators of signalling in both multicellular and unicellular 
eukaryotes would be an obvious choice for investigation and two genes encoding 
putative MAP kinase homologues have been isolated from T. brucei (see Table 1.2).
The control of the cell cycle is known to involve protein phosphorylation in both 
multicellular and unicellular eukaryotes. Of the T. brucei protein kinases predicted from 
DNA sequence all of the TbCRKs and TbPLK are probably involved in cell cycle 
regulation. It has not been determined whether any of the T. brucei CRKs acts a 
functional homologue of cdc2 which is the key regulator of entry into mitosis, however, 
identification and characterisation of a T. brucei functional homologue of cdc2 (assuming 
there is one) would be of great interest. The existence of a family of CRKs in T. brucei 
(Mottram and Smith, 1995 suggested that there might be at least 6 members of this 
family in T. brucei) might reflect the use of different CRKs to control different cell cycle 
checkpoints, the use of different CRKs in different life cycle stages or, possibly, the use 
of CRKs for roles other than controlling cell cycle checkpoints. The characterisation of 
the T. brucei CRKs as putative cell cycle kinases would complement other research into 
the cell cycle in T. brucei and research into differentiation. In order to answer questions 
about cell cycle regulation in T. brucei the identification of at least some of the proteins 
with which the TbCRKs interact will be required; the putative cyclin partners being the
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most obvious of these. The identification of proteins interacting with the TbCRKs would 
almost certainly be easier if the sequence of the T. brucei genome or a more extensive set 
of EST sequences were available. However, information from future studies into the 
function of cdc2-related kinases in higher eukaryotes might not be as important with 
respect to functional characterisation of the TbCRKs as for some other T. brucei protein 
kinases. There is abeady a large background of information available about cdc2 related 
kinases from both unicellular and multicellular eukaryotes but there are no unicellular 
eukaryotes currently being studied as model systems which are known to possess such a 
large a family of CRKs as T. brucei.
Possible future work into the cellular function of TbPLK is discussed in Chapter 
5. Briefly, the further study of TbPLK should complement previous studies of the 
procyclic cell cycle as the kinase is likely to be involved in regulation of the mitotic 
spindle. This is an interesting area of research since mitosis in T. brucei is very different 
to that in other eukaryotes in which it has been examined. Examination of the phenotype 
of mutants in tbplk may provide information about function. It seems likely that tbplk will 
be an essential gene in T. brucei but by expressing tbplk under the control of an inducible 
promoter it should be possible to perform switch-off and overexpression experiments 
and, assuming TbPLK is involved in regulating the mitotic spindle, the loss of function of 
tbplk should cause defects such as complete or partial failure of nuclear genome 
segregation (perhaps with the production of zoids) which could be observed by 
microscopy.
The possible fixture research on the TbPKAs, TbCRKs, TbPLK and the two T. 
brucei MAP kinase homologues has been considered above but the possible research on 
Nrk has not. This protein kinase and the genes encoding it have actually been studied in 
most detail. Nrk is an example of a protein kinase for which peptide sequence homology 
to known protein kinases gives little indication about likely cellular function. Studies 
have shown that Nrk protein levels are strongly upregulated in stumpy forms compared 
to slender bloodstream and procyclic forms, that this occurs early in the differentiation of 
slender to stumpy forms and that the regulation of expression is at the translational level 
(this would be worth investigating in its own right). Thus Nrk might have a cellular role 
specific to stumpy forms or to the slender to stumpy transformation and this would 
warrant further study. However, as homology gives no indication about what proteins
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are likely to interact with Nrk, the identification of these is likely to be difficult unless a 
technique such as the yeast two-hybrid screen can be applied successfully. The other T. 
brucei protein kinase identified by gene cloning is TbZFK but no information has been 
published regarding its function. Although it is a member of the PKC family, this is a 
large protein kinase family and the homology of TbZFK to PKCi, although perhaps 
suggesting that TbZFK may have particular biochemical properties, gives no real 
indication of likely cellular function. The remaining T. brucei protein kinases identified by 
gene cloning are those corresponding to the amplified cDNA fragments TbPK-A3-A5 
and TbPK-Bl-2 (Hua and Wang, 1994; Section 1.3.2.4). The predicted peptide 
sequences from these fragments, although clearly related to protein kinase catalytic 
domain sequences, are too short to give a reliable indication of the relatedness of each 
putative protein kinase to protein kinases from other eukaryotes. For instance, one of the 
two families of protein kinases to which the predicted peptide sequence of TbPK-A3 is 
most related, the Snfl family, includes S. cerevisiae SNF1, the mammalian AMP- 
activated protein kinase (AMPK) and the plant 3-hydroxy-3-methylglutaryl-CoA 
reductase kinase (HMG-CoA reductase kinase) which share acetyl-CoA carboxylase as 
substrate. The mammalian and plant enzymes also share HMG-CoA reductase as a 
substrate (see references in Stapleton et al., 1996). A T. brucei HMG-CoA reductase 
activity has recently been characterised (Coppens et al., 1995; Coppens and Courtoy, 
1995) and therefore the study of the protein kinase corresponding to TbPK-A3 might 
complement this research. However, without a full sequence it is not clear that the 
protein kinase corresponding to TbPK-A3 is most closely related to the AMPK/HMG- 
CoA reductase kinase enzymes. The isolation and sequencing of full length genes or 
cDNAs corresponding to these fragments of sequence has not been undertaken but 
would certainly be justified in terms of the overall study of protein kinases in T. brucei.
It seems unlikely that the purification approach to gene cloning taken with the 60 
kDa autophosphorylating protein kinase (Chapter 4) will be used in future studies into 
protein kinases in T. brucei. However, the 60 kDa protein kinase is undoubtedly suitable 
for the purification approach based on its biochemical properties: the activity is stable to 
both freezing and high salt concentrations as well as being readily assayed even in quite 
impure preparations. The property of autophosphorylation can be exploited to 
specifically label the protein kinase with 32P to allow its identification even after
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denaturing purification steps. Possible fixture approaches to completing the purification 
of the 60 kDa protein kinase are discussed in Chapter 4 but an alternative or complement 
to any such work would be the fiuther biochemical characterisation of the protein kinase 
activity. If, on the basis of such characterisation, the 60 kDa protein kinase could be 
placed into a particular protein kinase family then PCR with degenerate primers based on 
peptide sequences conserved in this protein kinase family could be used to try to isolate 
the gene encoding this protein kinase. This analysis would also allow an assessment of 
whether any protein kinase genes identified in other studies (including genome and EST 
sequencing projects) were likely to encode the 60 kDa protein kinase. A number of 
protein kinase inhibitors specific for members of particular protein kinase families were 
tested against the autophosphorylating activity of the 60 kDa protein kinase but the data 
obtained did not allow identification of the 60 kDa protein kinase as a member of any 
particular protein kinase family (data not shown). As the 60 kDa protein kinase activity 
was not characterised in detail, further analysis of other inhibitors, its substrate specificity 
and its activity with a wide range of divalent cations might allow its identification as a 
member of a particular protein kinase family.
In summary, the outlook for research into protein phosphorylation in T. brucei 
has changed a great deal since this project was initiated and the availability of the 
sequences of a number of genes encoding protein kinase catalytic subunits and newly- 
developed techniques for transfection of T. brucei should be of great value in analysis of 
the fiinction of these proteins. The detailed characterisation of T. brucei protein 
phosphorylation cascades involved in signal transduction and control of the cell cycle 
would undoubtedly be of interest with respect to the biology of this parasite. However, 
as discussed at the beginning of this chapter, protein phosphorylation research in a 
number of biological model systems is progressing rapidly and information about protein 
kinases from these systems would be very usefiil both with respect to deciding whether a 
particular T. brucei protein kinase should be studied fixrther and in actually conducting 
research into T. brucei kinases. The sequence of the T. brucei genome or a very 
complete set of EST sequences may be available in the relatively near future and this 
would also greatly simplify research into T. brucei protein kinases. Therefore, protein 
kinase research in T. brucei should probably be limited at present to protein kinases for 
which fiirther study seems likely to complement existing work. In addition, the study of
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T. brucei protein kinases may have relevance to the development of therapies for African 
trypanosomiasis. The ability of T. brucei to differentiate is fundamental to its complex 
life cycle and the identification of T. brucei signalling pathways through research into 
proteins such as the protein kinases may lead to the identification of key targets for 
chemotherapeutic intervention.
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